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ABBREVIATIONS 
In addition to the accepted abbreviations 
(Instructions to authors, BiochemJ.(1985) 225, 1-26), the following have been
adopted:
BCOADC branched chain 2-oxoacid dehydrogenase complex
DAHP 3-deoxy-D-arabino-heptulosonate 7-phosphate
DTNB [5,5*-dithiobis(2-nitrobenzoic acid)]
DTT dithiothreitol
EDTA ethylenediamine tetra acetic acid
FPLC fast protein liquid chromatography
GdnHCl guanidinium hydrochloride
Iodogen 1,3,4,6-tetrachloro-3a,6a-diphenyl glycouril
Leupeptin acetyl-L-leucyl-L-leucyl-L-arginal
Mr molecular mass (relative)
MOPS (3-[N-morpholino]propane-sulphonic acid)
NEM N-ethylmaleimide
OGDC 2-oxoglutarate dehydrogenase complex
PDC pyruvate dehydrogenase complex
PEG polyethylene glycol
PMSF phenylmethylsulphonylfluoride
PVDF polyvinylidene difluoride
RBS rat blood serum
SDS sodium dodecylsulphate
TCA trichloroacetic acid
TEMED N.N^Nketramethylethylenedi amine
TPP thiamine pyrophosphate
Tween 20 polyoxyethenesorbitan monolaureate
TX-100 Triton X-100
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SUMMARY
It has been shown that N-terminal sequence homology exists between protein 
X  from S. cerevisiae and the bovine heart OGDC E l enzyme. The N-terminus of 
OGDC E l exhibited lipoyl-like domain characteristics; however, it was found to 
be non-functional as judged by its inability to be reductively acetylated in the 
presence of radiolabelled substrate. By degrading the bovine heart OGDC E l 
enzyme specifically using trypsin, a stable lower M r species, termed E l1 was 
formed rapidly as a result of N -terminal cleavage of E l, generating a highly- 
immunogenic peptide with an approx. M r value of 8,000. Tryptic degradation of 
OGDC also resulted in the removal of the lipoyl domain from E2 at longer time 
intervals, the E3 enzyme remaining intact under these conditions. On gel 
permeation chromatography of trypsin-treated complex where E l1 had been 
formed, the E3 enzyme was found to exhibit a reduced affinity for the complex; in 
addition E l1 also showed a marked tendency to dissociate from the E2 core 
assembly. Similarly, protease arg C treatment of OGDC causing extensive but 
specific cleavage of E l only, also resulted in release of E3 from the core.
On treatment with trypsin, the overall activity of OGDC was found to 
decrease. This decline in activity was not caused by inactivation of E l as the 
modified E l enzyme retained approx. 100% activity. Loss of OGDC function is 
instead attributed to the reduced affinity of the E3 (and E l) enzymes for the core 
structure. There are indications that EF/El heterodimers of E l may be able to 
sustain overall complex activity.
From the above experiments coupled to sequence alignment analysis of 
protein X  from S. cerevisiae, it is proposed that a truncated, non-functional 
'lipoyl-like' domain is situated at the N-terminus of the E l enzyme of OGDC. 
Evidence is presented that this region is followed closely by an E3 binding 
domain, cleavage of which, results in E3 and E l dissociation from the complex.
( Xi i )
The exact mode of association which exists between E l and E3 within OGDC has 
not, as yet, been clearly defined.
Dissociation of intact OGDC in conditions of high ionic strength has no 
significant effect on complex activity; however, after tryptic degradation of 
OGDC to varying extents to form differing amounts of the El* species, the 
residual complex activity exhibits an increased salt sensitivity profile. It was also 
shown that treatment of the complex with 0.25M MgCl2  representing high ionic 
strength, was sufficient to render the E3 enzyme susceptible to inhibition by N- 
ethylmaleimide but only in an NADH dependent manner. Similar partial 
protection of the redox-active disulphide cysteine pair on E3 in the intact complex 
was observed in the presence of the specific active-site inhibitor p- 
aminophenyldichloroarsine. These findings are consistent with the view that the 
active-site of E3 is shielded from the external environment in the intact complex.
In bovine heart PDC, it has been proposed that protein X  performs a role in 
protecting the active site of E3. Since it is postulated that protein X  in this 
complex and the N-terminal region of bovine heart OGDC E l are both involved in 
binding E3, the possible role of the N-terminal region of OGDC E l in the active 
site protection of E3 was investigated. The E3 enzyme of OGDC was found to be 
susceptible to inhibition by N-ethylmaleimide in an NADH dependent manner 
when the complex was treated with high salt concentrations; in contrast, protease 
treatment of the complex with trypsin had little effect on E3 activity in the 
presence of NADH and N-ethylmaleimide. Protease arg C treatment, however, 
allowed N-ethylmaleimide in the presence of NADH to effect an overall reduction 
in complex activity of approx. 50%. These results indicate that the large E l1 
species may still protect released E3 from modification by N-ethylmaleimide. 
However, no evidence was obtained for the presence of a stable E l1/  E3 
subcomplex.
The importance of the N-terminal region of E l of OGDC in mediating the re-folding 
of the complex after denaturation of the enzyme with GdnHCl or in regulating its
( x i i i )
sensitivity to Ca2+ was investigated. It was established that this region was not critical to 
the stability of the enzyme or its capacity to renature. The Ca2+ dependence of its activity 
also appeared to be unaltered. Such data are consistent with the view that the primary 
role of this region of the E l enzyme is a structural one in promoting E3 and E l 
interactions with the core of the complex.
CHAPTER ONE 
INTRODUCTION
1.1 MULTIENZYME COMPLEXES
Compartmentation is one of the fundamental aspects in the organisation of living 
matter, as illustrated in for example, the existence of differentiated cells within a 
multicellular organism. Within eukaryotic cells, the intracellular space is further 
divided by the presence of organelles each possessing their own unique 
microenvironment. It is clear that the cell cannot be visualised as a simple ‘bag’ filled 
with enzymes and metabolites which are freely dissolved in solution. It has been 
calculated that the protein concentration in the matrix of the actively metabolising 
mitochondrion is approximately 560 mg/ml (Hackenbrock, 1968) which is thought to 
be similar to the protein concentration in enzyme crystals (Srere, 1982). In view of 
this, it is very unlikely that both enzymes and metabolites are able to move around 
freely in such a viscous environment.
Two levels of organisation are thought to exist for enzymes in the cell: the first is 
purely functional where the enzyme has evolved to have catalytic and kinetic properties 
which are compatible with other enzymes both in the same and other pathways; the 
second is structural-functional organisation involving the macromolecular association 
of enzymes in cases where precise topographical positioning of enzymes is critical, as 
in the membrane integrated mitochondrial respiratory chain complexes (De Pierre and 
Emster, 1977). Evidence now suggests that the structural organisation of enzymes 
within cells is now more common than envisaged previously.
Many pathways or consecutive enzyme sequences in the cell may be present in 
multienzyme clusters comprising two groups, complexes and conjugates. Within 
multienzyme complexes each enzyme is represented by non-covalently associated 
polypeptide chains; this is in contrast to multienzyme conjugates where the different 
enzymic activities reside on a single polypeptide chain. Multienzyme complexes can 
be represented by tryptophan synthase (Miles, 1991) and the 2-oxoacid 
dehydrogenase complexes (Reed, 1974; Perham, 1975). Examples of conjugates are
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the arom multienzyme conjugate from Neurospora crassa (Welch and Gaertner, 1980) 
and fatty acid synthase from eukaryotic sources (Lynen, 1972).
The arom multienzyme conjugate is common to micro-organisms but is absent in 
animals. It represents the primary route for the biosynthesis of polyaromatic 
compounds, including the aromatic amino acids, from non-aromatic sources. In 
N. crassa all five enzyme activities are present on a single polypeptide chain which is 
coded for by a single gene. In vitro, the arom multienzyme conjugate has been shown 
to effect a reduction in the transient time (Welch and Gaertner, 1975) which is defined 
as the speed at which a new steady state is attained in a particular sequence of 
reactions. It has been shown that transient times can be reduced if enzymes are in 
close proximity to each other (Easterby, 1989). In addition, co-ordinate effects 
involving all five of the component enzymatic activities were observed such that, on 
incubation of the conjugate with its first substrate, DAHP, the enzyme cluster 
exhibited a co-ordinated activation of enzyme activity (Welch and Gaertner, 1976).
In a stable multienzyme complex in which the components are permanently 
associated, the appropriate spatial arrangements of active sites relative to each other, 
ensures that the intermediates will bind with a high probability to the next enzyme 
instead of leaving the complex. This is most clearly seen with the tryptophan synthase 
multienzyme complex which catalyses the final two reactions in the biosynthesis of 
L-tryptophan. In E. coli the tryptophan synthase complex is composed of 2 non­
identical dissociable subunits; the CX2 P2  tetramer formed from a monomers and P2  
dimers, has a higher affinity for substrate as a result of mutual activation of the 
individual subunits. Indole produced in the active site of the a subunit becomes a 
substrate for the p subunit where it is converted to L-trytophan. In Salmonella 
typhimurium it has been shown that the active centres of the neighbouring a and p
e
subunits are 25A apart and are connected by a tunnel with a diameter equal to, or 
greater than the dimensions of indole (Hyde et a i ,  1988). The tunnel probably 
provides a pathway for the internal diffusion of indole between the two active sites and 
prevents the escape of indole to the solvent. This ensures that indole does not reach a
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diffusion-controlled equilibrium in the bulk phase of the cell. This can result in 
protection of metabolites and/or the cell from either degradative enzymes or toxic 
substances such as aldehydes which are known to be reactive towards protein side 
chains.
Substrate channelling can also decrease the transit time or the time it takes for a 
metabolite to diffuse towards the next enzyme in the pathway. Owing to the small 
distances within the cell, encounter times between metabolites and enzymes would be 
expected to be faster than the enzymic catalytic rate; however, it appears that the 
calculated difference between diffusion times and enzyme turnover rates is not as large 
as originally thought (Welch, 1977). In the absence of substrate channelling within 
the cell, a situation could arise where the volume occupied by total cellular metabolites 
would be so large that the solvent capacity of the cell would be rate limiting, thereby 
affecting transit times and cellular flux rates (Atkinson, 1969). Multienzyme 
complexes can also act to create a special environment around a pathway, the so called 
‘hot potato hypothesis’ such that the cell acquires the means of maintaining a high flux 
of substrates with a moderate number of intermediates. It does so by protecting 
intermediates which may be insufficiently stable to survive the normal diffusion 
process in an aqueousenvironment(Perham, 1991).
It is now thought that higher levels of enzyme organisation may exist in the cell; 
for example, some evidence has been presented which indicates that glycolytic 
enzymes may form functional particles known as glycosomes (Gorringe and Moses,
1978). The term ‘quinary structure’ is often used when discussing interactions 
between different protein species for example, the enzymes involved in the citric acid 
cycle which are present in the mitochondrial matrix, are thought to exist as a putative 
complex or quinary metabolon associated with the inner surface of the inner 
mitochondrial membrane (Srere et al., 1987). It is possible to prepare slightly 
damaged mitochondria with exposed citric acid cycle enzymes which remain stably 
bound to the membrane even at high ionic strength (Robinson and Srere, 1985).
When mitochondria are fully disrupted using sonication, all of the matrix proteins with
3
Table 1.1 Specific reactions catalysed by the 2-oxoacid dehydrogenase complexes
Complex
OGDC
PDC
BCOADC
R- C COOH 
C02CH2CH2-R
c h 3- r
(C H 3)2CHCH2-R
c h 3c h 2c h 3c h - r
(C H 3)2C H-R
Substrate
2-oxoglutarate
Pyruvate
2-oxoisocaproate
2-oxo-3-methyl-
valerate
2-oxo-iso-valerate
2-oxobutyrate
4-methyl thio 
2-oxobutyrate
Product 
Succinyl CoA
Acetyl CoA
Isovaleryl CoA
2-methyl-butyryl
CoA
Isobutyryl CoA
Propionyl CoA
4-methylthio- 
propionyl CoA
the exception of succinate dehydrogenase are released; it was subsequently shown that 
these solubilised enzymes could be cross-linked preferentially back onto the inner 
membrane of the mitochondrion adjacent to each other. Moreover, the solubilised 
citric acid cycle enzymes were capable of being cross-linked to each other 
demonstrating the specificity of such interactions (Srere et al., 1987). Within the cell 
the enzymes would function more efficiently at low apparent concentrations of 
substrate, since locally high concentrations could be maintained in the active site 
region of the enzyme.
1.2 THE 2-OXOACID DEHYDROGENASE COMPLEXES
The 2-oxoacid dehydrogenase multienzyme complexes are high M r assemblies 
containing multiple copies of three different enzymes which, acting in concert, are 
responsible for catalysing the oxidative decarboxylation of 2-oxoacids in the cell. The 
three members of this multienzyme family have been purified from many diverse 
sources (Section 1.2.1) and include the pyruvate dehydrogenase multienzyme complex 
(PDC) which is specific for pyruvate and 2-oxobutyrate, the 2-oxoglutarate 
dehydrogenase complex (OGDC) whose substrate is 2-oxoglutarate and the branched 
chain 2-oxoacid dehydrogenase complex (BCOADC) which shows specificity for the 
branched chain amino acids in the cell derived from valine, leucine and isoleucine 
(Table 1.1). In addition, BCOADC is also capable of metabolising 2-oxobutyrate, an 
intermediate formed during the breakdown of threonine and methionine (Jones and 
Yeaman, 1986). 2-oxobutyrate can either be formed directly by the transamination of 
threonine or indirectly via a trans-sulphuration pathway during methionine oxidation. 
Another pathway exists for methionine metabolism in the cell whereby its 
transamination results in the formation of the substrate 4-methylthio-2-oxobutyrate 
(Livesey, 1984).
2-oxoglutarate is a branch point metabolite in cellular metabolism generated by 
carbohydrate oxidation and by glutamate dehydrogenase during the deamination of
4
amino acids. It is also produced by the transamination of glutamate as part of the 
malate/aspartate shuttle which functions to transfer reducing equivalents from the 
cytoplasm into the mitochondrial matrix. Succinyl CoA, the product of 2-oxoglutarate 
oxidation, can be withdrawn for energy-requiring biosynthetic pathways such as those 
involved in the production of porphyrins, leucine and methionine. The citric acid 
cycle represents the major catabolic energy generating function in the cell and since 
OGDC is the major regulatory enzyme in the latter stages of the cycle, the flux of 
metabolites through OGDC is coupled to the energy state of the mitochondrion.
The oxidative decarboxylation of pyruvate to acetyl CoA, catalysed by PDC, 
represents the committed step in glucose homeostasis in mammals as it is the first 
physiologically irreversible reaction in the oxidative pathway of glucose metabolism. 
Acetyl CoA formed by PDC can undergo one of two possible fates: (a) it can be 
completely oxidised to form CO2  via the citric acid cycle or (b) it can perform a 
biosynthetic role in eukaryotic lipogenic tissues whereby, acetyl CoA entering the 
citric acid cycle via PDC can be utilised for fatty acid synthesis by condensing with 
oxaloacetate to form citrate, an intermediate in lipid synthesis.
BCOADC catalyses the committed step in the degradation of the branched chain 
amino acids in the cell. Inherited defects affecting the enzyme subunits of BCOADC 
may give rise to the symptoms of Maple Syrup Urine Disease which can be 
distinguished by amino- and ketoacidaemia (Herring et al., 1991).
1.2.1 PURIFICATION OF THE 2-OXOACID DEHYDROGENASE 
COMPLEXES FROM DIVERSE SOURCES
In order to investigate the properties and structure of these enzymes in greater 
detail, the 2-oxoacid dehydrogenase complexes have been isolated and purified to 
homogeneity from many sources, both prokaryotic and eukaryotic. For example, 
OGDC has been isolated from the following prokaryotic sources; Acetobacter xylinum 
(Komfeld et a l., 1977), Acinetobacter Iwoffi (Parker and Weitzman, 1973),
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Dictyostelium discoideum (Heckert et al., 1989), Escherichia coli (Reed and 
Mukherjee, 1969; Pettit et al., 1973) and also from eukaryotic sources which include 
bovine kidney (Reed and Oliver, 1968), bovine heart (Stanley and Perham, 1980), pig 
heart (Massey, 1960; Hirashima etal., 1967; Koike and Koike, 1976; M cCormack 
and Denton, 1979), pigeon breast (Severin and Gomazkova, 1971) and cauliflower 
mitochondria (Poulsen and Wedding, 1970).
In a similar manner PDC has been purified from Bacillus stearothermophilus 
(Henderson and Perham, 1980), Bacillus subtilis (Hodgson et al., 1983), Escherichia 
coli (Koike et al., 1960; Reed and Mukherjee, 1969; Danson et al., 1979), 
Pseudomonas aeruginosa (Jeyasselen et al., 1980) and eukaryotic sources such as 
Saccharomyces cerevisiae (Kresze and Ronft, 1981), bovine heart (Stanley and 
Perham, 1980), bovine kidney (Linn et al., 1972; Cate and Roche, 1979; Kresze and 
Steber, 1979) and pig liver (Roche and Cate, 1977).
Sources from which BCOADC has been purified include Pseudomonas putida 
(Sokatch etal., 1981a), bovine kidney (Pettit etal., 1978) and bovine liver (Danner et 
al., 1979; Heffelfinger et al., 1983), rabbit liver (Paxton and Harris, 1982) and rat 
kidney (Odessey, 1982).
1.2.2 REACTION CATALYSED BY THE 2-OXOACID DEHYDROGENASE COMPLEXES
Each of the multienzyme complexes is composed of multiple copies of three 
enzymes: a substrate specific 2-oxoacid dehydrogenase (E l) which requires TPP and 
Mg2+ for activity, a distinct dihydrolipoamide acyltransferase (E2) which contains a 
covalently attached lipoic acid group and dihydrolipoamide dehydrogenase (E3), a 
flavoprotein which is common to all of the complexes (Koike and Koike, 1976). In 
PDC and OGDC the E l and E2 components are specific to their respective complexes 
whereas, E3 has been shown to be functionally interchangeable between both 
(Mukheijee et al., 1965).
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NADH + H
ROSCoARCCOoH
[ROSLipSH]
CoASH
O 0
11 + 11 + RCC02H + CoASH + NAD -►RC'SCoA + C02 + NADH + H
Fig. 1.1 Reaction scheme for the oxidative decarboxylation of 2-oxoacids by the 
respective multienzyme complexes
The three constituent enzymes of OGDC are 2-oxoglutarate dehydrogenase (E l, 
EC 1.2.4.2), dihydrolipoamide succinyltransferase (E2, EC 2.3.1.61) and 
dihydrolipoamide dehydrogenase (E3, EC 1.8.1.4). For PDC the corresponding 
enzymes are pyruvate dehydrogenase (E l, EC 1.2.4.1), dihydrolipoamide 
acetyltransferase (E2, EC 2.3.1.12) and in common with OGDC, dihydrolipoamide 
dehydrogenase (E3, EC 1.8.1.4). The branched-chain 2-oxoacids in the cell are 
oxidatively decarboxylated by BCOADC which has comparable subunit structure to 
both PDC and OGDC (Randle et al., 1987).
The overall reaction catalysed by the 2-oxoacid dehydrogenase complexes can be 
represented by:
RCO-COOH + CoASH + N A D +-* RCO~SCoA + C 02 + NADH + H+
The complexes catalyse the oxidative decarboxylation of the 2-oxoacids by a 
series of reactions which generate C 02 and the corresponding acyl CoA as shown in 
Fig. 1.1. (Reed, 1974). The substrate-specific E l enzyme catalyses the 
decarboxylation of the 2-oxoacid and is also responsible for the reductive acylation of 
the lipoic acid moiety which is covalently attached to E2 via a specific lysine residue 
(Bleile et al., 1979). The lipoyl moieties present on the E2 enzyme comprise an 
interacting network that functions as an acyl group and electron pair relay system 
through thiol disulphide and acyl transfer reactions amongst all of the lipoyl groups.
In PDC, inter- and intra-chain transfers of acetyl groups and electron pairs can occur 
between S-acetyldihydrolipoyl groups and oxidised lipoyl moieties. ■ A similar 
situation exists for OGDC except that only interchain transfers can occur since the 
individual E2 subunits possesses only a single lipoyl group (Collins and Reed, 1977). 
E3, an FAD-linked enzyme, is responsible for the re-oxidation of the dihydrolipoyl 
moiety with NAD+ as the ultimate electron acceptor.
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Fig. 1.2 Schematic representation of the covalent modification of pyruvate 
dehydrogenase complex and its regulation by various metabolites 
(Reed etal., 1980)
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1.2.3 REGULATION OF 2-OXOACID DEHYDROGENASE COMPLEX ACTIVITY
It is important that the activity of the 2-oxoacid dehydrogenase complexes is 
closely regulated as they play both a central and critical role in cellular metabolism. 
Both OGDC and PDC are inhibited by an accumulation of product metabolites in the 
cell by a system of regulatory feedback inhibition, such that they are inhibited by 
succinyl CoA and acetyl CoA respectively (Smith et al., 1974; Tsai et al., 1973). The 
inhibitory effect that NADH has upon the activity of OGDC isolated from bovine 
kidney, can be reversed by either ADP or Ca2+ ions (Lawlis and Roche, 1981a). 
Adenine nucleotides such as ATP inhibit OGDC activity, with both ADP and inorganic 
phosphate capable of activating the complex by altering the affinity of the E l enzyme 
for 2-oxoglutarate such that the Km value is decreased (Lawlis and Roche, 1981b). 
Effects of the adenine nucleotides are also observed with OGDC purified from other 
sources such as bovine and porcine heart, suggesting that similar regulatory systems 
may be in operation in tissues throughout the body (M cCormack and Denton, 1979).
The mammalian 2-oxoacid dehydrogenase complexes (excluding OGDC), are 
subject to covalent modification whereby phosphorylation of specific serine residues 
present on the E la  subunit of the enzyme complex causes inactivation of overall 
complex activity (Reed and Yeaman, 1987). In PDC isolated from bovine kidney and 
heart and porcine heart, phosphorylation has been shown to occur on three serine 
residues in the E la  subunit, the amino acid sequence surrounding the phosphorylation 
sites possessing a high degree of homology (Yeaman et al., 1978; Sugden et al.,
1979). The kinase responsible is tightly bound to the E2 subunit in PDC and consists 
of an a subunit and a p subunit (Stepp et al., 1983). In contrast, the phosphatase 
responsible for de-phosphorylation and subsequent activation of the complex is much 
more loosely associated with the complex (Linn et al., 1972). Fig. 1.2 shows the 
effectors responsible for the regulation of kinase and phosphatase activity in PDC 
where acetyl CoA, NADH, ADP and pyruvate exert their effects directly upon the 
kinase. In PDC Ca2+ ions are required to bind the phosphatase, but not the kinase nor
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the E l enzyme to the core structure (Pettit et al., 1972). This Ca2+ ion controlled 
association of the phosphatase with the E2 core provides a means for regulation of 
complex activity: Ca2+ ions act to stimulate PDC phosphatase by decreasing the Km 
for the inactive phosphorylated PDC (Denton et al., 1972); this is in contrast to the 
antagonistic effects exerted by Ca2+ ions on the kinase which is slightly inhibited at 
submicromolar concentrations of Ca2+ ions (Cooper et al., 1974). In BCOADC, 
phosphorylation of the E la  subunit of the complex by the BCOADC kinase causes 
inactivation of the complex (Paxton and Harris, 1982), peptide mapping experiments 
indicating thatthreedistinct sites within the E la  subunit are phosphorylated (Cook et 
al., 1983). The relative activity states of PDC and BCOADC are usually very different 
and independendy regulated in any given tissue, owing to different factors regulating 
the respective kinases and phosphatases of these complexes (Harris et al., 1986). The 
branched chain 2-oxoacids are known to inhibit the kinase (Jones and Yeaman, 1986); 
however, other substrates as well as the products of the reaction catalysed by the 
complex, do not seem to regulate the kinase in a manner similar to that observed with 
PDC (Paxton and Harris, 1984). These differences between the complexes probably 
reflect the different metabolic role that each complex performs in controlling their 
respective pathways.
Mitochondria from vertebrate sources possess pathways both for the uptake and 
efflux of Ca2+ ions; accumulation of Ca2+ ions in the matrix occurs via a uniport 
mechanism, the inner mitochondrial membrane possessing an independent efflux 
pathway which functions as a Ca2+/2Na+ antiporter in mitochondria from most tissues 
including heart, brain and brown adipose tissue. In liver, the same pathway functions 
as a Ca2+/2H+ antiporter (Nicholls and Ferguson, 1992). The Ca2+ ion concentration 
present in heart mitochondria is approx. two to three times that of the cytoplasmic 
concentration, and represents the concentration range in which OGDC and PDC 
activity are affected (Denton et al., 1978). The main effect of Ca2+ ions upon OGDC 
activity is to decrease the Km for 2-oxoglutarate (Lawlis and Roche, 1981a; 
M cCormack and Denton, 1979), although micromolar concentrations of Ca2+ ions
9
may also reduce NADH inhibition by direct binding of these ions to the E l subunit 
(Lawlis and Roche, 1981b). OGDC isolated from non-vertebrate sources does not 
exhibit sensitivity to calcium so, as a means of regulation, this could be considered to 
be an evolutionary development (McCormack and Denton, 1981). It was originally 
thought that OGDC from plant sources was not subject to regulation by calcium 
(Poulsen and Wedding, 1970; M cCormack and Denton, 1979)i although it has recently 
been demonstrated that OGDC isolated from cauliflower is capable of being activated 
in a calcium dependent manner raising doubts about earlier hypotheses (Karam and 
Bishop, 1989).
Alternative mechanisms exist for the regulation of OGDC in some bacterial 
species; OGDC production is repressed in anaerobically grown E. coli which form 
succinyl CoA from oxaloacetate rather than by oxidation of 2-oxoglutarate. OGDC 
production can be induced either by 2-oxoglutarate or glutamate but it is not formed 
detectably on either glucose or lactate until substantial metabolite accumulation has 
occurred (Amarasingham and Davies, 1965). In B. subtilis levels of OGDC 
production are also induced by either 2-oxoglutarate or glutamate at the end of 
exponential growth owing to the requirement for a functional citric acid cycle needed 
for sporulation of this species (Ohne, 1975).
1.3 MACROMOLECULAR ORGANISATION OF THE 2-OXOACID DEHYDROGENASE
COMPLEXES
The 2-oxoacid dehydrogenase complexes are large multimeric enzyme assemblies 
with M r values ranging between 2.5-2.7 x 10 6 for OGDC and 7.0-9.0 x 10 6 for PDC 
(Linn et al., 1972). The general architecture of the complex is that of a symmetrical 
core consisting of E2 polypeptides around which are arranged E l and E3 subunits 
which bind non-covalently (Reed, 1974).
SDS/polyacrylamide gel analysis reveals that mammalian OGDC is composed of 
three individual polypeptide chains. The apparent M r values of these chains in pig
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heart are 113,000, 55,000 and 48,000 (Koike et al., 1974) and in E. coli 94,000,
54.000 and 47,000 (Pettit et a l ,  1973). Resolving the complexes into then- 
constituent chains by subjecting them to gel filtration analysis under dissociating 
conditions allows activities to be assigned to the enzyme subunits (Tanaka et al., 
1972). This revealed that for pig heart OGDC, the chains of Mr 113,000, 55,000 and
48.000 corresponded to E l, E3 and E2 activities respectively (Koike et al., 1974) and 
for E. coli OGDC the chains of 94,000, 54,000 and 47,000 represented the E l, E3 
and E2 enzyme activities (Pettit et al., 1973).
Similar treatments can be applied to PDC complexes such that E. coli PDC can be 
shown to have three polypeptide chains of M r 100,000, 80,000 and 56,000 which 
correspond to the E l, E2 and E3 enzyme subunits (Perham and Thomas, 1971; Vogel 
and Henning, 1971). PDC from mammalian sources differs slightly in its structure as 
the E l enzyme is composed of non-identical E la  and Eip subunits. Thus, PDC 
isolated from bovine heart is composed of five subunits with M r 72,000, 55,000,
50,000, 42,000 and 37,000 which correspond to the E2, E3, protein X  (Section 1.4), 
E la  and Elp polypeptide chains (Linn et al., 1972).
Two distinct forms of the E2 core exist which are easily identifiable by electron 
microscopy - the cube and the pentagonal dodecahedron, where a morphological unit 
consisting of three E2 subunits appears to be important in the assembly of both types 
of polyhedral forms (Oliver and Reed, 1982). The cube form is associated with cores 
which consist of twenty four identical E2 subunits arranged with octahedral (432) 
symmetry. E2 cores with this symmetry can be found in PDC isolated from E. coli 
(Reed, 1974; Danson et al., 1979), OGDC from A. vinelandii (Hanemaaijer et al.,
1989), E. coli (Danson et al., 1979) and mammalian sources (Reed, 1974).
BCOADC from mammalian sources also exhibits octahedral symmetry (Griffin et al.,
1988). In contrast to the cube, the pentagonal dodecahedron is composed of sixty E2 
subunits arranged with icosahedral (532) symmetry and E2 cores with this design are 
present in PDC from B. subtilis (Lowe et al., 1983), B. stearothermophilus 
(Henderson and Perham, 1980), S. cerevisiae (Keha et a l ,  1982) and mammalian
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sources (Reed, 1974). The M r values of the E2 polypeptides as calculated by 
SDS/polyacrylamide gel electrophoresis can be misleading as they may exhibit 
anomalous electrophoretic mobility due to the presence of elongated linker sequences 
which are responsible for the conformational flexibility of this polypeptide (Bleile et 
al., 1979). Sedimentation equilibrium analysis in the presence of 6M guanidine 
hydrochloride gave an M r value of 97,000 for E l of pig heart OGDC as opposed to a 
value of 113,000 as determined by SDS/polyacrylamide gel electrophoresis (Tanaka et 
a l., 1972).
Multiple copies of the E l and E3 enzymes bind tightly but non-covalently to the 
E2 core complex. Binding studies reveal that they do not interact with each other, but 
that each associates with E2 in a manner which does not prevent the E2 enzymes from 
associating with each other to form the large multimeric core of the complex (Tanaka et 
al., 1972; Pettit et al., 1973). E. coli OGDC is capable of binding six E l dimers and 
eighteen E3 dimers although maximum activity was obtained when only six E3 dimers 
were bound to the E1/E2 subcomplex. This implies that binding of the E l and E3 
enzyme subunits occurs in an ordered manner to give a native subunit composition of 
12 El:24 E2:12 E3 (Pettit et al., 1973). Titration with the transition state analogue 
inhibitor of E l, thiamine thiazolone pyrophosphate, confirmed the presence of twelve 
E l active sites per complex (Angelides and Hammes, 1979). In a similar manner, 
OGDC from mammalian sources contains six E l dimers and six E3 dimers associated 
with the 24-meric E2 core (Koike and Koike, 1982).
There are two structural types of PDC; type 1 which is found associated with 
Gram-negative bacteria and type 2 which is present in both mammalian mitochondria 
and Gram-positive bacteria. Type 1 is represented by PDC isolated from E. coli 
which has twelve E l dimers and six E3 dimers which position themselves around the 
icosahedral core, the E l enzyme binding along the twelve edges and the E3 dimers 
along the six faces of the cube (Reed et al., 1975). In contrast, type 2 PDC isolated 
from bovine heart can associate with 20-30 E l tetramers (012P2 ) and the six E3 dimers 
which position themselves along the thirty edges and the twelve faces of the
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pentagonal dodecahedron E2 core (Barrera et al., 1972). These structural features 
may be of evolutionary interest as B. stearothermophilus and B. subtilis, both Gram- 
positive bacteria, possess PDC with type 2 structures. This raises the possibility that 
the forerunner of mitochondria may have exhibited Gram-positive rather than Gram- 
negative characteristics (Keha eta l., 1982).
BCOADC is similar to PDC in that the E l enzyme forms an 012P2  heterodimer 
(Reed, 1974). Although it is generally assumed that this complex has six E3 dimers 
associated with the core, it is difficult to be precise about this since the E3 enzyme 
dissociates readily from the complex during its purification (Pettit et al., 1978).
1.3.1 SUBSTRATE SPECIFICITY OF THE 2-OXOACID DEHYDROGENASE (El) ENZYME
The 2-oxoacid dehydrogenase complexes all contain a substrate-specific 
dehydrogenase, designated E l, which catalyses the TPP-dependent decarboxylation of 
substrate in the rate-limiting step of the overall catalytic mechanism (Walsh, 1976; 
Bates et al., 1977; Danson et al., 1978; Cate et al., 1980). In studies performed on 
pig heart OGDC, all of the protein bound TPP was found to be associated with the E l 
component (Koike et al., 1974). The TPP content of the enzyme was estimated at 1 
mole per E l dimer (Mr 216,000) as determined by enzymatic assay of TPP and 
chemical analysis of total thiamine present. Furthermore, E l activity was found not to 
be stimulated by the addition of exogenous TPP suggesting that it remains associated 
with the enzyme during its isolation (Tanaka et al., 1972). Comparison of the primary 
amino acid sequences in all TPP-utilising enzymes suggests the presence of a common 
structural motif which may represent a specific binding site for TPP on the E l enzyme 
(Hawkins et al., 1989). This area of homology begins with the highly conserved 
sequence -GDG- concluding with the highly conserved sequence -N N -. The region 
between these two sequences comprises approx. 30 residues which although less well 
conserved, exhibits several common features: the tenth residue is normally either a 
glutamic acid or aspartic acid residue which is followed later by a conserved alanine
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Fig. 1.3 Mechanistic pathways for the reductive acetylation of lipoyl cofactors by
2-(l-hydroxyethylidene)-TPP at the active sites of pyruvate dehydrogenase
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and proline residue respectively. The region immediately preceding the -NN- 
sequence also contains a cluster of 6-7 amino acids all of which contain hydrophobic 
side chains. The predicted secondary structure of this region shows similarities to a 
region in the active sites of a large number of dinucleotide-binding enzymes. In these 
enzymes the binding of the dinucleotide occurs in a typical J3-tum-a-tum-p secondary 
structure, in which the conserved sequence pattern -G -X-G -X-X-G - forms a tight turn 
allowing a favourable interaction between the N-terminus of the a-helix and the 
pyrophosphate group of the dinucleotide. The -GDG- sequence present on the E l 
enzyme may be involved with allowing a similar p tum-ap structural motif so 
promoting TPP binding.
In addition to catalysing decarboxylation of the substrate, E l is also responsible 
for the reductive acylation of the lipoyl groups present on E2 which results in the 
concomitant opening of the dithiolane ring generating a free thiol. Acylation occurs 
initially at the S8-position of lipoic acid and not at the S6-position although 
isomerisation can occur in aqueous solution (Yang and Frey, 1986). Complete 
acylation of the complexes is possible with a limited number of active E l polypeptide 
chains indicating that the lipoyl domains in addition to interacting with each other, 
must also be able to interact with any given E l active site (Perham et al., 1981; Stepp 
et al., 1981).
Early studies of the 2-oxoacid dehydrogenase complexes gave results that could 
be interpreted in terms of the involvement of acyl intermediates such as acetyl-TPP 
(Das et al., 1961). Acetyl-TPP and succinyl-TPP were indirectly implicated as 
intermediates in reactions catalysed by these complexes (Steginsky and Frey, 1984). 
The product of the E l reaction sequence for PDC, 2-(l-hydroxyethylidene)-TPP, 
remains tightly bound to E l with the least well understood step of the reaction 
mechanism being the interaction of this intermediate and the lipoyl group on E2 to 
form TPP and S-acetyldihydrolipoamide (Frey et al., 1989). Two mechanisms have 
been proposed for this reaction as shown in Fig. 1.3; the first, depicted as pathway A 
in the figure, involves the coupling of the electron and group transfer reactions such
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Fig. 1.4 Schematic representation of the domain structure of the E2 acyltransferases 
and protein X  component
- extended flexible linker region 
u**ts- lipoic acid containing domain, where all OGDC and BCOADC have been found to 
contain one lipoyl domain only, regardless of the source from which they are 
isolated.
E3- E3 and/or E l binding domain
Cat- catalytic domain containing acyltransferase active site
that 2-(l-hydroxyethylidene)-TPP reacts with lipoamide to form the tetrahedral 
transition adduct in a single step (Breslow and McNelis, 1962; White and Ingraham, 
1962). The second mechanism, shown as pathway B in Fig. 1.3, is thought to occur 
when the electron transfer and group transfer steps are distinct such that initiation of 
the reaction occurs by oxidation of 2-(l-hydroxyethylidene)-TPP to form acetyl-TPP 
and the reduction of lipoamide to produce dihydrolipoamide. This step is then 
followed by an acetyl group transfer to form TPP and S^-acetyldihydrolipoamide 
(Daigo and Reed, 1962).
The main distinguishing feature between the two mechanisms is the compulsory 
involvment of acetyl-TPP in the second pathway where electron transfer and group 
transfer are distinct. It has recently been shown that acetyl-TPP is transiently formed 
in the overall reaction catalysed by PDC, although it cannot be determined whether this 
is a compulsory intermediate on the available evidence (Gruys et al., 1989). Thus at 
present, both pathways must be considered as being viable.
1.3.2 THE DIHYDROLIPOAMIDE ACYLTRANSFERASE (E2) ENZYMES
All dihydrolipoamide acyltransferase (E2) enzymes possess a unique multidomain 
structure, comprising an extended flexible outer domain in conjunction with a compact 
inner domain (Guest et al., 1989; Perham and Packman, 1989; Reed and Hackert,
1990). A schematic representation of the domain structure of the E2 polypeptide chain 
is depicted in Fig. 1.4. The N-terminal region of the E2 polypeptide contains the 
extended, flexible lipoyl domains where the lipoic acid residues capable of being 
acylated are located. Each domain is approx. 80 amino acids in length (Dardel et al.,
1991), with the number of lipoyl domains present on a particular E2 polypeptide 
dependent upon the source material; for example, E. coli PDC possesses three 
homologous tandemly arrayed lipoyl domains in contrast to OGDC which only has 
one lipoyl domain, regardless of the source from which it is isolated. A ll of the 
domains present on the E2 polypeptide are linked to each other by conformationally
flexible linker domains, represented by the zig-zag lines in Fig. 1.4, which are an 
important feature with respect to active site coupling within the complex. Downstream 
of the lipoyl domain a small structurally distinct domain responsible for binding the E3 
and/or the E l enzymes to the core is present. Located at the C-terminus of the E2 
polypeptide is the compact inner domain which, in addition to possessing the catalytic 
site of acyltransferase activity also contains the E2 binding sites, so allowing the E2 
polypetides to bind to each other forming the large multimeric core of the complex. 
Each of the above features will be dealt with in turn in the remainder of this particular 
section.
1.3.2.1 LIPOYL DOMAINS
The lipoyl domains present at the N-terminus of the E2 polypeptide represent the 
site of acylation within the complex. As was shown in Fig. 1.4, the number of lipoyl 
domains present on a particular E2 polypeptide can vary between the different 
2-oxoacid dehydrogenase multienzyme complexes. There appears to be no correlation 
between the number of lipoyl domains per E2 chain, the symmetry of the E2 core or 
the source of the E2 core (Allen and Perham, 1991). Estimation of the number of 
lipoic acid containing regions within the E2 polypeptide can be achieved in several 
ways however, these methods can give rise to erroneous results. For example, the 
number of lipoyl domains present on E2 of E. coli PDC was initially determined by 
measuring the content of radioactive lipoic acid in PDC isolated from E. coli cells that 
had been grown in the presence of DL-[35S] lipoic acid (Eley et al., 1972). Differing 
results were often obtained when using this method, as biosynthesis and incorporation 
of endogenous lipoic acid was still occurring at an unknown rate within the cell. If  
PDC is incubated with [2-14C] pyruvate in the absence of CoA, radioactive acetyl 
groups subsequently become incorporated into the lipoyl domains of E2. Employing 
this method, it was initially estimated that E. coli PDC contained two lipoic acid 
residues per E2 chain (Danson et al., 1981). Cloning of the E2 enzymes of the 
complexes from various sources has eliminated many of the ambiguities present in the
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earlier type of experiments. Direct sequencing of the cloned enzyme allows for easy 
identification of the sequences associated with the presence of lipoyl domains. For 
example, it has since been shown that there are in fact three lipoyl domains present on 
the E2 enzyme of E. coli PDC, as it appears that earlier estimations suffered from 
systematic errors in estimating the extent of reductive acylation (Spencer and Guest, 
1985). Crosslinking studies were performed with bovine heart PDC and OGDC 
treated with phenylene-o-bismaleimide in the presence of substrate; in the case of 
OGDC, a single cross-linked dimer was produced indicating the presence of only one 
lipoyl group per E2 subunit of OGDC. In contrast, a more complicated variety of 
cross-linked products indicating trimers with higher M r aggregates were produced for 
PDC. This result was consistent with the acetylated lipoyl groups of different E2 and 
protein X  subunits in PDC being able to interact in all possible combinations 
(Hodgson etal., 1988).
The observed differences in the number of lipoic acid residues per E2 chain, 
raises the question of whether individual lipoyl domains perform different roles in the 
enzyme mechanism. Protein engineering experiments involving the deletion of either 
one or two of the homologous lipoyl domains from the aceF gene of E. coli, resulted 
in the truncated E2 chains being unimpaired in their catalytic activity proving that 
lipoyl domains are able to fold and function independently of each other (Guest et al., 
1985; Graham et al., 1986). E. coli mutants were also constructed which consisted 
of different combinations of both functional and non-functional lipoyl domains; in 
each casewherelhe mutant possessed at least one functional domain the enzyme activity 
was comparable to that of the wild type (Allen et al., 1989). It is not clear why the E2 
polypeptide subunit of E. coli PDC has three lipoyl domains, an apparent surplus of 
lipoyl groups, compared with two for the mammalian complex and one lipoyl domain 
for both mammalian OGDC and yeast PDC (Fig. 1.4). It is unlikely that all of the 
lipoyl domains present within these complexes would be fully acetylated at any time.
A possible explanation for this apparent surplus of lipoyl groups could be that they are
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acting as reservoirs, storing acetyl groups until such times as they are required by the 
cell.
Lipoic acid co-factors are attached in amide linkage to the N6-amino groups of 
specific lysine residues. The sequence surrounding the lipoate attachment site has 
been determined for both bacterial and mammalian sources as shown in Table 1.2 and 
appears to be highly conserved (Stephens et al., 1983; Spencer et al., 1984; Bradford 
et al., 1987(a, b); Hummel et al., 1988). Experiments have been performed with a 
subgene encoding a hybrid lipoyl domain such that, residues 1-33 and residues 238- 
289 corresponding to the first and third lipoyl domains respectively of wild type 
E. coli PDC E2 enzyme, were taken to represent the first 85 residues of a single lipoyl 
domain. Overexpression of this subgene in a wild type E. coli host, resulted in the 
formation of both lipoylated and unlipoylated domain products. (Miles and Guest, 
1987). This hybrid lipoyl domain when expressed in an E. coli lipoic acid 
biosynthetic mutant in the absence of lipoic acid, resulted in the production of 
unmodified lipoyl domains in conjunction with octanoylated domains (Ali et al.,
1990). Similarly, Dardel et al. (1990) expressed a subgene encoding a lipoyl domain 
from B. stearothermophilus in E. coli, resulting in the formation of unlipoylated, 
lipoylated and octanoylated domains. From their results the authors assumed that the 
octanoyl modification of these domains was a direct result of lipoyl-deficiency, unsure 
of whether this modification represented a true intermediate on the lipoyl biosynthetic 
pathway. The results of both groups differed from those of Packman et al. (1991) 
who achieved full lipoylation of native PDC E. coli lipoyl domains in E. coli, with no 
apparent mis-modification. In view of the results obtained by Packman and co- 
workers, it would appear that octanoyl substitution in the lipoyl domains is caused by 
an abberation in the post-translational modification of the recombinant protein, the 
E. coli lipoylation system being unable to cope with the excessive amount of protein 
generated by the expression vectors.
The lipoyl groups present on the E2 polypeptide of the 2-oxoacid dehydrogenase 
complexes are attached to small, folded protein domains. It has been shown that free
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lipoic acid or lipoamide are capable of acting as substrates for both the E2 and E3 
enzymes of the E. coli PDC complex, yet reductive acetylation of these compounds by 
E l could not be detected to any significant extent (Reed et al., 1958; Reed, 1966). 
Lipoamide is a very poor substrate for the E l enzyme of E. coli PDC with Km values 
in excess of 2mM (Graham et al., 1989). Lipoylated decapeptides with amino acid 
sequences identical to that surrounding the critical lipoylated lysine residues in E. coli 
PDC, were also found to have similarly high Km values. In contrast, lipoyl domains 
proteolytically excised from either bovine heart PDC (Bleile et al., 1981) or E. coli 
PDC (Packman et al., 1984), were reductively acetylated by E l in the presence of 
substrate and the necessary cofactors with a Km value of approx. 26|iM (Graham et 
al., 1989). These results indicate that lipoyl domains must be folded in the correct 
conformation in order to be reductively acetylated by E l.
1.3.2.2 LINKER DOMAINS
A distinctive property of the E2 domains of the 2-oxoacid dehydrogenase 
complexes is the large degree of conformational flexibility that they exhibit. This 
phenomenon is especially important for the mechanism of active site coupling. The 
flexibility of the E2 chain is promoted by linker regions which act to connect the lipoyl 
domains to each other and to the subunit-binding/catalytic domains. The linker 
regions show similarities to each other between different species i.e. they are 
characteristically rich in alanine and proline residues although the relative amounts of 
the amino acids present may differ. In several cases hydrophobic and charged amino 
acids have also been shown to be present within the linker region (Perham and 
Packman, 1989).
Evidence for the flexibility of these regions has come from several sources: 
iH-n.m.r. spectroscopy reveals the presence of sharp resonances which show that the 
linker regions have a high degree of flexibility with respect to the bulk of the structure. 
In vitro deletions of the aceEFlpd operon in E. coli PDC to delete two of the three
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lipoyl domains resulted in the disappearance of these sharp resonance patterns 
(Radford et al., 1987). In later experiments, nested deletions were made in the long 
alanine-proline rich linker sequence; this represents the region which separates the 
lipoyl domain from the E3 binding domain in the genetically engineered one lipoyl 
domain PDC complex. The full length linker region was 32 residues in length and 
deletions were performed which reduced this to 20,13,7 and 1 residue(s) 
respectively. In all cases, these deletions were accompanied by a corresponding fall in 
the ^-n.m .r. intensities (Miles et al., 1988). Progressive deletions in the alanine- 
proline linker region resulted in impairing the overall complex reaction without 
affecting the individual enzyme activities. Shortening the interdomain sequence from 
32-20 residues left the system of active site coupling unimpaired; however, reducing 
the length of this region to 13 residues or less resulted in substantial losses in active 
site coupling. These effects were accompanied by corresponding reductions in 
acetylation of the lipoyl domains. The existence of a multiple random coupling 
mechanism was proposed for these complexes, where one lipoyl group services each 
E l subunit and an extensive lipoyl-lipoyl interaction network exists for the exchange 
of electrons and acyl groups (Hackert et al., 1983). Further analysis with synthetic 
peptides of 32 residues in length which were identical to, or related to the long alanine- 
proline rich region, supported the view that the linkers were exposed to solvent and 
had a substantial conformational flexibility within the enzyme complex. Furthermore, 
circular dichroism experiments showed that although disordered in structure, the linker 
regions did not represent random coils but from their predicted conformation appeared 
to cause a slight stiffening of the peptide structure.
Limited proteolytic digestion studies have revealed the existence of the multi­
domain structure of E2; it is possible to remove lipoyl domains preferentially from the 
core structure by cleaving within the proteolytically-sensitive linker domains. The E2 
subunit of E. coli PDC (M r 64,500) produces two fragments when digested with trypsin; 
one corresponding to the outer lipoyl bearing domain region (M r 31,600), the other to 
the inner catalytic/subunit binding domain with (M r 29,600) (Bleile et a l., 1979). In a
2 0
similar manner, E. coli OGDC digested with trypsin results in cleavage of the region 
between the lipoyl domain and the E3 binding site causing release of a single lipoyl 
domain (Packman and Perham, 1987). These cleaved lipoyl fragments, unlike the 
inner E2 core, proved difficult to visualise by electron microscopy owing to their 
physical flexibility (Bleile et a l., 1979).
The E2 polypeptides of the complexes provide a flexible lipoyl arm of 
approximately 1.4nm which allows the dithiolane ring to rotate and interact with both 
the E l and E3 enzymes and other E2 subunits so promoting active site coupling 
(Koike et al., 1963). The interaction between different lipoyl groups can be analysed 
using fluorescence spectra measurements where the formation of excimers arises due 
to the close proximity and interaction of neighbouring lipoic acids (Angelides and 
Hammes, 1979). When this method was applied to both complexes excimer 
formation was detected with PDC but not with OGDC, signifying that in PDC, inter- 
and intrachain transfer of acetyl groups and electron pairs can occur between 
s-acetyldihydrolipoamide groups and oxidised lipoamide groups. The situation for 
OGDC was different to that of PDCwhereonly interchain transfer could occur since 
OGDC possesses only a single lipoyl moiety per E2 chain (Collins and Reed, 1977).
Reporter groups such as maleimide groups carrying a nitroxide spin label, can be 
introduced into lipoic acid groups on the E2 polypeptides of these complexes and their 
movements detected using electron spin resonance (e.s.r.). Reporter groups were 
introduced into the E2 enzyme of E. coli PDC, the e.s.r. spectra showing that the 
nitroxide group had a high degree of mobility on the spin labelled enzyme.
Calculation of rotational correlation values of the order 10'9 sec indicated that the 
reporter group seemed essentially free to rotate within the enzyme complex (Ambrose 
and Perham, 1976). Results of structural and kinetic studies carried out with E. coli 
PDC indicated that the distance between the active sites was 4.5nm with the span of 
the lipoyl-lysine arm being 3nm or less. This implied that the distances between the 
catalytic sites were too large to be linked by the rotation of a single lipoyl-lysine group 
during the catalytic cycle, and that two or more lipoic acid groups were used to
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transfer the intermediates between the catalytic sites of the complex (Shepherd and 
Hammes, 1977). This differs from E. coli OGDC where a normal catalytic cycle 
involves the rotation of a single lipoic acid between the catalytic sites although, both 
E l and E3 can interact with two or more lipoic acid groups during catalysis (Angelides 
and Hammes, 1977). It is possible to remove the lipoyl domains from either OGDC 
or PDC with either trypsin or lipoamidase; trypsin selectively removes the lipoyl 
domains from E2 in contrast to lipoamidase which cleaves the lipoyl moiety itself from 
the domain structure (Stepp et a l., 1981). Release of lipoyl domains by trypsin and 
lipoyl moieties by lipoamidase proceeded at rates faster than the accompanying loss of 
overall activity. When E. coli PDC was treated with trypsin, approx. 50% of the total 
number of lipoyl domains were removed without any significant effect on overall 
activity, the catalytic cycle proceeding via the remaining lipoyl domains. Lipoamidase 
treatment of both E. coli OGDC and PDC, in which only the lipoyl moiety was 
removed from E2, resulted in a decrease of complex activity whereby the modified 
lipoyl domain was proposed to act as a dead-end inhibitor of either the E l, E2 or E3 
active sites. This model may help to explain previous observations made with respect 
to active site coupling within the complexes.
1.3.2.3 THE E3 ENZYME BINDING DOMAIN
On the basis of sequence homology amongst enzymes of the 2-oxoacid 
dehydrogenase complexes, a stretch of 32 amino acids has been identified as 
representing an E3 binding site (Thekkumkara et al., 1989). The sequence implicated 
as representing the E3 binding domain is shown in Table 1.3 with striking 
conservation of the amino acid sequence within this region being observed; this is not 
entirely unexpected since the E3 enzyme is a common component of all of these 
complexes (Hummel et al., 1988; Lau et al., 1988). Several amino acid residues 
within this region are strikingly conserved in all of the E2 sequences that were 
compared, with the exception of the OGDC E2 sequence from rat, and are shown
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boxed in Table 1.3. Within the E3 binding domain, sequence homology as compared 
to the human PDC E2 sequence, is 91 % for rat PDC E2 and 50% for E. coli
PDC E2. Sequence homology for the E2 components of the OGDC and BCOADC 
compared with human PDC E2 is generally lower, in the region 40-50%. Recently, 
the amino acid sequence of the rat OGDC E2 subunit was deduced from the cDNA 
sequence of the cloned gene (Nakano et al., 1991); close analysis of the entire gene 
sequence revealed the absence of a region representing the E3 binding domain. The 
same sequence also showed very little sequence homology to the majority of the E2 
sequences shown in Table 1.3. The absence of an E3 binding domain for this enzyme 
suggests that an alternative site within the complex is involved in binding the E3 
enzyme to the core structure. In view of the absence of an E3 binding domain within 
the E2 subunit, the possibility existes that it may be located at an alternative site in the 
complex perhaps on the E l enzyme (see results).
Different complexes bind the E3 subunit in different ways. For example, electron 
microscopy techniques coupled with disassembly-reconstitution experiments 
performed with E. coli PDC, revealed that the E3 enzyme binds along the faces of the 
octahedral E2 core, whereas the E l enzyme binds along the core edges (Reed et al., 
1975). In this type of complex the E3 enzyme binds to a separate site from E l. 
Therefore, on limited proteolysis, the E3 enzyme dissociates from the complex while 
the E l enzyme remains associated. In B. stearothermophilus, the E3 binding domain 
is capable of also binding the E l enzyme, such that limited proteolysis of the E2 
enzyme causes both the E l and E3 enzymes to dissociate from the complex leaving 
only a naked inner core (Packman et a l,  1988; Perham and Wilkie, 1980). The three 
dimensional structure of an E3 binding domain has been described recently by analysis 
of the solution structure of a synthetic peptide corresponding to the E3 binding domain 
of E. coli OGDC E2 (Robien et a l, 1992). When the sequences shown in Table 1.3, 
representing the E3 binding domains, were compared with data derived from the three- 
dimensional structure, several characteristic features emerged; it was shown that there 
are two helical regions which lie parallel to each other in conjunction with an irregular
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and more disordered loop whose orientation relative to the main body of the domain 
cannot be determined. Proline, a structurally restrictive amino acid, which commonly 
occurs at the N-termini of helices, is absolutely conserved at a position near the start of 
the E3 binding domain, suggesting that this residue probably represents the N-terminal 
boundary of the domain.
1.3.2.4 ACTIVE SITE OF THE DIHYDROLIPOAMIDE ACYLTRANSFERASE ENZYME
Chloramphenicol acetyltransferase (CAT) (EC 2.3.1.38) catalyses the 
O-acetylation and subsequent inactivation of chloramphenicol in antibiotic resistant 
bacteria, it does so by using acetyl CoA as the acyl donor in the inactivation reaction. 
The amino acid residue histidine 195 in the sequence His-Xaa-Xaa-Xaa-Asp-Gly, 
located at the C-terminus of CAT, has been implicated in the catalytic mechanism 
(Kleanthous et al., 1985). The C-terminal domain of the PDC E2 enzyme contains the 
lipoate acetyltransferase activity (Bleile e ta i, 1979; Angier etal., 1987); this region 
shows remote, but significant similarity with CAT, suggesting that the lipoate 
acyltransferases use a general base-catalysed mechanism analogous to that proposed 
for CAT (Guest, 1987). Alignment of the sequences of several lipoate 
acyltransferases revealed the existence of a highly conserved sequence motif Asp-His- 
Xaa-Xaa-Asp-Gly which closely resembled the CAT active site sequence (Russell and 
Guest, 1991).
That structural and functional relationships existed between the lipoate 
acyltransferases and CAT, was confirmed from the results of site-directed 
substitutions of the putative active site histidine and serine residues in both E. coli 
PDC E2 (Russell and Guest, 1990) and bovine BCOADC E2 (Griffin and Chuang,
1990); substitution of the putative active site histidine 602 for cysteine in E . coli PDC 
E2 and histidine 391 for asparagine in bovine BCOADC, resulted in losses of 
acetyltransferase activity in both cases. Further site-directed substitutions involving 
serine residues thought to be important in stabilising the transition-state of the enzyme,
also caused losses of acetyltransferase activity. These results differ from that seen 
with site-directed substitutions performed on the S. cerevisiae lipoate acetyltransferase; 
mutation of the putative active site histidine 427 to either alanine or asparagine, 
effected no loss of enzyme activity (Niu et al., 1990). Further analysis of E. coli PDC 
which involved mutating the active site histidine to either cysteine, alanine or glycine, 
resulting in losses of acetyltransferase activity in all cases, confirmed the importance 
of this residue in the catalytic mechanism (Russell et al., 1992). The result obtained 
for S. cerevisiae is puzzling since a high degree of sequence conservation exists 
between the E2 enzymes. It is unlikely that the role of histidine 427 in 
S. cerevisiae varies greatlyfromlhat of the active site histidine present in E. coli, unless 
some feature of the S. cerevisiae E2 enzyme allows for replacement of this residue 
without affecting the enzyme activity.
1.3.3 DIHYDROLIPOAMIDE DEHYDROGENASE (E3)
The dihydrolipoamide dehydrogenase enzyme (E3) is responsible for re-oxidising 
dihydrolipoamide groups which are bound to lysine residues present on the E2 
enzymes of the 2-oxoacid dehydrogenase complexes. The E3 enzyme, present as a 
homodimer in the enzyme complex, catalyses the oxidation of lipoic acid groups in a 
NAD+ dependent manner (Guest, 1978). Catalysis occurs via two half reactions 
involving the reduction of the oxidised enzyme followed by a re-oxidation step. The 
reaction sequence can be represented as follows:
Lip(SH)2 + NAD+ --------> LipS2 + NADH + H+
[where Lip(SH )2  represents reduced lipoic acid and LipS2 oxidised lipoic acid]
In mammalian complexes, E3 exhibits a low degree of immunogenicity, probably 
related to a high degree of primary sequence conservation which it has retained
2 5
throughout its evolution (De Marcucci et al.y 1985). This evolutionary stability of E3 
may be explained in terms of it being a common component in all of the mammalian 
2-oxoacid dehydrogenase complexes. Isolated E3 also has the property of being 
resistant to a wide range of harsh denaturing conditions including urea, high 
temperatures and various proteolytic enzymes (Williams, 1976).
In addition to its involvement with the 2-oxoacid dehydrogenase complexes, E3 is 
present as the L-protein of the glycine cleavage system (GCS), found in animal and 
plant mitochondria, which catalyses the reversible oxidation of glycine in the cell 
(Olson, 1989). E3 is also a member of the family of pyridine nucleotide-disulphide 
oxidoreductases which includes glutathione reductase, thioredoxin reductase and 
mercuric reductase (Williams, 1976; Curti et al.y 1991). Both structural and functional 
similarities exist amongst several enzymes in this family in particular, between 
dihydrolipoamide dehydrogenase and glutathione reductase, the latter responsible for 
catalysing the NADPH dependent reduction of glutathione disulphide in order to 
maintain a high ratio of reduced to oxidised glutathione in the cell. Although both 
these enzymes function physiologically in opposite directions by passing reducing 
equivalents to NAD+ or from NADPH respectively, both contain a redox-active 
disulphide bridge which undergoes oxidation-reduction during catalysis causing them 
to cycle between oxidised and two electron reduced forms. Site directed substitution 
of the active site cysteines (Cys 44 and 49) for serine residues in the Ipd gene of 
E. coli, led to a complete loss of E3 enzyme activity confirming the role of these 
cysteine residues in the catalytic mechanism (Williams et al., 1989). It has also been 
shown that the thiol group nearer the N-terminus interacts with the dithiol substrate, in 
contrast to the C-terminal thiol which associates with the FAD cofactor (Williams et 
al., 1982). In addition to the sequence conservation observed at the active site, 
considerable homology extends throughout the primary amino acid sequence of these 
molecules; for example, at the FAD and NAD(P) binding sites (Rice et a l., 1984). 
Reports of the three-dimensional crystal structures of the E3 enzyme from
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Table 1.4 M r values of dihydrolipoamide dehydrogenase enzyme isolated from 
eukaryotic and prokaryotic sources
Source Mr£Dal Complexes
Human liver a50,216
349,702
OGDC; PDC; BCOADC; GCS?
Bovine kidney 55,000 OGDC; PDC; BCOADC
Rat liver 56,000
S. cerevisiae 56,000 OGDC; PDC
351,558 OGDC; PDC
E. coli 51,274 OGDC; PDC
Ps. putida 49,000 BCOADC
56,000 OGDC; PDC; GCS
Ps. aeruginosa 50,000 BCOADC
54,000 OGDC; PDC
A. vinelandii 56,000 PDC
B. subtilis — OGDC; PDC-BCOADC
B. stearothermophilus 54,000 PDC
H. halobium *>58,000 - - -
a-Mr value obtained from amino acid sequence deduced from the nucleotide sequence 
b-lacks the 2-oxoacid dehydrogenase complexes
(Adapted from Carothers et al., 1989).
S. cerevisiae (Takenaka et a l 1988) and A. vinelandii (Schierbeek et al., 1989), 
should allow for conserved sequence motifs to be matched to specific structural 
features of these enzymes.
1.3.3.1 SPECIES DIFFERENCES WITH RESPECT TO DIH YDROLIPOAMIDE 
DEHYDROGENASE
Although similar E3 enzymes exist for a wide range of both prokaryotic and 
eukaryotic species large variations are often observed in their M r values (Table 1.4). 
The M r of E3 from human sources is commonly determined from the amino acid 
sequences deduced from the nucleotide sequences of the cloned enzymes; using this 
approach a calculated M r of approximately 50,000 is obtained as opposed to migration 
of these proteins as 55,000 species in SDS/polyacrylamide gel electrophoresis (Pons 
et al., 1988). Full length cDNA clones obtained seem to indicate that E3, from human 
and S. cerevisiae sources, is encoded by a single nuclear gene and synthesised as a 
precursor with a cleavable leader sequence (Kim et a l., 1991; Browning et a l., 1988). 
In addition to the E3 enzyme, many mammalian enzymes including the E l and E2 
subunits from the 2-oxoacid dehydrogenase complexes, are synthesised as larger 
precursors (Hunter and Lindsay, 1986). These presequences, which are important for 
targetting enzyme subunits to their correct subcellular locations, vary in length from 
15-70 amino acids and are located at the N-terminus. Although having no obvious 
sequence similarity with each other, they are usually rich in positively charged amino 
acids which form amphipathic a-helices on import of the protein through the plasma 
membrane (Glover and Lindsay, 1992).
E. coli contains the OGDC and PDC complexes but lacks BCOADC. The E l and 
E2 enzymes of OGDC are encoded by the sucAB operon and the same enzymes in 
PDC are coded for by the aceEF operon. For both complexes, the E3 enzyme is 
produced by the Ipd gene which is adjacent to the aceEF operon such that most of the 
E3 enzyme necessary for PDC activity is produced as a full length transcript from the
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aceEFlpd genes, with an independently transcribed Ipd transcript providing much of 
the E3 enzyme required for OGDC activity (Guest, 1978). The Pseudomonas species 
is unique in that it has been proven to have two genetically distinct E3 proteins 
(Sokatch et al., 1981b; McCully et al., 1986); Ps. aeruginosa produces two proteins 
of M r 50,000 and 54,000, the former species associating specifically with BCOADC 
with the high M r enzyme interacting with both the OGDC and PDC complexes. The 
proteins produced in Ps. aeruginosa are analogous to those produced in Ps. putida.
In several cases dihydrolipoamide dehydrogenase activity has been detected in 
species which are known to lack functional 2-oxoacid dehydrogenase complexes. For 
example, the halophilic archaebacteria which catalyse the oxidative decarboxylation of 
both 2-oxoglutarate and pyruvate using ferredoxin oxidoreductases (Kerscher and 
Oesterhelt, 1982; Kerscher et al., 1982) have been shown to also contain 
dihydrolipoamide dehydrogenase activity (Danson et al., 1984). Halobacterium 
halobium contains an enzyme which can be chemically modified and inactivated with 
the trivalent arsenical compound p-Aminophenyldichloroarsine, which is diagnostic 
for the presence of a catalytically essential disulphide bond as is found in the 
dihydrolipoamide dehydrogenases (Danson et al., 1986). Despite the existence of 
similar active site residues in E3 isolated from H. halobium , E. coli and pig heart, 
amino acid sequence comparisons show that a very low level of homology exists 
between the mammalian and H. halobium E3 proteins, the latter containing higher 
mole fractions of acidic residues and reduced numbers of basic amino acid residues. 
These sequence differences probably reflect adaptations related to the harsh 
environmental conditions in which these halophilic organisms exist (Carothers et al., 
1989). E3 has been isolated from the bloodstream of the African parasite 
Trypanosoma brucei where it appears to be associated with the plasma membrane of 
the organism (Danson et al., 1987). Complete subcellular fractionation of T. brucei 
confirmed that E3 associated exclusively with the membrane and was absent from 
other cellular fractions, although it remains to be established whether the attachment of 
E3 to the plasma membrane signifies a function specific to that location (Jackman et
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al., 1990). Ipd mutants of E. coli have been isolated which show low abundance 
residual E3 activity; it has been postulated that the E3 species present may be involved 
with protein dependent transport of sugars such as galactose and maltose in the cell 
(Richarme, 1989). These discoveries raise the question as to whether 
dihydrolipoamide dehydrogenases perform other distinct functions within the cell in 
addition to their established role in the 2-oxoacid dehydrogenase complexes.
1.4 PROTEIN X
The eukaryotic pyruvate dehydrogenase complex, in addition to its constituent 
enzymes E l, E2 and E3, also contains an additional tightly bound polypeptide of M r
51,000. This extra band, commonly referred to as component or protein X , remained 
undetected for many years since it does not separate readily from the E3 subunit on 
SDS/phosphate gels run under denaturing conditions (Weber and Osborn, 1969). The 
eventual resolution of protein X  from the E3 enzyme in mammalian PDC was achieved 
on SDS/polyacrylamide gels which were electrophoresed in Tris/glycine buffers (De 
Marcucci and Lindsay, 1985; Jilka et al., 1986). Protein X, originally observed in 
PDC isolated from a variety of sources including bovine heart (Stanley and Perham, 
1980), bovine kidney (Bleile et al., 1981) and S. cerevisiae (Kresze and Ronft, 1981; 
Behai et al., 1989), was thought to be the associated kinase activity or a degradation 
product of either the E2 or E3 enzymes (Bleile et al., 1981); however, immunological, 
limited proteolysis and peptide mapping studies provided evidence that protein X  was 
a distinct polypeptide of PDC (De Marcucci et al., 1986). High titre antisera were also 
produced to both the E2 and protein X  polypeptides, with each antiserum found to be 
monospecific in reacting only with its parent antigen. This lack of observed cross­
reactivity between the antisera demonstrated that the two polypeptides were 
immunologically distinct (De Marcucci and Lindsay, 1985). In contrast to these 
findings, Jilka and co-workers (1986) prepared antisera to protein X  which cross- 
reacted with both protein X  and the E2 enzyme. These irregularities in the cross-
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reactivity patterns exhibited between the antisera prepared by the two groups may 
reflect differences in the methods used to produce them, such as the immunisation 
regime used and each animal’s individual immune response.
Immune mapping studies allow for the detection of proteolytic fragments derived 
from a single subunit in the presence of fragments from other subunits. The E2 
enzyme and protein X  polypeptides were isolated and purified from bovine heart PDC 
before digestion with elastase (De Marcucci and Lindsay, 1986). Cleavage of the E2 
enzyme resulted in the production of two major proteolytic fragments, a fragment of 
M r 45,000 which was highly immunogenic and a smaller M r 29,000 fragment. At 
longer time intervals the M r 45,000 peptide is degraded further while an increase in the 
M r 29,000 band is observed. These fragments had been previously observed by 
Coomassie blue staining after elastase digestion of purified E2 enzyme, where the M r
45,000 peptide corresponded to the lipoyl bearing domain and the M r 29,000 peptide 
to the intersubunit binding domain of E2 (Kresze and Ronft, 1980). In contrast to the 
E2 enzyme, protein X  produced two peptides with M r values of 29,000 and 26,000 
which were rapidly cleaved to form smaller peptides of M r 15,000 or below. When 
the E2 enzyme and protein X  polypeptides were labelled with [ l25I]NaI for use in one 
and two dimensional peptide mapping studies, characteristic cleavage patterns were 
produced for each protein (De Marcucci et al., 1986; Jilka et a l , 1986). The 
differences observed in the peptide maps of E2 and protein X  clearly demonstrated that 
protein X was a separate and distinct polypeptide species which did not originate from 
degradation of the larger E2 polypeptide. The cloning of both protein X  and the E2 
enzyme of PDC from S. cerevisiae (Section 1.5) has proved unequivocally that 
although these two species may be structurally similar, they are separate gene products 
which have probably evolved from a common ancestor.
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1.4 .1  S T R U C T U R A L  P R O P E R T IE S  O F  P R O T E IN  X
Protein X  appears to be functionally active within the complex as incubating PDC 
with [2-14C] pyruvate in the absence of CoASH results in the incorporation of 
radiolabel into both the E2 enzyme and protein X. Protein X  retains 12-14% of 
radiolabel which suggests that there may be approximately eight to twelve molecules 
of the protein X  polypeptide per E2 core (De Marcucci and Lindsay, 1985). 
Alternatively, both the E2 enzyme and protein X  can be radiolabelled with 
[2,3-14C]N-ethylmaleimide in a substrate dependent manner by incubating PDC either 
in the presence of pyruvate and absence of CoA or, by addition of NADH so 
generating the free thiol group (Hodgson et al., 1986). The sites of acylation on the 
E2 enzyme have been identified as lipoic acid residues situated within domains present 
at the N-terminus; characterisation of the released radiolabelled product after 
hydrolysis in 6M HC1, confirmed that the acetylatable site on protein X  was also a 
lipoic acid group (Hodgson et al., 1986). Cross-linking studies with PDC were 
performed with phenylene-o-bismaleimide in the presence of acylating substrate to 
determine the number of lipoyl groups present on the protein X species; high M r 
aggregates containing both the E2 enzyme and protein X  were formed as a result of 
these cross-linking studies, with the formation of E2/E2, E2/X and X /X  dimers in 
conjunction with trimers, proving that the lipoic acid groups of different E2 enzymes 
and protein X  subunits were able to interact in all possible combinations. From the 
calculated M r values of the cross-linked species, it was deduced that there were two 
lipoic acid groups per E2 subunit with a single lipoyl group present on protein X  
(Hodgson et a l., 1986). Proteolytic degradation of mammalian PDC with trypsin has 
also verified the presence of two lipoyl domains per E2 subunit; two major tryptic 
products are formed with M r 45,000 and 26,000. The small fragment contains the 
acyltransferase active site in contrast to the larger peptide species which contains the 
lipoyl domains; further degradation of the large fragment to M r 36,000 occurred as a
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result of removal of the N-terminal lipoyl domain, with an estimated M r 15,000 as 
deduced from SDS/polyacrylamide gel electrophoresis (Kresze and Ronft, 1980).
The genes which encode the E2 acetyltransferase and protein X  species from 
S. cerevisiae have been cloned and sequenced (Niu e ta l., 1988; Behai e ta l., 1989). 
The N-terminal part of protein X  (residues 1-195) appears to show some resemblance 
to E2, with particularly strong homology (approx. 50%) existing over the residues 1- 
84, the expected location of the lipoyl domain (Behai et a l, 1989). The sequence 
PALSPTM present on E2 which corresponds to the presence of a lipoyl domain 
further downstream, is also present in protein X although in a slightly modified form 
PAMSPTM, confirming that protein X  possesses a lipoyl domain at its N-terminus. 
The remainder of the two proteins (from residues 195 onwards) are quite different to 
each other, especially at the C-terminus where protein X  lacks the highly conserved 
acyltransferase active site sequence which is normally found in this region. The lack 
of the acyltransferase sequence motif from protein X  might suggest that this subunit 
does not participate in acetyltransferase reactions within the complex; collagenase 
treatment of mammalian PDC results in removal of the lipoyl domains from E2, 
leaving those on protein X intact. After such treatment the complex retains approx. 
10% of its original activity, suggesting that the lipoyl domain of protein X is capable 
of supporting the overall complex reaction (Rahmatullah et a l , 1990).
1.4.2 POSSIBLE FUNCTIONAL ROLE FOR PROTEIN X
Prior to the discovery of protein X , it had been shown that PDC kinase activity 
was capable of being stimulated by either pyruvate or acetyl CoA as a direct 
consequence of acetylation of lipoyl domains present on the E2 enzyme of the complex 
(Cate and Roche, 1978; 1979). The role of protein X  as a modulator of PDC kinase 
activity was proposed, when it was shown that reduction and subsequent acetylation 
of the recently discovered protein X subunit by pyruvate or NADH and acetyl CoA 
resulted in increases in kinase activity associated with the complex (Rahmatullah and
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Roche, 1987). In this way, the acetylation state of the complex was linked to changes 
in kinase activity; however, the sole involvement of protein X  in kinase stimulation 
could not be proved conclusively, since the results did not eliminate the possibility that 
E2 itself may have been responsible for the observed kinase activation.
Protein X  is known to associate very strongly with the E2 core structure of PDC 
as treating the complex under dissociating conditions and then subjecting the complex 
to gel filtration chromatography, causes release of E l and E3 only from the E2/X core 
structure (Linn et al., 1972; Kresze and Steber, 1979). Protease arg C degradation of 
isolated E2/X subcomplex prepared from intact PDC results in cleavage of the lipoyl 
domain from protein X, where the loss of overall PDC activity in subsequent 
reconstitution experiments paralleled the rate of cleavage of protein X (Gopalakrishnan 
et a l., 1989; Rahmatullah et al., 1989). It was concluded from such analyses that the 
lipoyl domain of protein X  was performing a major role in the overall reaction 
catalysed by PDC. In contrast to treatment with protease arg C which cleaves only the 
lipoyl domain from protein X, collagenase treatment of the complex selectively 
removes the lipoyl domains from the E2 subunits while leaving those on protein X  
intact (Rahmatullah et al., 1990). After treatment of the complex with levels of 
collagenase sufficient to remove all of the E2 lipoyl domains, 10% of complex activity 
persisted suggesting that the lipoyl domains present on protein X were capable of 
supporting the overall complex reaction.
Protein X  was also shown to be capable of interacting with the E3 enzyme; in 
microplate assays E3 was found to bind to the E2/X subunit fraction immobilised on 
the plate surface, the same group also showing that cleavage of protein X  by protease 
arg C was reduced in the presence of exogenously added E3 (Gopalakrishnan et al.,
1989). Methods were developed which allowed for protein X to be removed from the 
isolated E2/X subcomplex, resulting in an E2 oligomer free from protein X  (Powers- 
Greenwood et a/., 1989). The purified E2 oligomer was shown to be incapable of 
maintaining the overall reaction sequence in reconstitution experiments with E l and 
E3, and exhibited a reduced affinity for binding the E3 enzyme. Neagle and Lindsay
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(1991), while agreeing that protein X  was involved in binding the E3 enzyme to the 
core, showed that proteolytic degradation of protein X  using protease arg C causing 
removal of the lipoyl domain, had no effect on overall complex activity. The major 
difference between this and the previous group’s experiments, was that intact bovine 
heart PDC was used in the later study as opposed to the isolated E2/X subcomplex. 
The decrease in complex activity observed by other groups during attempted 
reconstitution experiments was attributed to degradation of the E l a enzyme which also 
occurred as a result of protease arg C digestion. It may also be that observed 
differences are a reflection of the instability of the truncated protein 35kD species and 
its ability to maintain overall complex stability.
The existence of a small domain which shows distant but related homology to an 
E3 binding domain has been found on protein X (residues 144-180) of S. cerevisiae 
(Lawson et al., 1991). When bovine heart protein X is cleaved using protease arg C 
to remove the lipoyl domain so producing an M r 35,000 fragment, reduced binding of 
E3 is observed following release of the lipoyl domains. The release of E3 may reflect 
instability of the E3 binding region after lipoyl domain release; the putative E3 binding 
domain has an estimated M r 5,000 and at longer incubation times, the M r 35,000 
species is further cleaved to form an M r 30,000 species probably as a result of removal 
of this putative E3 binding domain (J. Neagle and S. Sanderson, unpublished results). 
Interestingly, collagenase treated E2/X subcomplex retains the ability to bind E3, 
where it is known that only the lipoyl domain and its associated linker domain are 
removed as a result of proteolytic treatment (Rahmatullah et a l,  1990). Lawson et al., 
(1991), suceeded in isolating a mutant of S. cerevisiae in which the chromosomal 
copy of protein X had been disrupted. Although this deletion did not affect growth of 
the yeast under the conditions tested, extracts of mitochondria from this mutant were 
unable to catalyse the CoA/NAD+ linked oxidation of pyruvate. Purification of PDC 
from the mutant showed that PDC contained the E2, E l a and Elp subunits only, 
lacking both E3 and protein X. In order to determine the particular region of protein X  
involved with binding E3, a series of deletion mutants were produced such that either
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the lipoyl domain (residues 1-80) or the putative E3 subunit binding domain (residues 
144-180) were deleted. The mutant in which the lipoyl domain had been removed 
showed little effect on overall activity; PDC purified from this mutant exhibited 60- 
70% of overall wild type activity, the complex also containing E3. It would appear 
that the lipoyl domain together with its covalently bound lipoyl moiety, is non- 
essential for protein X  function in S. cerevisiae. The mutant in which the putative 
subunit domain had been deleted showed a total loss of overall PDC activity in 
conjunction with a loss of high affinity E3 binding, indicating that this domain 
performs a role in binding E3.
To date, no evidence has been presented for the existence of protein X  in the 
2-oxoacid dehydrogenase complexes except those found in mammalian PDC, although 
the possibility that a similar structure exists in the other complexes cannot be ruled out.
1.5 CLONING OF THE ENZYME SUBUNITS OF THE 2-OXOACID DEHYDROGENASE
COMPLEXES
In recent years efforts have been directed towards the cloning and sequencing of 
the constituent enzyme subunits of the 2-oxoacid dehydrogenase complexes. This is 
desirable to allow for the comparative analysis of the nucleotide and deduced amino 
acid sequences, and to aid the identification of any common motifs or structural 
characteristics which may exist between the complexes isolated from both prokaryotic 
and eukaryotic sources.
The E l enzyme of OGDC in E. coli is encoded by the sucA gene (Darlison et al., 
1984) and the E2 enzyme by sucB (Spencer et al., 1984; Carlsson and Hederstedt,
1987). Both these genes are found arranged in an operon where the Ipd gene coding 
for E3, common to both OGDC and PDC, is found not on the sucAsucB operon but 
as part of the aceEaceF operon encoding the E l and E2 enzymes of PDC (Spencer and 
Guest, 1985). Organisation of the genes encoding the OGDC subunits in B. subtilis 
is similar to that of E. coli; the E l (odhA) and E2 (odhB) genes constitute one operon
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where the E3 gene is found on the operon which encodes the PDC subunits (Carlsson 
and Hederstedt, 1989). In addition to similarity in their gene organisation, OGDC 
from E. coli and B. subtilis are structurally very similar as indicated by 
complementation studies in which the E2 enzymes from both complexes were able to 
interact with each other forming active complexes both in vivo and in vitro (Carlsson 
and Hederstedt, 1987). The genes responsible for encoding OGDC in A. vinelandii, 
in contrast to those of E. coli, belong to one gene cluster; a common promoter in the 51 
untranslated region of the gene together with a lack of promoter and terminator 
sequences for E2, suggests that all three genes are transcribed as a single mRNA 
transcript. The Ipd gene possesses its own promoter allowing it to be expressed 
independently in order to synthesise the E3 necessary for PDC assembly.
Many of the subunits of these complexes have now been cloned from mammalian 
sources; the sequence of the E l subunit of OGDC from S. cerevisiae (Repetto and 
Tzagoloff, 1989) and cDNA encoding E l from a human foetal liver library (Koike et 
al., 1992) are now known. The human E la  subunit of PDC has also been cloned 
(Dahl et al., 1987; De Meirlier et a l,  1988; Koike et al., 1988; Ho et al., 1989), where 
a high degree of sequence conservation exists between all of the cloned E la  sequences 
except in the case of Dahl et al. (1987), which shows considerable sequence variation 
when compared to the sequences of Koike et al. (1988) and De Meirlier et al. (1988). 
The E la  subunit of BCOADC has also been cloned from human liver (Zhang et al.,
1988) and bovine liver (Hu et a l,  1988). A common feature of many of these 
sequences is the presence of a leader sequence at the N-terminus, a feature responsible 
for the correct targetting and assembly of these large multimeric complexes.
The E2 enzymes of the three complexes have also been cloned from various 
sources. For example, PDC E2 has been cloned from S. cerevisiae (Niu et al., 1988), 
A. vinelandii (Hanemaaijer et a l ,  1988) and B. stearothermophilus (Borges et al.,
1990). The sequence obtained for human PDC E2 (Thekkumkara et a l ,  1988) was 
identical to that for rat liver E2 (Gershwin et a l, 1987) in the region of the second 
lipoyl domain; however, the deduced amino acid sequence from rat liver did not
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extend far enough into the N-terminal region of the protein to include the first lipoyl 
domain. The nucleotide sequence of the E2 enzyme from OGDC has also been 
deduced for rat heart (Nakano et a l., 1991), E. coli (Spencer et al., 1984; Carlsson 
and Hederstedt, 1987), B. subtilis (Carlsson and Hederstedt, 1989) and A. vinelandii 
(Westphal and de Kok, 1990). BCOADC E2 from mammalian sources (Hummel et 
a l., 1988; Danner et al., 1989) has a similar structural organisation to the PDC and 
OGDC E2 enzymes all of which are synthesised with a leader sequence. The presence 
of these leader sequences is essential for the correct targetting of these nuclear-encoded 
cytoplasmically synthesised proteins to the mitochondria (Glover and Lindsay, 1992). 
These similarities in the structure of the E2 proteins from the different complexes 
suggest that they may be evolutionary related. For example, the primary structure of 
the inner E2 core domain of bovine BCOADC is similar to PDC E2 isolated from both 
human and E. coli sources (Griffin et a l., 1988) and the E2 domain of OGDC (Lau et 
al., 1988).
The gene encoding dihydrolipoamide dehydrogenase (E3) has been cloned from 
several sources including pig (Otulakowski and Robinson, 1987), human (Pons et al.,
1988), S. cerevisiae (Browning et a l., 1988), E. coli (Stephens et a l., 1983),
A. vinelandii (de Kok et a l., 1987), Ps. putida (Bums et a l., 1989) and Ps. 
fluorescens (Benen et al., 1989). Considerable homology has been demonstrated in 
the primary amino acid sequences of these proteins for example, human E3 shows 
96% homology with pig heart E3 and 44% homology with E. coli E3. This high 
degree of sequence conservation is unsurprising since E3 is a common component in 
all of the 2 -oxoacid dehydrogenase complexes, and as such has not shown large 
sequence variations throughout its evolution.
1.6 AIMS OF PROJECT
The members of the 2-oxoacid dehydrogenase complex family of enzymes are 
composed of three distinct enzymes E l, E2 and E3. Inaddition^PDC isolated from 
mammalian sources has been found to contain an extra polypeptide termed protein X,
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implicated in assisting with binding E3 to the core. The absence of this particular 
subunit in OGDC and BCOADC is puzzling since both these complexes contain an 
identical E3 gene product species to that found in PDC.
The aim of this project therefore, was to investigate the possible existence of a 
protein X-like component in bovine heart OGDC and determine its location within the 
complex. Studies would then be made relating to its structural role within the 
complex, particularly its involvement in binding the E3 subunit. In addition, the role 
of any such component in the catalytic functioning of the complex would also be 
examined.
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CHAPTER TWO 
MATERIALS AND METHODS
2.1 MATERIALS
2.1.1 CHEMICALS
Substrates and coenzymes for enzymatic assays, PMSF, benzamidine-HCl, 
MOPS, Tween-20, antifoam A concentrate, Coomassie brilliant blue type R250 and 
N-ethylmaleimide were obtained from Sigma Chemical Co., Poole, Dorset U.K. 
Pyronin Y  dye was purchased from George T. Gurr Ltd., London. Polyethylene 
glycol 6000 grade and Triton X-100 were obtained from Fisons, Loughborough, 
England. Folin and Ciocalteu phenol reagent was from FSA laboratory supplies, 
Loughborough, England. Iodogen was purchased from Pierce Laboratories, 
Rockford, Illinois, U.S.A. DTT was from Boehringer Mannheim GmbH, Germany. 
Sodium salicylate was obtained from Aldrich Chemical Company, Ltd., Gillingham, 
U.K. Ultra pure acrylamide used for protein sequencing was from Fluka, Derbyshire, 
England. All other chemicals including reagents for polyacrylamide gel 
electrophoresis were of analaRgrade from BDH Chemicals Ltd., Poole, U.K. or were 
of the highest grade available commercially.
2.1.2 RADIOCHEMICALS
[l25i]NaI, N-ethyl[2,3-1 4C]maleimide and 2-oxo[5-14C]glutaric acid were 
purchased from Amersham, Bucks., England. [2-1 4C]pyruvic acid (sodium salt) was 
from Du Pont de Nemours GmbH, Germany.
2.1.3 ENZYMES AND PROTEINS
The following commercial preparations were obtained from Sigma Chemical Co., 
Poole, Dorset: protein A {Staphylococcus aureus, Cowan 1 strain), TPCK-treated 
trypsin, lipoamide dehydrogenase from pig heart and low molecular weight markers
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for M r determinations by tricine-SDS/polyacrylamide gel electrophoresis. Protease arg 
C was obtained from Boehringer Mannheim GmbH, Germany. Low molecular 
weight marker proteins for M r determinations by SDS/polyacrylamide gel 
electrophoresis were bought from Pharmacia Ltd., Milton Keynes. Leupeptin was 
purchased from the Protein Research Foundation, Osaka, Japan.
2.1.4 ANIMALS
Bovine hearts were obtained from Paisley Abbatoir, Sandyford Road, Paisley and 
stored at 4°C until they reached the laboratory. On arrival the hearts were cut into 
small cubes, care taken to excise fatty deposits, and stored at -80°C until required. 
New Zealand White Rabbits for antisera production were purchased at 3 months old 
from MRC accredited sources.
2.1.5 MISCELLANEOUS
Hybond-C extra nitrocellulose was purchased from Amersham International, 
Bucks., U.K. Immobilon PVDF membrane for protein sequencing was bought from 
BioRad, Richmond, CA, U.S.A. 0.22pm nitrocellulose filters were from Millipore 
S.A., Molsheim, France. Rat serum, Freund’s complete and incomplete adjuvant 
were obtained from Sigma Chemical Co., Poole, Dorset, U.K. Plast-X 
autoradiography cassettes were from Anthony Monk (England) Ltd., Sutton in 
Ashfield, U.K. FPLC columns and gel chromatography materials were from 
Pharmacia Ltd., Milton Keynes, England.
2.1.6 PHOTOGRAPHIC MATERIALS
X-Omat S film, Kodak FX-40 liquid fixer and Kodak LX-24 X-ray developer 
were purchased from Kodak Ltd., Dallimore Road, Manchester, U.K. Hyperfilm™
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was from Amersham, Bucks., England.
2.2 M ETH O D S
2.2.1 CONCENTRATION OF PROTEIN SAMPLES
Protein samples were concentrated in one of several ways: freeze-drying involved 
freezing the sample in a dry ice/methanol bath prior to drying down under vacuum. 
Alternatively, samples for gel electrophoresis were concentrated by the addition of 4 
volumes of acetone and then stored at -20° C overnight. Next day the sample was 
centrifuged at 1 l,600g, the acetone removed and the pellet resuspended in Laemmli 
sample buffer.
TCA precipitation was employed when it was necessary to remove salt or other 
reagents which might interfere with electrophoresis. TCA from a 100%(w/v) stock 
was added to a final concentration of 10%(w/v) and the sample kept at 4°C for 1-2 h. 
The pellets obtained after a short centrifugation at 1 l,600g for approx. 2 min were 
washed with ether to remove any remaining traces of TCA, air dried and resuspended 
in sample buffer.
2.2.2 MEASUREMENT OF PROTEIN CONCENTRATION
Protein concentration was determined by the method of Lowry et al. (1951) as 
modified according to Markwell et al. (1976).
Stock solutions were prepared as follows:
Solution A - 25%(w/v) sodium carbonate/0.4%(w/v) sodium hydroxide/0.16%(w/v) 
potassium sodium tartrate/1 %(w/v) SDS.
Solution B - 4%(w/v) copper sulphate
Solution C- 1ml of solution A added to distilled water to a final volume of 100ml. 
Solution D - Folin and Ciocalteu phenol reagent diluted 50:50 with distilled water.
A 1 mg/ml stock of bovine serum albumin was used as the standard protein and a 
standard curve was constructed with protein amounts between 0-150pg. The final 
volume of the assay was made up to 1ml with distilled water before addition of 3ml of 
solution C. The tubes were then vortexed and allowed to stand at room temperature 
for 15 min. Colour development was effected by addition of 0.3ml of solution D and 
absorbance was measured at 660nm after 30 min.
2.2.3 CONDITIONS FOR RESOLUTION OF PROTEINS BY SDS/POLYACRYLAMIDE GEL 
ELECTROPHORESIS
(a) CONDITIONS FOR POURING OF SLAB GELS
Protein samples were analysed using a discontinuous Tris-glycine system 
according to the method of Laemmli (1970). Gels were cast in slabs with the 
dimensions 16cm x 19.5cm x 0.15cm; however, in the case of gels which were to be 
processed for fluorography [Section 2.2.3 (e)] gels of thickness 0.8cm were poured. 
Gels were subjected to electrophoresis at a constant current of 40-60mA in 192mM 
glycine/0.1%(w/v) SDS/25mM Tris base, pH 8.3 using Bethesda Research 
Laboratory vertical gel electrophoresis apparatus. Electrophoresis was continued until 
the Pyronin Y tracker dye was approximately 0.25cm from the bottom of the gel. 
Stock solutions for the pouring of analytical gels were prepared as follows : 
Acrvlamide stock 29.2%(w/v) acrylamide
0.8%(w/v) N,N’-methylenebisacrylamide 
Resolving gel buffer 0.75M Tris-HCl (pH 8 .8 )
0.2%(w/v) SDS 
Stacking gel buffer 0.17M Tris-HCl (pH 6 .8 )
0.14%(w/v) SDS 
Ammonium persulphate: lg dissolved in 10ml of distilled water
Resolving gels of the required percentage of acrylamide were prepared from stock 
solutions according to the following table were all volumes shown are in ml.
4 2
%(w/v) acrylamide
1 0 % 12.5% 15%
Acrylamide stock 50.00 62.00 74.00
Resolving gel buffer 72.00 72.00 72.00
Ammonium persulphate 1.44 1.44 1.44
Distilled water added to a final volume of 144ml.
These solutions were mixed, degassed and polymerisation initiated by the addition 
of 0.1%(v/v) TEMED before pouring into the casting apparatus. The resolving gel 
was overlaid with propan-2-ol to ensure an even surface on the top gel. Propan-2-ol 
was removed after the gel had set and the gel surface thoroughly rinsed with distilled 
water prior to pouring the stacking gel.
The 5% stacking gel was poured as follows :
Acrylamide stock 7.20
Stacking gel buffer 32.80
Ammonium persulphate 0.48
Distilled H 2 O added to 48.00
(All volumes in table are in ml)
Polymerisation was initiated by the addition of 0.1%(v/v) TEMED and after 
setting, gel plates were wrapped in damp tissue and stored at 4°C .
(b) PREPARATION OF PROTEIN SAMPLES FOR SDS/POLYACRYLAMIDE GEL 
ELECTROPHORESIS
Protein solutions were mixed with an equal volume of Laemmli sample buffer 
[2%(w/v) SDS/10%(w/v) sucrose/0.001 %(w/v) Pyronin Y/62.5mM Tris-HCl, pH 
6 .8 ] containing lOmM DTT. Samples were boiled for 2-3 min prior to loading.
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(c )  S T A IN IN G  O F  G E L S  W IT H  C O O M A S S IE  B L U E
After electrophoresis, gels were stained for protein in 0.04%(w/v) Coomassie 
brilliant blue R250/25%(v/v) methanol/10%(v/v) acetic acid for lh at room temperature 
with gende agitation.
(d) DESTAINING OF GELS
Excess stain was removed from gels by washing in 20%(v/v) methanol/ 10%(v/v) 
acetic acid. Destaining of gel took approximately l-2h with the destaining solution 
being changed every 30 min during this period.
(e) FLUOROGRAPHY
Fluorography was performed according to the method of Chamberlain (1979) 
using sodium salicylate as fluor. Gels to be processed for fluorography were fixed 
overnight by incubation in 25%(v/v) propan-2-ol/10%(v/v) acetic acid. After fixing, 
gels were rinsed several times with distilled water over a 30 min period and then 
soaked in 1M sodium salicylate for 30 min. Gels were dried down under vacuum at 
60°C and then exposed to Hyperfilm™ MP before being stored at -80°C .
(f) Mr DETERMINATION
The molecular weight of protein species was determined by comparing their 
mobility to those of a set of molecular weight standards which included phosphorylase 
b, M r 97,000, albumin, M r 67,000, ovalbumin, M r 43,000, carbonic anhydrase, M r 
31,000, soya bean trypsin inhibitor, M r 20,100 and lysozyme, M r 14,000.
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Rf value = distance migrated by protein
distance travelled by dye front
The calculated Rf value obtained for a individual polypeptide subunits is plotted
against its log M r to produce a calibration curve from which the subunit molecular
weight of the unknown species can be determined by interpolation.
2.2.4 TRICINE-SDS/POLYACRYLAMIDE GEL ELECTROPHORESIS OF PROTEINS
(a) CONDITIONS FOR TRICINE-SDS/POLY ACRYLAMIDE GEL ELECTROPHORESIS OF 
PROTEINS
When used as the trailing ion, tricine allows for the resolution of small proteins at 
lower acrylamide concentrations than in the glycine SDS/polyacrylamide gel 
electrophoresis systems (Schagger and Von Jagow, 1987).
The stock solutions prepared for gel electrophoresis are shown in the table below:
Buffer Tris(M) Tricine(M) % SDS (w/v) pH
Anode buffer 0 . 2 — — 8.90
Cathode buffer 0 .1 0 .1 0 . 1 8.25
Gel buffer 3.0 . . . 0.3 8.45
48%(w/v) acrylamide/1.5%(w/v) NjN’-methylenebisacrylamide solution
Gels of dimension 16cm x 19.5cm x 0.15cm were poured which consisted of three 
distinct gel layers i.e. a small pore 16.5%(w/v) acrylamide resolving gel (14.5cm), 
10%(w/v) acrylamide spacer gel (3cm) and 4%(w/v) acrylamide stacker gel (2cm). 
Composition of gels shown in table: (all volumes in table are in ml)
Stacking gel 
4% (w/v)
Spacer gel 
1 0 % (w/v)
Resolving gel 
16.5%(w/v)
Acrylamide/bisacrylamide mix 1 .0 6 .1 1 0 . 0
Gel buffer 3.1 1 0 . 0 1 0 . 0
Glycerol — . . . 4g
d. H 2 O added to 12.5 30.0 30.0
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Polymerisation of resolving and spacer gels were initiated by addition of 150pl of 
10%(w/v) ammonium persulphate and 0.05%(v/v) TEMED. Stacking gel was 
polymerised by adding 1 0 0 j.il of 1 0 %(w/v) ammonium persulphate and 0.08%(v/v) 
TEMED. During polymerisation the gel surface was kept even with an overlay of 
propan-2 -ol; once the gel had set completely, this was removed and top of gel rinsed 
thoroughly with distilled water to ensure that all traces of propan-2 -ol had been 
removed.
Gels were electrophoresed at room temperature, with cathode buffer in the upper 
reservoir and anode buffer in the lower reservoir, at a constant voltage of 30V for lh 
or until the loaded protein had completely left the sample well. Once the sample had 
entered the spacer gel, the gel was electrophoresed at 80mA (constant voltage) which 
decreased to 50mA once the sample had entered the resolving gel.
(b) PREPARATION OF PROTEIN SAMPLES FOR TRICINE-SDS/POLYACRYLAMIDE
GEL ELECTROPHORESIS
Protein solutions were mixed with an equal volume of sample buffer,
[4%(w/v)/l 2%(w/v)glycerol/2%(v/v)mercaptoethanol/0.01 %(w/v)Pyronin Y
/50mMTris-HCl, pH 6 .8 ] and boiled for 2-3 min before being loaded into 
the sample wells.
(c) Mr DETERMINATION USING TRICINE-SDS/POLYACRYLAMIDE GEL 
ELECTROPHORESIS
The molecular weight for proteins run on this gel system was calculated using a 
set of marker peptides of known molecular weights, the majority of which were 
fragments of myoglobin: myoglobin residues 1-153, M r 16,950; myoglobin (I+ II) 
residues 1-131, M r 14,400; myoglobin (I+ III) residues 56-153, Mr 10,600; 
myoglobin I residues 56-131, M r 8,160; myoglobin II  residues 1-55, M r 6,210;
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glucagon, M r 3,460 and myoglobin I I I  residues 132-153, M r 2,510. As described 
previously a calibration curve of Rf values versus log M r was plotted from which the 
molecular weights of unknown peptides could be calculated.
2.2.5 PROTEIN SEQUENCING
(a) ELECTROPHORESIS CONDITIONS
This procedure was used in the microsequencing of proteins according to Speicher 
(1989) for either N-terminal or internal amino acid sequence determination.
Mini gels with a 5%(w/v) acrylamide stacker were cast with dimensions 7.3cm x 
10.2cm x 0.75mm according to the method outlined for SDS/polyacrylamide gel 
electrophoresis in section 2.2.3(a), the only modification being that ultra pure 
acrylamide was used in the pouring of these gels. Prior to use the gel solutions were 
filtered through Millipore (0.22pm) nitrocellulose filters (type GS). Gels were run on 
a BioRad mini-protean II vertical slab gel apparatus according to the Method described 
in section 2.2.3(a) with the following modifications: pre-run electrophoresis - 0.05mM 
reduced glutathione was added to 70ml of electrophoresis buffer in the upper reservoir 
and the gel electrophoresed at 3mA constant current for 2h prior to loading of the 
sample. Sample electrophoresis - pre-run buffer in the upper reservoir was decanted 
and the reservoirs re-filled with 70ml of fresh buffer solution to which 0.1 mM sodium 
thioglycolate was added. Gels were electrophoresed at 10mA constant current until the 
dye front reached the bottom of the gel.
(b) IMMUNOBLOTTING AND SEQUENCING OF RESOLVED PROTEINS
Resolved proteins were electrophoretically transferred onto Inimobilon PVDF 
membrane as described in section 2.2.6(a). Modifications included reducing the 
transfer time to lh at a constant current of 150mA and pre-wetting the membrane for
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15 min in 100% methanol. After transfer the membrane was washed in distilled water 
for 5 min and then stained for 5 min in 0.5%(w/v) Coomassie brilliant blue R.
40%(v/v) methanol was used to destain the membrane ( 2x5  min wash), the 
membrane finally washed in distilled water. The protein band of interest was excised 
from the membrane using a scalpel and sequenced using an Applied Biosystems model 
470A protein sequencer with online PTH amino acid analyses (model 120A), in 
conjunction with a modification of the manufacturer’s Blott 4 programme.
2.2.6 IMMUNOBLOTTING TECHNIQUES
(a) IMMUNE BLOTTING (IMMUNE REPLICA ANALYSIS, WESTERN BLOTTING)
This protocol allows for the immunological detection of proteins following their 
electrophoretic transfer from polyacrylamide gels onto nitrocellulose paper (Towbin et 
al., 1979; Batteigeretal., 1982).
Proteins to be immunoblotted were resolved on 10%(w/v) polyacrylamide gels 
[Section 2.2.3(a)] and transferred electrophoretically onto Hybond-C nitrocellulose 
paper either at 40mA overnight or 400mA for 2.5 hours in a BioRad trans-blot cell in 
192mM glycine/0.02%(w/v)SDS/20%(v/v) methanol/25mM Tris, pH 8.3. After 
transfer the nitrocellulose membrane was stained with Ponceau S solution to allow the 
visualisation of the transferred proteins, and then washed free of this stain with 
distilled water prior to immunoblotting. Excess binding sites were blocked by 
washing the nitrocellulose membrane for lh in 0.15M NaCl/0.5%(v/v) Tween- 
20/20mM Tris, pH 7.2. The wash buffer was discarded and the blot was incubated 
with the desired antibody, normally at 1:100 dilution for 90 min in wash buffer 
supplemented with 5%(v/v) heat inactivated donkey serum. The membrane was then 
rinsed with several changes of wash buffer over a period of 1 h to remove any 
unbound antibody.
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At this stage, 1 25i_iabelled protein A (3 x 10 6 c.p.m.) was added to the 
nitrocellulose membrane with 50 ml of wash buffer for lh, after which the blot was 
washed in a similar manner to that desribed in the previous step. After washing, the 
nitrocellulose immunoblot was allowed to dry in air and mounted in cassettes in close 
contact with X-Omat S film and exposed at -80°C for a period of 1-7 days.
(b) PREPARATION OF ANTISERA
Rabbits were injected initially with 0.25-1.0mg of desired antigen dissolved in 
0.75ml of 0.9%(w/v) NaCl mixed with 0.75ml of complete Freund’s adjuvant. 
Thorough mixing was achieved by passing the solution several times through a narrow 
gauge needle until a thick creamy emulsion was formed. This was injected 
subcutaneously at multiple sites in the neck, back and thighs of a New Zealand White 
Rabbit. A booster dose was then administered four weeks later consisting of 0.1- 
0.5mg antigen/0.75ml of 0.9%(w/v) NaCl/0.75ml Freund’s incomplete adjuvant 
mixed to form an emulsion in a similar manner to that described above. Further 
booster doses were administered 2 weeks prior to bleeding. Rabbits were bled from 
an ear vein and the collected blood was reamed to ensure that fibrous clots formed 
away from the walls of the collecting tube permitting the serum to be easily removed. 
Serum was spun at 700g for 5 min to remove any remaining red blood cells and stored 
in 1 ml aliquots at -80°C.
(c) PREPARATION OF IgG FRACTION FROM WHOLE ANTISERA
This method allows for the purification of immunoglobulin G (IgG) from whole 
antisera. IgG was normally prepared from antisera which gave unsatisfactory results 
in immunoblotting studies caused by its non-specific binding to the nitrocellulose 
membrane.
4 9
2 ml of antiserum was stirred gently at 4°C while 1ml of saturated ammonium 
sulphate was added dropwise. This solution was stirred for a further 30 min. 
Precipitated IgG was recovered by centrifugation at 5000g for 10 min, the resultant 
pellet solubilised in 2ml of 0.9%(w/v) NaCl and the above step repeated twice more. 
After the third precipitation, the pellet was resuspended in 1ml of 0.9%(w/v) NaCl and 
dialysed overnight at 4°C in 170mM NaCl/3.4mM KCl/10mM Na2HPC>4/80mM 
KH 2PC>4 5 pH 7.2. After dialysis the sample volume was decreased by covering the 
sample, still in its dialysis tubing, with polyethylene glycol until the desired volume 
was obtained. The IgG fraction of the antiserum was then stored at -80°C in 0.5ml 
aliquots.
2.2.7 PURIFICATION OF THE 2-OXOGLUTARATE DEHYDROGENASE COMPLEX FROM
BOVINE HEART
The 2-oxoglutarate dehydrogenase complex was purified according to the method 
of Stanley and Perham (1980) involving the following modifications. All steps were 
performed at or near 4°C. Heart tissue (300g) was homogenised for 5 min in 2.7mM 
EDTA/O.lmM DTT/3%(v/v) Triton X -100/1 mM PMSF/lmM benzamidine- 
HCl/silicone antifoam (0.5ml/l)/50mM MOPS, pH 7.0. The homogenate was then 
diluted with an equal volume of the same buffer and spun at 10,000g for 20 min. The 
pH of the resulting supernatant fraction was adjusted to pH 6.45 using 10%(v/v) acetic 
acid after which 0.15 volumes of 35%(w/v) polyethylene glycol was added rapidly. 
The solution was allowed to stir on ice for 30 min before the precipitated material was 
centrifuged at 18,000g for 15 min. The pellets were resuspended by homogenisation 
with a loose-fitting teflon-glass homogeniser in 200 ml of 2.7 mM EDTA/0.1 mM 
DTT/l% (v/v) Triton X-100/0.15pM leupeptin/1 mM PMSF/lmM benzamidine- 
HCl/50mM MOPS, pH 6 .8 . The homogenised material was filtered through muslin in 
order to remove fat particles and adjusted to give final concentrations of 13mM MgCl2  
and 50mM sodium phosphate, pH 6.3, during which the pH of the solution was not
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allowed to fall below 6.8. The pH was then lowered to 6.45 using 10%(v/v) acetic 
acid, 0.12 volumes of 35%(w/v)poly ethyleneglycol was added and the solution 
stirred for 30 min on ice. The precipitated material was spun at 25,000g for 10 min 
and the pellets resuspended as before in 80ml of 2.7mM EDTA/O.lmM D TT/l% (v/v) 
Triton X-100 and stored overnight at 4 °C  in the presence of Im M  PMSF/lmM  
benzamidine-HCl/0.5%(v/v) rat serum. The latter was included in the buffer to 
prevent loss of 2-oxoglutarate dehydrogenase complex activity from occurring 
overnight (Wieland, 1975). If  omitted, losses of up to 50% OGDC activity were 
found to occur during overnight storage.
Next day, the suspension of partially purified enzyme was clarified by 
centrifugation at 35,000g for lh. PDC and OGDC were separated from each other by 
selective precipitation: the addition of 0.04 volumes of 35%(w/v) polyethylene glycol 
was sufficient to precipitate approx. 90% of the OGDC activity while leaving 95% of 
PDC activity in the supernatant fraction. The precipitated material was then pelleted at 
25,000g for 10 min and the resulting OGDC pellet solubilised in 2.7mM EDTA/1%  
(v/v)Triton X-100/50mM MOPS, pH 6.8.
(a) FURTHER PURIFICATION OF THE MULTIENZYME COMPLEX BY GEL FILTRATION
ON SEPHAROSE CL-2B COLUMNS
Partially purified OGDC could be purified further to near homogeneity by using 
gel filtration chromatography. A Sepharose CL-2B column (100cm x 3cm) was pre­
equilibrated at 4°C with 2.7mM EDTA/l%(v/v)Triton X-100/50mM NaCl/50mM 
potassium phosphate buffer, pH 7.0. Approx. lOOmg of OGDC was loaded onto the 
column in a final volume of 4ml and the column was eluted at 4°C using the same 
buffer as before at a flow rate of 24ml/h during which 12ml fractions were collected. 
A 2 8 O of the collected samples was monitored continuously with alternate fractions 
being assayed for both OGDC and PDC activity. The tubes containing peak OGDC 
activity in the absence of contaminating PDC, were pooled and spun at 130,000g for
2.5h to pellet the complex. The OGDC was resuspended in approx. 1ml of 2.7mM 
EDTA/0. Im M  DTT/1 %(v/v) Triton X-100/50mM MOPS, pH 6 .8 . Purified complex 
was stored at either 4°C for short term (1-3 weeks) or for longer periods at 
-20°C in 50% glycerol.
2.2.8 ENZYME ASSAYS
(a) 2-OXOACID DEHYDROGENASE COMPLEXES
The overall activities of the 2-oxoglutarate dehydrogenase and pyruvate 
dehydrogenase complexes were assayed according to the method of Brown and 
Perham (1976). Assays were performed at 30°C in a final volume of 0.67ml of 50 
mM potassium phosphate buffer, pH 7.6, containing 3 mM NAD+/lm M  MgCl2 /0 . 2  
mM TPP/2.6 mM cysteine-HCl/0.13 mM CoA/2 mM sodium 2-oxoglutarate (or 2mM 
sodium pyruvate when assaying for PDC activity). The assay was initiated by 
addition of enzyme and the reaction followed by monitoring the formation of NADH 
spectrophotometrically at 340nm (Danson et al., 1978). One unit of activity (katal) is 
defined as the amount of enzyme required to convert one mole of substrate per second 
at 30°C under the conditions of the assay.
(b) 2-OXOGLUTARATE DEHYDROGENASE (El) ACTIVITY
Assaying of 2-oxoglutarate dehydrogenase (E l) activity was performed according 
to the method of Khailova et al. (1976). Assays were carried out at 30°C by following 
the rate of change of absorbance at 600nm corresponding to the reduction of DCPIP 
(2,6-dichlorophenol-indophenol) in 0.67ml of 50mM potassium phosphate buffer, pH 
7.6, containing 3mM NAD+/lm M  MgCl2/0 .2 mM TPP/2mM 2-oxoglutarate/l4pg 
DCPIP.
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(c ) D IH Y D R O L IP O A M ID E  D E H Y D R O G E N A S E  (E 3 ) A C T IV IT Y
Assays were carried out at 30°C in a final volume of 0.67ml of 50 mM potassium 
phosphate buffer, pH 7.6, containing 3mM NAD+/lm M MgCl2 /0 .2 mM TPP/20pg of 
reduced lipoic acid (Section 2.2.9) according to the method of Jackman et al. (1990). 
The reaction was initiated by addition of enzyme and activity followed by monitoring 
NADH formation at 340nm.
2.2.9 PREPARATION OF REDUCED LIPOIC ACID
Reduced lipoic acid was prepared according to the method described by Kochi and 
Kikuchi (1976) with the following modifications: 240mg of DL-6 ,8 -thiotic acid amide 
(oxidised form) was solubilised in 4.8ml of 1M potassium phosphate buffer, pH 8.0 
which was diluted 50:50 with ethanol. 9.6 ml of 5%(w/v) sodium borohydride was 
then added and incubated for 10 min at 4°C, after which the solution was neutralised 
by the slow addition of 4.8ml of 3M HC1. Reduced dihydrolipoamide was extracted 
with toluene and recovered by evaporation of the toluene under a stream of nitrogen, 
the recovered material being solubilised in ethanol. Estimation of the number of 
reduced sulphydryl groups formed by borohydride reduction was estimated by the use 
of DTNB according to the method of Ellman (1959).
2.2.10 RADIOLABELLING OF PROTEINS
(a) RADIOLABELLING OF PROTEINS USING IODOGEN
This method of radiolabelling proteins (Fracker and Speck, 1978) was used for 
the iodination of protein A for use in immunoblotting studies [Section 2.2.6 (a)]. 
Iodogen, a mild solid phase oxidising agent, was solubilised in 1ml of chloroform and 
the solvent evaporated by drying under an gentle air current so that a thin layer of the
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Iodogen covered the base of the reaction vessel. Protein A (lm g) was dissolved in 
0.5ml of 1.5M NaCl/O.lM Tris-HCl, pH 7.2 and added to the Iodogen.
500|iCi of [1 2 5 I]NaI was added to the Iodogen-protein A mix and incubated for 15 min 
at room temperature with occasional mixing. The reaction mixture was then applied to 
a 10ml Sephadex G25 column which had been equilibrated previously with 50ml of 
0.15M NaCl/O.lM Tris-HCl, pH 7.2. 1ml fractions were collected and the 
radioactivity in each sample counted to determine the fractions containing the iodinated 
protein A; these fractions were pooled and then dispensed into Eppendorf tubes to give 
1.5-2.5pCi aliquots for use in immunoblotting studies.
(b) MODIFICATION OF PROTEINS USING [2,3-14C]N-ETHYLMALEIMIDE
Proteins were labelled in this manner to allow for their use as marker proteins on 
gels which were processed for fluorography [Section 2.2.3(e)]. 100|ig of protein was 
diluted with 100|il of Laemmli sample buffer (omitting DTT) and boiled for 
approximately 2-3 min to denature the protein. lpCi of [2,3-1 4C]N-ethylmaleimide 
was added and protein modification allowed to proced for lh at room temperature.
Four volumes of acetone were then added to the radiolabelled protein which was 
allowed to precipitate overnight at -20°C. Sample was spun at 11,600g for 5 min, the 
acetone removed and the sample allowed to dry. The protein pellet was resuspended 
in lOOpl of sample buffer which included lOmM DTT and stored at -20°C.
2.2.11 ELUTION OF ENZYME SUBUNITS FROM SDS/POLYACRYLAMIDE GELS
This method permits the elution of protein bands from polyacrylamide gels (Tolan 
et al., 1980). Complex (3mg) was electrophoresed on 10%(w/v) polyacrylamide 
preparative gels with only a single large sample well. This allows the enzyme subunits 
to migrate as one single band across the entire length of the gel. Once the protein 
subunits had been resolved, the gels were stained and destained as described
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previously [Sections 2.2.3(c) and (d)]. The protein bands of interest were then 
carefully excised using a scalpel and rinsed with distilled water for 30 min after which 
the gel pieces were passed through 2ml disposable syringes to ensure fragmentation. 
The gel fragments were frozen in a dry ice/methanol bath and dried under vacuum 
overnight in the presence of sodium hydroxide pellets which helped to remove any 
acid still remaining from the destaining solution. The dried gel pieces were swollen in 
approx. 2-3ml of freshly prepared extraction buffer (50mM 
triethanolamine/l%(w/v)SDS/lmM DTT, pH 8.0) which was filtered through 
Millipore 0.22pm nitrocellulose filters (type GS) prior to use. The resulting 
suspension was heated for 5 min at 70°C and the protein extracted from the gel slurry 
by continuous stirring at room temperature for 16h. Gel fragments were removed by 
centrifugation at lOOOg for 5 min after which the supernatant fraction, containing the 
extracted protein was removed. The remaining gel slurry was re-extracted and the 
supernatant obtained was pooled with the supematent fraction collected from the first 
extraction. The pooled fractions were concentrated by freeze-drying, the dried 
samples re-dissolved in 1ml of distilled water. Protein was recovered by acetone 
precipitation (Section 2.2.2) and the pellets re-dissolved by boiling in 500|il 
l%(w/v)SDS and stored at -20°C.
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CHAPTER THREE
SIMILARITIES BETWEEN THE FAM ILY OF E2 
ACETYLTRANSFERASES AND THE 2-OXOGLUTARATE 
DEHYDROGENASE (E l) ENZYME OF BOVINE HEART OGDC
Fig. 3.1 Subunit profiles of the mammalian 2-oxoacid dehydrogenase
complexes as examined by SDS/polyacrylamide gel electrophoresis
Samples of the three purified complexes were subjected to electrophoresis on a 
10%(w/v) SDS/polyacrylamide gel and stained with Coomassie blue. Samples 
applied to each lane were as follows: lane 1, low M r standards (10pg); lane 2, 
purified pig heart E3 (5pg); lane 3, bovine heart OGDC (15pg); lane 4, bovine 
kidney BCOADC (15pg) and lane 5, bovine heart PDC (15pg).
BCDCMr OGDC PDC
68  —
1 2 3 4 5
3.1 INTRODUCTION
Each of the three main members of the family of 2-oxoacid dehydrogenase 
multienzyme complexes are known to be composed of three constituent enzymes E l, 
E2 and E3 which, acting in concert, are responsible for the decarboxylation of 
2-oxoacids in the mitochondrial matrix. The complexes share similar structural 
features with the E2 enzymes binding together to form large oligomeric core structures 
around which the E l and E3 enzymes arrange themselves (Reed, 1974). In addition 
to these three enzymes, PDC from eukaryotic sources such as bovine heart and 
S. cerevisiae has been shown to contain an extra polypeptide, termed component or 
protein X  (De Marcucci and Lindsay 1985; Behai et al., 1989). The absence of a 
comparable protein in both mammalian OGDC and BCOADC is surprising in view of 
similarities between the multienzyme complexes which all possess an identical E3 
enzyme, particularly in view of the postulated role of protein X  in assisting with the 
binding of E3 to the core structure (Neagle and Lindsay, 1991).
Evidence is presented in this chapter which suggests that OGDC may also contain 
protein X-like sequences; however, whereas in PDC these are present as a separate 
polypeptide species, in the OGDC, protein X like sequences are located at the 
N-terminus of the 2-oxoglutarate dehydrogenase (E l) enzyme.
3.2 RESULTS
3.2.1 ELECTROPHORETIC ANALYSIS OF THE 2-OXOACID DEHYDROGENASE 
MULTIENZYME COMPLEXES
The subunit structure of the 2-oxoacid dehydrogenase multienzyme complexes 
OGDC, PDC and BCOADC can be visualised by resolving the complexes using 
SDS/polyacrylamide gel electrophoresis as shown in Fig. 3.1. OGDC is composed of 
3 polypeptide subunits of apparent M r 96,000, 55,000 and 48,000 corresponding to
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the E l, E3 and E2 enzymes respectively. PDC also contains the same 3 enzymes 
although with differing M r values such that E2 has a M r 70,000, E3, 55,000 and the 
E l enzyme which is split forming a tetramer composed of E la , M r 41,000 and Elp, 
M r 36,000. In addition to these enzymes PDC also contains a novel polypeptide 
termed protein X  with M r 51,000. The M r values of the enzymes in BCOADC are 
E2, 52,000, E la , 46,000 and Elp, 37,000 although from its gel profile, it is seen to 
lack the E3 enzyme. E3 is loosely associated with the BCOADC and is often lost on 
purification of the complex. The apparent loss of the E3 enzyme from this complex 
reflects the purification protocol used since methods do exist which allow for 
BCOADC to be purified containing endogenous E3 (Danner et al., 1979; Heffelfmger 
et al., 1983). In cases where the E3 enzyme is absent purified E3, usually from pig 
heart, must be added back to allow for measurement of the overall complex activity.
The M r values of the integral polypeptides of these complexes as calculated from 
SDS/polyacrylamide gel electrophoresis are different to those deduced from the 
corresponding nucleotide sequence of these enzymes. Throughout the course of this 
thesis any references to the M r values of the enzyme subunits of these complexes will 
be quoted as those determined from SDS/polyacrylamide gel electrophoresis unless 
otherwise indicated. Electrophoretic migration of the lipoyl bearing E2 chains in 
particular, is highly anomalous in the presence of SDS giving aberrantly high M r 
values; this effect is attributed to lengthy alanine and proline rich sequences occurring 
within the regions which link the lipoyl domains together in the E2 domain structure 
(Guest et al., 1985; Graham et al., 1986).
3.2.2 N-TERMINAL SEQUENCE ANALYSIS OF THE E2 SUBUNITS OF BOVINE HEART 
OGDC AND PDC
The amino acid sequences of most of the constituent enzymes of the 2-oxoacid 
dehydrogenase complexes are now known either from cloning studies or by direct 
protein sequencing, usually from the N-terminus. The E l enzyme of OGDC has been
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Table 3.1 Comparison of the N-terminal amino acid sequences of the
acyltransferases (E2) of the mammalian 2-oxoacid dehydrogenase 
complexes
N-terminal amino acid sequences were determined as outlined in the Methods 
with regions of sequence identity boxed as shown. An asterisk beside a sequence 
indicates that it was determined at Glasgow as opposed to being deduced from the 
published nucleotide sequence.
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Table 3.2 Comparative analysis of the N-terminal amino acid sequence of 
eukaryotic acetyltransferases (E2) with protein X  and the 
2-oxoglutarate dehydrogenase (E l) enzyme of bovine heart OGDC
N-terminal amino acid sequencing of proteins was performed as described in the 
Methods. Regions of sequence identity are boxed as shown were hyphens 
represent spacing to allow for the alignment of sequences: amino acid residues in 
parenthesis have only been identified tentatively. An asterisk beside a sequence 
indicates that it was determined at Glasgow in contrast to being deduced from the 
nucleotide sequence.
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sequenced from various sources including E. coli (Darlison et al., 1984), B. subtilis 
(Carlsson and Hederstedt, 1989), S. cerevisiae (Repetto and Tzagoloff, 1989) and 
human foetal liver (Koike et a l., 1992). An initial aim of this project was to sequence 
the E l enzyme of OGDC from a mammalian source, since at the outset of this project, 
this had not yet been achieved. It was decided to sequence the E l enzyme from 
bovine heart, such that the N-terminal sequence would be obtained and used in 
conjunction with internal amino acid sequence to produce oligonucleotide primers for 
use with the polymerase chain reaction (PCR). By using PCR in conjunction with 
these oligonucleotides, a probe would be produced for use in screening a XgtlO cDNA 
library to isolate a clone for the E l enzyme of bovine heart OGDC.
Initial alignment of the primary structures of many proteins can be performed 
either by visual inspection or, by the use of specialised computer programmes which 
are capable of scanning for regions of sequence identity between particular protein 
sequences. In addition to sequence identity, conservative amino acid changes can also 
be taken into account which may act to increase the percentage similarity between 
sequences. Table 3.1 shows the N-terminal sequences of the acyl transferase (E2) 
enzymes as isolated from bovine heart and bovine liver. The overall observed 
similarity between the sequences is very low although a few residues do appear at 
common positions in each of the sequences; all of the acyltransferases contain a 
conserved lysine at position 7, whereas OGDC and PDC have additional sequence 
identity with proline at position 9, serine at position 14 and threonine at position 16. 
OGDC also exhibits sequence similarity to BCOADC with glutamic acid at position 17 
and a valine at position 20. In all cases numbering is from the N-terminus towards the 
C-terminus. Although sequence identity is low, a number of conservative 
substitutions have also occurred between the sequences.
In contrast to the acyltransferases, comparison of corresponding sequences of the 
acetyltransferases (PDC E2) isolated from various sources including bovine heart, rat 
liver, human liver and S. cerevisiae, reveals the presence of regions of distinctive 
homology at the N-terminus as shown in Table 3.2. Features of this region include a
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conserved N-terminal serine, a proline at position 3/ 4  (position 4 with respect to the 
yeast sequence), a glycine at position 2 0 /2 1  (position 21 with respect to yeast) and the 
most distinctive feature, the sequence motif PSLS p/gTM . A ll of these sequence 
features are characteristic of the E2 lipoyl bearing domains of the acetyltransferase 
enzymes. Protein X  shows a similar pattern of amino acid residues to those of the 
acetyltransferases in the N-terminal region except that it lacks the conserved histidine 
located at position 5/6- It also possesses the sequence motif PSLSp/gTM  in common 
with the acetyltransferases except for the substitution p / g  in position 5.
Table 3.2 also shows the N-terminal protein sequence obtained for the 
2-oxoglutarate dehydrogenase (E l) enzyme of bovine heart OGDC. Observation of 
this sequence showed that significant similarity existed between OGDC E l, the E2 
acetyltransferases and protein X. Comparison of the E l sequence of bovine heart 
OGDC with those of the acetyltransferases revealed the presence of invariant proline 
and glycine residues at positions 3/ 4  and 20/2 i respectively, although in common with 
protein X  it lacked the N-terminal conserved serine and histidine residues which were 
present in the acetyltransferases. The 2-oxoglutarate dehydrogenase enzyme also 
contained a variation on the characteristic sequence PSLSp/gTM  namely, PFLSGTS. 
Comparing limited N-terminal sequence for the E l enzyme of OGDC with those of the 
E2 acetyltransferases, revealed the existence of sequence identity in the region of 30- 
40%; the highest homology between these sequences was observed with the bovine 
heart and rat liver E2 sequences, each having 37% sequence identity (7 identical 
residues) to the bovine heart E l enzyme. This figure decreased to 32% (6 identical 
residues) when the sequence for E l of OGDC was compared to both the human liver 
and S. cerevisiae E2 acetyltransferase sequences. The sequence which showed the 
greatest similarity to the N-terminus of the E l OGDC sequence was protein X  from 
S. cerevisiae; these sequences had 42% sequence identity (8 identical residues) to each 
other, although this figure increased to 47% depending on whether the valine residue 
at position 23 of the protein X sequence was taken into account. In all cases, the 
percentage identity was calculated by expressing the number of conserved identical
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Fig. 3.2 Existence of cross-reactivity between protein X and the E l
enzyme of the mammalian 2-oxoglutarate dehydrogenase complex.
Proteins were resolved on 10%(w/v) SDS/polyacrylamide gels, transferred onto 
nitrocellulose membranes and challenged with antisera as described in the 
Methods.
Panel A : Lane 1, OGDC (2pg); lane 2, PDC (2pg); lane 3, PDC (lug); lane 4, 
PDC (2pg); lane 5, PDC (lpg). Lanes 1-3 were challenged with the IgG fraction 
of antisera which had been raised to protein X (1:50 dilution). Lanes 4 and 5 were 
challenged with anti-(intact OGDC) serum (1:100 dilution).
Lanes 1,4 and 5 were exposed to film for approx. 10 days at -80°C; this was in 
contrast to lanes 2 and 3 which were exposed to film for 3 days only.
Panel B: Purified protein X was obtained by resolving bovine heart PDC on 
SDS/polyacrylamide preparative gels and eluting the polypeptide as outlined in the 
Methods.
Lane 1, PDC (l|ig); lane 2, protein X  (12pg); lane 3, protein X (8pg). Lane 1 was 
incubated with the IgG fraction of anti-X sera (1:50 dilution), lanes 2 and 3 were 
incubated with anti-(intact OGDC) serum (1:100 dilution).
( A ) (B)
E1
X
residues as a percentage of the total number of the E l amino acid residues shown in 
Table 3.2.
In addition to considering sequence identity, conservative amino acid changes 
between the sequences were taken into account as described by Rice et al. (1984). 
Taking such changes into account did not significantly increase the percentage 
sequence similarity between the E l enzyme of OGDC and the E2 acetyltransferase 
sequences; the only conservative amino acid change between the E l enzyme of OGDC 
and protein X  sequences, occurring where a valine residue in the E l sequence was 
replaced by an isoleucine residue in the protein X sequence at position 4. This 
N-terminal sequence similarity exhibited by the E l enzyme of bovine heart OGDC to 
the E2 acetyltransferases and protein X  was entirely unexpected, and suggested that 
protein X-like sequences may exist on the E l subunit of OGDC.
3.2.3 IMMUNOLOGICAL CROSS REACTIVITY BETWEEN PROTEIN X AND 
THE El ENZYME OF OGDC
Since protein X  of PDC and the E l enzyme of OGDC exhibit considerable 
sequence similarity at their N-termini, it is possible that further regions of homology 
may extend into their sequences. Any significant degree of similarity may be 
displayed as immunological cross-reactivity between the two enzymes.
Fig. 3.2 shows the results of cross-reactivity experiments in which bovine heart 
OGDC and PDC were resolved on SDS/polyacrylamide gels and then immunoblotted 
with antisera raised either to PDC, OGDC or protein X  of PDC. Panel A shows the 
result of challenging OGDC with antisera specific for protein X  of PDC (lane 1); a 
band corresponding to protein X  of PDC was observed in this track as verified by 
comparison with control lanes 2 and 3, in which PDC was loaded and challenged with 
anti-X sera. This result is explained by the fact that purified OGDC is often 
contaminated with residual amounts of PDC, representing 1-5% of total protein in 
most preparations. In addition to cross reacting with the contaminating protein X  of
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PDC, a weak but specific cross reaction between the anti-X serum and the E l enzyme 
of OGDC was observed in lane 1. The identity of this band was confirmed by 
comparison with a control lane in which intact OGDC was challenged with anti-(El 
OGDC) subunit specific serum (not shown). Lanes 4 and 5 in Fig. 3.2 show that on 
challenging PDC with antisera raised to intact OGDC, a weak cross-reacting band 
corresponding to protein X  was identified. That this cross-reaction was not due to 
contamination of PDC with OGDC, was shown by the absence of any corresponding 
reaction with the E l and E2 enzymes of OGDC; the cross-reacting species is also 
unlikely to be E3, as this particular subunit is known to have a low titre when 
challenged with earlier bleeds of anti-(intact OGDC) serum as in this case (De 
Marcucci et a l., 1985).
The possibility remained, however, that protein X  was not the true identity of the 
cross-reacting species seen in lanes 4 and 5 when PDC was challenged with anti- 
(intact OGDC)serum. In order to incubate transferred protein on the same immunoblot 
with different antisera, it is necessary to cut the nitrocellulose into strips; this 
necessitates that the individual strips be re-aligned before exposure to the photographic 
film. Care was taken in the cutting and re-alignment of the nitrocellulose strips; 
however, a small mis-alignment of the nitrocellulose strips could result in mis- 
identification of the protein X  (M r 51,000) and E3 (M r 55,000) protein species. This 
ambiguity was removed by resolving PDC on SDS/polyacrylamide preparative gels 
and selectively eluting the protein X  band as described in the Methods (Section 
2.2.11). In panel B of Fig. 3.2, lane 1 represents the control track in which PDC was 
challenged with antisera raised to protein X, thus demonstrating the monospecific 
nature of the anti-X sera with respect to the other subunits of this complex; lanes 2 and 
3 shows gel purified protein X  immunoblotted with anti-(intact OGDC) serum. A 
corresponding cross-reaction was observed to occur between protein X  and the anti- 
(intact OGDC) serum. Immunological data demonstrate therefore, that a significant, 
albeit weak, cross reactivity can be observed between the E l enzyme of bovine heart 
OGDC and protein X  of mammalian PDC. It would appear that epitopes present on
Fig. 3.3 SDS/polyacrylamide gel analysis of tryptic digested bovine heart OGDC
Bovine heart OGDC was diluted with 0.2mM TPP/ 2mM M gC V  3mM NAD+/ 
50mM potassium phosphate buffer pH 7.6 and treated with 0.01% (w/w) trypsin 
at 30°C. At the times indicated, aliquots (15pg) were removed into Laemmli 
sample buffer and resolved by electrophoresis on a 10%(w/v) SDS/polyacrylamide 
gel.
Lane M  - low M r marker proteins (lOpg).
M r (x10-3)
30—
M O  1 3 5 10 20 30 60
Time of trypsin  treatment (m ins )
Fig. 3.4 Immunological detection of peptides derived from the
dihydrolipoamide succinyltransferase (E2) and the dihydrolipoamide 
dehydrogenase (E3) enzymes after proteolysis of bovine heart OGDC 
with trypsin
Bovine heart OGDC was incubated at 30°C in 0.2mM TPP/ 2mM M gC V  3mM 
NAD+/ 50mM potassium phosphate buffer pH 7.6. 0.01%(w/w) trypsin was 
added and at the indicated time points aliquots (15jig) were removed into Laemmli 
sample buffer and boiled for 2-3 min. Samples (lpg) were resolved on 10%(w/v) 
SDS/polyacrylamide gels and immunoblotted as described in the Methods.
Panel A: products of OGDC tryptic digestion probed with anti-(E2 OGDC) serum 
(1:100 dilution).
Panel B: OGDC treated with trypsin challenged with anti-E3 serum (1:100 
dilution).
(A (B)
E3 ft
E2
0 1 3 5 10 20 30 60 0 1 3 5 10 20 30 60
Time of tryptic digestion (mins )
protein X  are recognised by anti-(intact OGDC) serum however, in later experiments 
protein X  was found not to cross react wth anti-(El OGDC) serum (not shown).
These differences in cross-reactivity as exhibited by anti-(intact OGDC) and anti-(El 
OGDC) sera, may be related to differences in their titre which in some cases can vary 
10-100 fold as determined by enzyme linked immunoabsorption assay (ELISA).
3.2.4 LIMITED TRYPTIC PROTEOLYSIS OF BOVINE HEART OGDC
OGDC from bovine heart has a distinctive and reproducible profile of digestion 
when incubated with trypsin. As illustrated in Fig. 3.3, it is apparent that E l is the 
most proteolytically sensitive enzyme of the complex, being degraded within 3 min to 
form a stable, lower M r species (approx. M r 100,000) which is designated E l1. In 
contrast to E l, the E2 enzyme of OGDC is not degraded to any appreciable extent until 
later in the time course when two peptides with M r values 35,000 and 15,000 are 
formed. The M r 15,000 species is not readily resolved on 10%(w/v) 
SDS/polyacrylamide gels (Fig. 3.3) as it tends to co-migrate with the dye front under 
these conditions. This M r 15,000 peptide corresponds to the N-terminal lipoyl domain 
on E2, cleaved as a result of tryptic digestion. In cases where SDS/polyacrylamide 
gels containing higher percentages of acrylamide were run in an attempt to visualise 
this band, it proved difficult to detect, tending to stain very poorly with Coomassie 
blue. In contrast to the E l and E2 enzymes of the complex, the E3 enzyme was 
extremely resistant to proteolytic degradation, remaining virtually intact under the 
conditions used in these experiments.
The origin of the M r 35,000 band resulting from tryptic digestion was assessed by 
immunoblotting digested OGDC with monospecific antisera raised to the individual 
subunits of the enzyme complex (Fig. 3.4). Panel A shows the immunoblot obtained 
when trypsin treated OGDC was probed with anti-dihydrolipoamide 
succinyltransferase (E2) specific antiserum. The lower M r species in panel A  
corresponds to a M r 35,000 peptide which is formed as a direct result of digestion of
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Table 3.3 Amino acid sequence of the M r 35,000 peptide resulting from 
tryptic digestion of the E2 enyme of bovine heart OGDC
OGDC was diluted in 0.2mM TPP/ 2mM MgCl2/  3mM NAD+/ 50mM potassium 
phosphate buffer pH 7.6, and treated with 0.01%(w/w) trypsin for 60 min. 
Samples (5pg) were resolved on mini-protein sequencing gels and blotted onto 
Immobilon PVDF membrane as described in the Methods. The M r 35,000 species 
of interest was excised from the membrane and sequenced on an Applied 
Biosystems 477A protein sequencer, with on-line 120A phenylthiohydantoin 
derivatives analyser using the manufacturer’s BLOTT 4 programme. Amino acid 
residues in parenthesis have only been identified provisionally and those residue 
positions which are represented by a dash were unable to be conclusively 
determined.
The bovine heart E2 protein sequence obtained was aligned with sequence from 
the linker region of the rat heart E2 enzyme (Nakano et aL, 1991).
OGDC E2
iSt 172
Rat heart P A V  D P A A (S) (S) P A Q P V
Bovine heart P A V  D P A A (S) (S) P —  Q P V
the E2 enzyme; it cross-reacts with the anti-(E2 OGDC) serum and its appearance 
closely corresponds to the disappearance of the E2 enzyme; as before, under these 
conditions the lower M r 15,000 species appeared not to be resolved. The lipoyl 
bearing domains of these proteins are generally considered to be highly antigenic 
however, analysis by Lau et al. (1988) of the antigenicity associated with BCOADC 
E2 demonstrated that it is not the lipoyl domains which are immunogenic, but the 
highly flexible hinge regions linking the lipoyl domains to the catalytic core which are 
responsible for the antigenicity exhibited by these enzymes. It is possible therefore, 
that the M r 15,000 peptide representing the cleaved lipoyl domain may have been 
resolved, but does not show a high level of immunogenicity owing to the absence of 
the linker domain region. In the same experiment, OGDC incubated with trypsin was 
immunoblotted with anti-E3 serum (Fig. 3.4 panel B); no immunologically-detectable 
proteolytic fragments were observed as a result of trypsin treatment, indicating that the 
E3 enzyme is not degraded to any significant extent under these conditions.
N-terminal amino acid sequence of the M r 35,000 peptide species formed on 
tryptic treatment of OGDC was obtained and is shown in Table 3.3. Although only 
eighteen amino acid residues in length, it is apparent that this stretch of sequence is 
rich in both alanine and proline residues. This type of sequence is characteristic of the 
linker regions found within the E2 domain structure, an important feature necessary 
for the conformational flexibility associated with the catalytic activity of the complex. 
Analysis of the amino acid sequence as deduced from the recently cloned rat OGDC 
E2 enzyme (Nakano et al., 1991) reveals the presence of a high proportion of alanine 
and proline residues in the region which links the lipoyl domain to the inner catalytic 
domain. Thus, tryptic digestion of the E2 enzyme of bovine heart OGDC results in 
two distinct species being formed; an M r 15,000 peptide corresponding to the lipoyl 
domain which is cleaved from the N-terminus of the enzyme, and an M r 35,000 
species whichcontains both the flexible linker domain and the acyltransferase active 
site region.
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Table 3.4 Comparison of the N-terminal sequence of the E l1 species from bovine 
heart OGDC with protein X of S. cerevisiae
Bovine heart OGDC was diluted in 0.2mM TPP/2mM MgCl2/3mM 
NAD+/50mM potassium phosphate buffer pH 7.6, and digested with 0.05%(w/w) 
trypsin for 30 min. Samples (5pg) were resolved on a 10%(w/v) 
SDS/polyacrylamide sequencing gel and were subsequently blotted onto 
Immobilon PVDF membrane. The band corresponding to the lower M r E1 species 
resulting from tryptic digestion of E l was cut from the membrane, its 
N-terminal sequence obtained as described in the Methods. The amino acid 
sequence of the E l1 species of OGDC, was compared to that of protein X from 
S. cerevisiae as deduced from the published nucleotide sequence.
Bold lines between residues are indicative of sequence identity in contrast to 
dashed lines which represent conservative amino acid changes.
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3.2.5 IMMUNOLOGICAL AND SEQUENCE ANALYSIS OF THE PEPTIDES RESULTING 
FROM CLEAVAGE OF THE El ENZYME OF MAMMALIAN OGDC
Digestion of OGDC with trypsin revealed that the E2 enzyme of the complex 
undergoes digestion in a manner similar to that of the acetyltransferases and protein X, 
with cleavage occurring within the flexible linker domain so causing removal of the 
lipoyl domain located at the N-terminus. Trypsin treatment of E l resulted in its rapid 
cleavage to form the so called El* species. It was necessary to know if  E l was being 
cleaved in a manner similar to that of protein X and the E2 acyltransferases, so as to 
determine if the peptide cleaved from E l was formed as a result of N-terminal 
cleavage, analogous to removal of the lipoyl domain region. Thus, OGDC was 
degraded with trypsin to produce the stable E l1 species which was then sequenced 
from its N-terminus. The results obtained are shown in Table 3.4.
It is evident from the results that when the N-terminal sequence of the E l1 
fragment is compared to the sequence obtained previously for E l of OGDC, the 
sequences are quite distinct. This signifies that the E l1 species is formed as a result of 
removal of the protein X-like sequence from the N-terminus of the E l enzyme. In 
addition to undergoing N-terminal cleavage in a manner similar to protein X , the El* 
sequence shows some degree of similarity to protein X  from S. cerevisiae. The 
predicted amino acid sequence of protein X  was deduced from the nucleotide sequence 
of the cloned gene (Behai et al., 1989). When the similarity between E l of OGDC 
and protein X  is considered, the region of protein X  to which El* maps is dependent 
on the method used to match them. Table 3.4 shows the outcome of matching OGDC 
E l1 to protein X of S. cerevisiae by eye (panel A) or by using a computer search 
programme such as SWISSPROT (panel B); both methods result in different regions 
of protein X  being aligned with the E l1 sequence. These searches were performed 
prior to publication of the entire amino acid sequence for the human OGDC E l enzyme 
as deduced by Koike et al. (1992). For alignment by eye (panel A), El* of OGDC 
was matched to residues 64-86 of the protein X sequence. This contrasts with the
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Fig. 3.5 Immune blotting analysis of the extent of 2-oxoglutarate
dehydrogenase (E l) enzyme degradation during digestion of OGDC
OGDC diluted with 3mM NAD+/ 2mM MgCl2 /  0.2mM TPP/ 50mM potassium 
phosphate buffer pH 7.6, was treated with 0.1%(w/w) trypsin at 30°C for the 
times shown. Samples (lpg) were resolved on a 12.5%(w/v) 
SDS/polyacrylamide gel after which proteins were transferred electrophoretically 
onto nitrocellulose paper for incubation with anti-(El OGDC) serum (1:100 
dilution). Bound antibodies were detected by autoradiography after incubation 
with [125l]-labelled protein A as described in the Methods.
E'
t
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computer search alignment (panel B) which recognised sequence similarity between 
residues 144-164. Both matches are closely comparable in the number of identical and 
conserved residues which they have between them; However, the match between E l1 
and residues 144-164 of the protein X  sequence may be slightly more favourable as, 
unlike the visual match, no gaps were introduced into the E l1 sequence to aid 
alignment. The significance of this result will be dealt with in greater detail in the final 
discussion chapter. However, the above results confirm that sequence similarity 
between protein X  and the E l1 species is not confined solely to the N-terminus.
Tryptic digestion of OGDC results in release of the N-terminal region of the E l 
enzyme in a manner similar to the cleavage of lipoyl domains from either the 
acetyltransferases or protein X of PDC. As shown in Fig. 3.5, immunoblotting of 
tryptic digested OGDC with anti-(El OGDC) serum results in a very strong and 
specific cross-reaction. On digestion of E l to form E l1, the antigenicity of E l1 is 
gready reduced with respect to the undigested E l control. The major immune 
response is now exhibited by the small peptide formed as a result of 
N-terminal cleavage of the E l enzyme, which runs near the dye front. This small 
peptide elicits a high proportion of the total immune response against the original E l 
subunit, even though it represents less than 10% of the overall sequence when 
compared to the entire length of the E l enzyme. The high immunogenicity displayed 
by this peptide is very similar to that observed with lipoyl domain regions and their 
linker regions which dominate the antigenic response to the native undegraded E2 
enzyme (Kreszee ta l., 1980).
Lipoyl domains commonly show M r values of approx. 15,000 when resolved by 
SDS/polyacrylamide gel electrophoresis. An accurate size determination of the 
N-terminal cleaved peptide was necessary, to allow a comparison to be made between 
it and the lipoyl domain on the basis of their M r values. OGDC was digested using 
trypsin for a sufficient time to ensure that the E l enzyme was fully converted to E l1 
and that this small N-terminal peptide was formed. The digested sample was then 
resolved on both 12.5%(w/v) and 15%(w/v) SDS/polyacrylamide gels (not shown) in
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Fig. 3.6 Determination of M r of peptide species cleaved from the N-terminus 
of the 2-oxoglutarate (E l) enzyme during tryptic digestion
OGDC from bovine heart was diluted with 0.2mM TPP/ 2mM MgCl2 /  3mM 
NAD+/  50mM potassium phosphate buffer pH 7.6, and digested with 0.1%(w/w) 
trypsin for times indicated. Samples were resolved on tricine-SDS/polyacrylamide 
gels (Section 2.2.4) after which the slab gel was cut in half: one half was stained 
with Coomassie blue (Panel A), the other half immunoblotted with subunit specific 
antisera (Panel B).
Panel A : samples of tryptic digested OGDC (20jig per track) were stained with 
Coomassie blue to allow visualisation of protein.
Lane M  - marker proteins for M r range determinations between 16,950 - 2,510 
dOng)
Panel B: resolved protein (5p.g per lane), was transferred electrophoretically onto 
nitrocellulose membrane and blotted with anti-(El OGDC) serum (1:100 dilution).
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an attempt to resolve the peptide and calculate its M r by comparison with standard 
marker proteins on the same gel. Difficulties were experienced when the peptide was 
resolved and the gels treated with either Coomassie blue dye or silver stain, since there 
was negligible staining of this low M r peptide.
An alternative strategy was developed whereby tryptic digested OGDC was 
resolved on tricine-SDS/polyacrylamide gels (Section 2.2.4), the protein transferred 
onto nitrocellulose membrane and challenged with anti-(El OGDC) serum. The 
results of such an experiment are shown in Fig. 3.6. When tricine is used as the 
trailing ion, this allows for the resolution of small peptides at lower acrylamide 
concentrations than on glycine SDS/polyacrylamide gel electrophoresis (Schagger and 
Von Jagow, 1987). Panel A shows one half of the gel stained with Coomassie blue, 
panel B the other half blotted with anti-(El OGDC). From the Coomassie blue stained 
gel the small N-terminal cleavage product is not apparent; however, its presence can be 
detected on the immunoblot probed with anti-(El OGDC) serum. Although the anti- 
(E1 OGDC) antisera is specific for the small N-terminal peptide which appears to run 
near the bottom of the resolving gel, a large amount of cross-reactivity with this 
antiserum is seen in the top portion of the gel within the the region of the spacer gel. 
The tricine-SDS/polyacrylamide gel system is capable of separating complex mixtures 
of proteins to a high degree of resolution. It is possible that a small amount of non­
specific E l enzyme degradation has occurred during storage of the enzyme as the same 
non-specific cross-reaction with anti-(El OGDC) serum is also observed in the 
undigested control sample. On their resolution, the E l degradation products were 
detected by immunoblotting, an extremely sensitive method capable of detecting 
amounts of protein as low as 0.1 pg. The level of the anti-(El OGDC) cross-reaction 
within the spacer gel is seen to decrease during the time course of tryptic digestion, 
this is probably as a result of the original degradation products being cleaved to form 
smaller peptides which are no longer recognised by the antiserum. Direct comparison 
with the low M r marker proteins on the Coomassie blue stained gel gave an approx.
M r 8,000 to the small N-terminal peptide. The calculated M r of this peptide species is
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Fig. 3.7 Treatment of bovine heart OGDC with protease arg C.
OGDC diluted in 0.2mM TPP/ 2mM M gC V 3mM NAD+/  50mM potassium 
phosphate buffer pH 7.6, was digested with 9%(w/w) protease arg C for lh at 
30°C. The protease was added in 3 aliquots of 3%(w/w) at times 0 min, 20 min 
and 40 min respectively. Samples (15pg) were removed at times shown with the 
samples at 20 min and 40 min being taken before addition of the protease. 
Digested protein was then resolved on a 10%(w/v) SDS/polyacrylamide gel and 
stained with Coomassie blue.
Track M  - M r marker proteins (lOpg).
Track C - Control OGDC i.e untreated OGDC incubated at 30°C for the duration 
of the experiment.
Time of arg C treatment (m ins)
lower than that expected for a lipoyl domain, although it may be postulated that this 
species represents i modified form of the domain. No evidence exists for the presence 
of a linker region atsociated with this peptide which exhibits a large immunogenic 
response when chalenged with anti-(El O G DC) serum.
3.2.6 TREATMENT OF BOVINE HEART OGDC WITH PROTEASE ARG C
Bovine heart OGDC was also digested with the more specific protease arg C to 
determine if  E l showed a similar digestion profile with this protease as compared with 
trypsin. From the results shown in Fig. 3.7 it can be seen that although the E l 
enzyme was degraded extensively resulting in the production of a variety of low Mr 
peptides, there was no detectable cleavage of either the E2 or E3 enzyme subunits. 
Extensive degradation of the E l enzyme was not accompanied by formation of the 
stable E l1 species as was observed with tryptic digestion. It seems unusual that a 
more specific proteolytic enzyme such as protease arg C which cleaves arg-arg bonds, 
is capable of totally digesting the E l enzyme while trypsin, which cleaves peptide 
bonds at the C-teminal side of both arginine and lysine residues, causes a more 
specific cleavage of the E l enzyme. It has been reported in the literature that protease 
arg C, in addition to cleaving arg-arg bonds, is also capable of cleaving lys-lys bonds 
(Chartier et al., 1989) and lys-arg bonds (Bousfield and Ward, 1988). It would 
appear from this result that protease arg C may be capable of cleaving the E l enzyme 
at several different sites at similar rates while lower levels of trypsin causes a rapid and 
very specific cleavage at a highly susceptible site. The possibility may also exist that 
proteolysis of E l is promoted by a minor contaminating activity present in commercial 
preparations of proease arg C; this is unlikely as all batches of protease tested were 
found to cleave protein X of bovine heart PDC at two specific sites only, to produce a 
M r 35,000 peptide, corresponding to the inner domain fragment which was further 
degraded to a M r 30,000 species and a M r 15,000 lipoyl domain peptide (J. Neagle 
and S. Sanderson, unpublished results).
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Fig. 3.8 Immune replica analysis of mammalian OGDC with monospecific 
subunit antisera after digestion of complex with protease arg C.
OGDC was diluted in 0.2mM TPP/ 2mM MgCl2 /  3mM NAD+/ 50mM potassium 
phosphate buffer pH 7.6. 9%(w/w) protease arg C was added in 3 equal aliquots 
at times 0 min, 20 min and 40 min respectively, samples (15jig) were removed 
prior to the addition of protease. Samples (lpg) were resolved on a 10%(w/v) 
SDS/polyacrylamide gel and after transferring onto nitrocellulose, the bound 
protein was incubated with anti-(El OGDC) serum (1:100 dilution). After the 
immunoblot had been exposed to photographic film for several days at -80°C, the 
nitrocellulose was removed from the film cassette and incubated in wash buffer 
[Section 2.2.6(a)] for lh to remove the bound [125I]-labelled protein A. 
Nitrocellulose was then re-probed with anti-(E2 OGDC) serum (1:100 dilution). 
This process was repeated once more when the same blot was re-challenged with 
anti-E3 serum (1:100) dilution.
Track C - Control OGDC (l|ig) incubated at 30°C for the duration of the 
experiment.
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Immunoblotting of protease arg C digested OGDC (Fig. 3.8) further confirms that 
the E l enzyme is extensively degraded in contrast to the E2 and E3 enzymes which are 
unaffected. The low Mr cross-reacting peptides seen at later time intervals of digestion 
were produced as a direct result of E l enzyme degradation. This result differs from 
trypsin which cleaves the E2 enzyme forming the two peptide species described 
previously. This would suggest that, either the cleavage site present in the flexible 
linker domain of the E2 enzyme is specific for trypsin only or, that the same site is not 
susceptible to digestion by protease arg C.
3.3 D ISCUSSIO N
In contrast to the individual acyl transferase (E2) enzymes of the family of 
2-oxoacid dehydrogenase complexes which show little homology to each other in 
their N-terminal regions, the acetyl transferase enzymes of PDC exhibit sequence 
similarities at their N-termini which are characteristic of lipoyl bearing domains, in 
particular, the conserved amino acid sequence motif Ps/aLSPTM which occurs 
approx. 30 amino acids before the lipoylated lysine residue in human E2. A major 
new piece of evidence is presented in this chapter relating to the discovery of an E2 
acetyltransferase lipoyl like domain on the 2-oxoglutarate (E l) enzyme of mammalian 
OGDC, the region of sequence similarity located at the N-terminus; E l was also 
shown to possess sequence similarity to protein X of bovine heart PDC in the region 
of their N-termini.
When considering if  two sequences show significant similarity to each other, the 
number of identical or conservatively substituted amino acids which the two sequences 
have in common are taken into account. On analysis, the percentage identity existing 
between any two sequences which is considered to be the so called ‘twilight zone’ or 
lower limit of significant identity, is approx. 20% especially if gaps are inserted into 
the sequence to allow for optimisation of alignment. Matching of the N-terminal 
regions of both the OGDC El and protein X species gave an average percentage
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identity in the range 42-47%, although gaps were introduced to allow for matching of 
the sequences. This value, which is significant and clearly above the lower limit of 
percentage identity, confirms that real sequence similarity does exist between these 
two proteins at their N-termini. Similarly, the percentage sequence similarity between 
OGDC E l and the E2 acetyltransferases in the range 30-40%, demonstrates that 
significant sequence similarity also exists between these proteins at their N-terminal 
regions.
Correlations have been observed between the degree of immunological cross­
reactivity and the degree of sequence homology existing between sequences, with 
values of approx. 60% sequence identity being necessary before an immunological 
cross-reaction is observed. This assumption is based on experiments performed by 
Prager and Wilson (1971a, b) who tried to examine in a quantitative manner, the 
relationship between immunological cross-reactivity in a family of lysosomal proteins 
with respect to their sequence homology. The immunological techniques used in these 
determinations such as immunodiffusion, precipitin analysis and micro-complement 
fixation studies, are known to be insensitive and inaccurate, so that the results 
obtained in studies of this type may not be entirely correct.
From the observed results E l of OGDC was found to be capable of cross-reacting 
with antiserum raised to protein X. In addition, protein X  exhibited cross-reactivity 
with anti-(intact OGDC). These results disagree with the assumptions of Prager and 
Wilson since E l of OGDC and protein X do not possess 60% sequence similarity to 
each other, as can be verified by the computer matching of their sequences (not 
shown). It is perhaps too simplistic to relate the extent of cross-reactivity to sequence 
similarity except in cases were a high degree of sequence conservation exists. In the 
case of the dihydrolipoamide dehydrogenase (E3) enzyme which is a common 
component of the 2-oxoacid dehydrogenase complexes, the low level immunogenicity 
observed with this protein is attributed to the high degree of conservation of its 
primary structure and hence its tertiary structure during evolution (De Marcucci et al., 
1985). Cross-reactivity may not be solely dependent on sequence similarity but may
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also be related to the conformation which the protein adopts therefore, although 
polypeptides may exhibit relatively low levels of sequence similarity to each other, 
they may assume similar three-dimensional structural epitopes allowing for cross- 
reactivity. Thus, for protein X  and E l of OGDC, sequence similarity and structural 
characteristics common to both of these polypeptides must be present on account of 
the observed cross-reactivity.
Cases have been reported were antisera raised to protein X  has recognised the E2 
enzyme (Jilka et a l., 1986), although it is possible to produce monospecific antiserum 
to protein X  (De Marcucci and Lindsay, 1985). These conflicting results probably 
reflect differences in antisera production, since the epitopes which are responsible for 
eliciting antibodies in an individual animal depends on various host factors such as the 
immunoglobulin gene repertoire, the method of antigen presentation and sometimes 
even the regime used to immunise the animal.
Bovine heart OGDC has been shown to undergo a very specific pattern of 
degradation when subjected to limited proteolysis with trypsin. The E l enzyme which 
appears to be the most proteolytically sensitive subunit of the complex, is cleaved by 
trypsin to form a lower M r species which is termed E l1. Protein sequence analysis 
showed that cleavage of the E l enzyme was occurring at the N-terminal region, the 
result of which was the production of a peptide with an estimated M r of approx. 8,000 
as estimated by tricine-SDS/polyacrylamide gel electrophoresis. In addition, this small 
peptide was shown to be responsible for a large proportion of the E l immunoresponse 
as shown by immunoblotting studies. The E2 enzyme of OGDC was cleaved by 
trypsin to produce two fragments of M r 35,000 and 15,000; the smaller fragment 
representing the lipoyl domain cleaved from the N-terminus of the enzyme, the larger 
fragment possessing the catalytic acyltransferase active site. The nature of the 
polypeptides formed on E2 degradation were further confirmed by the use of anti-(E2 
OGDC) serum in immunoblotting studies of the tryptic degraded OGDC. In contrast 
to E l and E2, the E3 enzyme remained intact during tryptic degradation of OGDC as 
determined by immunoblotting analysis.
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A different proteolytic degradation pattern was observed when bovine heart 
OGDC was treated with protease arg C; normally specific for arg-arg bonds only, this 
protease was shown both by SDS/polyacrylamide gel analysis and immunoblotting 
studies, to extensively degrade E l producing a complex pattern of low M r peptides 
while leaving the E2 and E3 enzymes intact. The extensive degradation of E l with 
protease arg C in contrast to the lower M r El* species formed upon tryptic treatment, 
may reflect additional cleavage sites for protease arg C within the E l enzyme; in some 
cases protease arg C has shown itself to be capable of cleaving arg-lys bonds 
(Bousfield and Ward, 1988) and lys-lys bonds (Chartier et a l., 1989).
In contrast to bovine heart OGDC which has three distinct polypeptides as shown 
by SDS/polyacrylamide gel electrophoresis, OGDC purified from bovine kidney, 
resolves into four bands (Linn, 1974). Three of these bands represent the known 
enzyme activities of E l, E2 and E3 together with an additional polypeptide of M r 
90,000. The origin of this polypeptide is unknown but it is thought to be formed as a 
result of proteolytic degradation of the E l enzyme (M r 96,000), by an enzyme termed 
inactivase. This enzyme is thought to be a thiol sensitive protease which although 
found in bovine kidney is also present in rat liver mitochondria. The specificity of 
inactivase has not been well characterised but in addition to cleaving E l, it also 
degrades E2 in the complex in a manner reminiscent of tryptic degradation. It would 
appear that inactivase may be cleaving the complex in a manner similar to the tryptic 
digestion of bovine heart OGDC.
E l of bovine kidney OGDC can also be degraded specifically with papain (Kresze 
et al., 1981) where the E l species of M r 96,000 is cleaved to form a species with an 
estimated M r 94,000; the protease also cleaves at a susceptible site within the linker 
region of E2 to form two species of M r 29,5000 and 27,000. A major difference 
existing between the tryptic and papain digestion profiles is that papain digests E2 at a 
much faster rate than E l; this situation is contrary to trypsin where E l is 
proteolytically more sensitive than E2. With both proteases, E3 has been shown to be
resistant to proteolysis, remaining intact under conditions where both E l and E2 are 
subject to degradation.
7 2
CHAPTER FOUR
ROLE OF THE E l ENZYME OF THE 2-OXOGLUTARATE 
DEHYDROGENASE MULTIENZYME COMPLEX IN  BINDING OF 
THE E3 ENZYME TO THE CORE COMPLEX
4.1 INTRODUCTION
In the previous chapter, it was established that the N-terminal region of E l of 
bovine heart OGDC, exhibited a significant degree of sequence similarity to the 
N-termini of both the eukaryotic E2 acetyltransferase and protein X  components of 
PDC. On account of this, the possibility that this region of E l shared either functional 
or structural characteristics with the acetyltransferases and/or protein X  was 
investigated. The conserved sequence Ps/aLSPTM  which is found located at the N- 
terminus of all eukaryotic acetyltransferases, is indicative of the presence of a lipoyl 
domain; in human E2, this motif occurs approx. 30 amino before the lysine residue 
which is lipoylated. Since a modified form of this sequence is also found at the N- 
terminus of E l of OGDC, it may indicate the presence of a modified lipoyl domain 
which, however, may still be functional, and therefore subject to acylation in a manner 
similar to that of the E2 acetyltransferases.
Protein X , which also shares sequence similarity with E l of OGDC, is known to 
be involved in promoting an association between the E3 enzyme and the core assembly 
of PDC. The exact nature of this interaction is not as yet clearly defined; however 
removal of protein X  from PDC, in particular the putative E3 binding domain, either 
by genetic or biochemical means causes the E3 enzyme to dissociate from the complex. 
Interestingly, OGDC and BCOADC, which both contain an identical E3 enzyme to that 
found in PDC, have not been found to possess a polypeptide analogous to protein X.
The aim of the work presented in this chapter was to determine if the sequence 
present at the N-terminus of E l of OGDC was representative of either a functionally 
active lipoyl domain or, if  it was implicated in assisting with the binding of E3 in this 
complex. Data presented in this chapter were obtained prior to the publication of the 
complete amino acid sequence for the OGDC E l enzyme from a mammalian source. 
This has now been achieved by Koike et al. (1992) who recently cloned the human 
foetal liver E l enzyme for OGDC.
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Fig. 4.1 Analysis of acetylated proteins after incubation of native OGDC and 
PDC with [2-l4C]pyruvate.
Bovine heart OGDC and PDC were diluted with 0.2mM TPP/ 2mM M gC V  
3mM NAD+/ 50mM potassium phosphate buffer pH 7.6, to a final concentration 
of 1 mg/ml. OGDC (150|ig) and PDC (150pg) were both radiolabelled 
individually with 2pCi of [2-14C] pyruvate for 10 min at room temperature. 
Laemmli sample buffer including lOmM DTT (see below) was added to terminate 
the reaction. Samples were incubated at 37°C for 5 min before resolution by 
10%(w/v) SDS/polyacrylamide gel electrophoresis. Gels were subjected to 
fluorography as described in the Methods.
Lanes 1 and 3, OGDC (20pg); lanes 2 and 4, OGDC (40|ig); lanes 5 and 7, PDC 
(20jig); lanes 6 and 8, PDC (40pg). Samples 1, 2, 5, and 6 were prepared in the 
presence of lOmM DTT, samples 3, 4,7 and 8 prepared in the absence of DTT.
Lane S - radiolabelled OGDC marker protein (lOpg)
Lane M  - radiolabelled PDC marker protein (10pg)
OGDC
4.2 RESULTS
4.2.1 MODIFICATION OF OGDC AND PDC WITH RADIOLABELLED SUBSTRATE
Both protein X  and the E2 acetyltransferases of PDC contain covalendy attached 
lipoyl groups which are capable of being acetylated by substrate in the absence of 
CoASH (De Marcucci et al., 1986). The N-terminal region of E l from bovine heart 
OGDC contains a variation on the sequence motif Ps/aLSPTM, which precedes the 
lipoyl domains present on the E2 eukaryotic acetyltransferases. Owing to the 
unexpected presence of this sequence on E l of OGDC, the experiments performed in 
this section sought to determine if this sequence represented a functionally active lipoyl 
domain on E l which was capable of being modified by acylating substrate.
The result of incubating the complexes with [2-14C]pyruvate, which was readily 
available in the laboratory, and subsequent analysis of the products by 
SDS/polyacrylamide gel electrophoresis and fluorography is shown in Fig. 4.1. DTT 
was omitted from the sample buffer in some tracks in an attempt to minimise the 
release of radiolabelled substrate from the enzyme subunits, since it has been shown 
that retention of radioactivity in these polypeptides is dependent on the method of 
sample preparation ( De Marcucci et al., 1986). Minimal losses of radioactivity could 
be achieved by solubilising the sample at 37°C in the absence of thiol reagents. 
Treatment of PDC with radiolabelled [2-l4C]pyruvate resulted in incorporation of label 
into both the E2 and protein X  subunits as expected, owing to the formation of the 
S-acetyldihydrolipoamide intermediate. In contrast, incubation of OGDC with 
[2-l4C]pyruvate caused modification of the E2 subunit only; no incorporation of 
radiolabel into E l was detected suggesting that it does not contain a functional lipoyl 
group.
Although E l of OGDC did not become acetylated in the presence of 
[2-l4C]pyruvate, it is still possible that a lipoyl group may have been present. The 
putative lipoy 1-like domain present on E l may not incorporate label unless treated with
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Fig. 4.2 Modification of native OGDC and PDC with 2-oxo[5-14C]glutaric acid 
and [2-14C]pyruvate
Bovine heart OGDC and PDC were diluted with 0.2mM TPP/ 2mM M gCiy  
3mM NAD+/ 50mM potassium phosphate buffer pH 7.6, to a final concentration 
of lmg/ml. OGDC and PDC were labelled with either 2-oxo[5-14C]glutaric acid 
(l|iC i) or [2-14C]pyruvate (ljJ-Ci) for 10 min at room temperature. Laemmli 
sample buffer containing no DTT was added to stop the labelling reaction.
Samples were warmed at 37°C for 5 min and resolved by 10%(w/v) 
SDS/polyacrylamide gel electrophoresis. Gels were processed for fluorography as 
outlined in the Methods.
Lanes 1 and 2, OGDC (20pg), lanes 5 and 6, PDC (20pg); these samples were 
labelled with 2-oxo[5-14C]glutaric acid. Lanes 3 and 4, OGDC (20|ig), lanes 7 
and 8, PDC (20p.g); these samples were labelled with [2-14C]pyruvate.
Lane M  - radiolabelled OGDC marker protein (lOpg)
PDC
X —
OGDC
— E1
— E3 
- E 2
1 2 3 4  5 6 7 8  M
Fig. 4.3 Tryptic digestion of bovine heart OGDC; effect on 2-oxoglutarate 
dehydrogenase (E l) activity and OGDC activity.
OGDC diluted in 0.2mM TPP/ 2mM MgCl2/  3mM NAD+/  50mM potassium 
phosphate buffer pH 7.6, was incubated with either 0.01%(w/w) trypsin (a — a ) 
or 0.1%(w/w) trypsin (a— A) at 30°C. At times indicated samples were 
withdrawn and digestion stopped by addition of soya bean trypsin inhibitor, after 
which samples were assayed for overall OGDC activity. Samples digested with 
0.1%(w/w) trypsin were also assayed for E l activity (•— •).
Samples from the digestions were also resolved on 10%(w/v) 
SDS/polyacrylamide gels and stained with Coomassie blue (see Fig. 4.4). The 
areas of the bands coresponding to the amount of E l remaining and E l1 formed as 
a result of tryptic digestion was determined by densitometric scanning as outlined 
in the Methods. Variations in the levels of E l (o— □) and E l1 (■— ■) are 
expressed with respect to the combined values of E l and E l1 at each time point.
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its natural substrate, 2-oxoglutarate. The results of such an experiment are shown in 
Fig. 4.2. On incubation with 2-oxo[5-14C]glutaric acid, succinyl groups were 
incorporated into the E2 lipoyl domain but no labelling of the E l subunit was detected. 
Surprisingly, only weak labelling of the E2 subunits was apparent. This may reflect 
the instability of the 8-succinyl dihydrolipoamide intermediate. This result provides 
strong evidence that E l of OGDC lacks a functionally active lipoyl domain. 
Interestingly, neither the E2 or protein X  subunits of PDC were modified when treated 
with 2-oxo[5-14C]glutaric acid.
Since incorporation of [14C]acetyl groups from [2-l4C]pyruvate into the E2 
subunits of OGDC was observed, enzyme activity measurements were performed in 
which the activity of OGDC was monitored when pyruvate was used as substrate; E l 
of OGDC is capable of using pyruvate as substrate such that acetyl groups are 
incorporated into the E2 enzyme; However, no measurable enzyme activity was 
observed when pyruvate was used as substrate. It would appear that incorporation of 
acetyl groups into E2 of OGDC is a result of the complex turning over very slowly, 
which under normal conditions functions at a rate of 1800 sec*1.
4.2.2 EFFECT OF TRYPTIC DIGESTION ON OGDC ACTIVITY
Trypsin treatment of OGDC results in cleavage of the N-terminal region of E l. 
The effect of tryptic digestion of OGDC on complex activity was examined to 
determine the importance of this cleaved region in maintaining overall complex 
activity.
Fig. 4.3 shows the observed results when OGDC was digested with trypsin and 
assayed for residual complex activity. Digestion with 0.1%(w/w) trypsin resulted in a 
rapid loss of complex activity such that total inhibition occurred within 10 min. More 
gradual, controlled losses of complex activity were achieved by using lower 
concentrations of trypsin. Treatment with 0.01%(w/w) trypsin ensured that 50% of 
OGDC activity was still present after 30 min.
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Fig. 4.4 Time course of tryptic digestion of bovine heart OGDC
OGDC was digested with 0.01%(w/w) trypsin (panel A) or 0.1%(w/w) trypsin 
(panel B) as described in Fig. 4.3. Samples (20|ig) from each time point were 
taken and resolved by 10%(w/w) SDS/polyacrylamide gel electrophoresis. Gels 
were stained with Coomassie blue.
Lane M  - low M r marker proteins (10pg)
Lane C - OGDC (20jig) incubated at 30°C for duration of experiment in the 
absence of trypsin.
(A) (B)
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The possibility that loss of overall OGDC function could be attributed to 
degradation of the E l enzyme and concomitant loss of function was investigated 
initially since this is the rate-limiting enzyme within the complex. To test this 
hypothesis OGDC was digested with 0.1%(w/w) trypsin as previously shown and E l 
activity monitored instead of overall complex activity. This level of trypsin, which 
was sufficient to cause complete loss of OGDC activity within 10 min , caused little or 
no decrease in E l activity with approx. 80-100% of total E l activity remaining after lh 
of digestion. This result implied that loss of overall OGDC activity as a consequence 
of tryptic digestion could not be attributed to digestion of the E l enzyme, with the 
resultant El* fragment retaining full enzymatic activity under conditions in which 
OGDC activity was totally inhibited.
Samples of tryptic digested OGDC were removed at various time intervals during 
the above experiment and resolved by SDS/polyacrylamide gel electrophoresis. Fig. 
4.4 shows the Coomassie blue stained gels where panels A and B represent OGDC 
digested with 0.01%(w/w) and 0.1%(w/w) trypsin respectively. From visual 
inspection of these gels there appears to be no detectable proteolysis of either E2 or 
E3, although at longer time intervals degradation of E2 is apparent. The major effect 
of tryptic cleavage is on the E l enzyme, the extent of E l proteolysis appearing to 
proceed in conjunction with the loss of OGDC activity. In order to quantify the rate of 
E l to E l1 conversion the Coomassie blue stained gels were subjected to densitometric 
scanning, the results shown in Fig. 4.3. The rate of E l degradation appears to 
proceed in parallel with the loss of OGDC activity; however, in the early stages of the 
digestion, this conversion proceeds at a rate faster than the loss of overall complex 
activity. The combined areas under the E l and E l1 peaks representing a particular time 
point remained constant throughout the time course indicating that under these 
conditions, the E l1 species is a stable intermediate formed by the specific degradation 
of E l. From these results it would seem that the E l to E l1 conversion effected by 
trypsin occurs approx. in parallel with the loss of overall OGDC activity, as 
determined by enzyme activity measurements and gel scanning analysis. However,
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Fig. 4.5 Gel filtration of bovine heart OGDC and pig heart dihydrolipoamide 
dehydrogenase (E3)
Gel filtration was performed using a Superose 12 gel filtration column (HR 
16/50, bed volume 100ml) attached to a Pharmacia FPLC system. The column 
was equilibrated and eluted with lOmM NaCl/50mM potassium phosphate buffer 
pH 7.6, at a flow rate of lml/min. Native bovine heart OGDC (2mg) was loaded 
onto the column and collected fractions were assayed for both overall OGDC
activity (o o) and E3 activity associated with the complex (a  a). In a
separate experiment E3 from pig heart (2mg) was eluted from the column as 
described above, with the collected fractions being assayed for E3 activity (d— □).
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loss of OGDC function cannot be attributed to the inhibition of E l, since the large 
stable E l1 fragment retains approx. 80-100% of its original enzymatic activity.
4.2.3 CONDITIONS FOR RESOLVING DISSOCIATED E3 ENZYME FROM INTACT OGDC
It would appear from results obtained so far that the segment of polypeptide at the 
N-terminus of E l of OGDC, which possesses primary amino acid sequence similarity 
to both the eukaryotic acetyltransferases and protein X  from PDC, does not represent a 
functional lipoyl domain. The specific removal of this region by proteolytic 
degradation has a profound effect on complex activity resulting in a complete loss of 
OGDC activity while E l remains fully active. This phenomenon may be explained by 
the involvement of the cleaved N-terminal region in a structural role whereby, it binds 
the E3 enzyme to the core assembly in a situation similar to that which exists in PDC 
for protein X . It was necessary to examine if dissociation of E3 from OGDC occurred 
as a direct result of the E l to E l1 conversion. In the following experiments OGDC 
was treated with either trypsin or protease arg C, both of these proteases known to 
degrade E l specifically. In the event of E3 dissociation from the complex as a result 
of E l degradation, it would be resolved from the enzyme core using gel permeation 
chromatography.
Initial efforts were concerned with finding a suitable gel filtration column which 
would allow for good resolution between intact OGDC and free E3. This was 
necessary to distinguish between E3 associated with the core from that which was 
released as a result of specific proteolytic degradation of E l at its N-terminus. Optimal 
resolution between OGDC and free E3 was obtained on a Superose 12 gel filtration 
column (bed volume 100ml), which was used in conjunction with a Pharmacia FPLC 
system. Fig. 4.5 shows a typical elution profile obtained with bovine heart OGDC 
and free E3 isolated from pig heart. OGDC (M r 3.25 x 10 6) eluted in a sharp peak 
with an elution volume of 32ml which was equivalent to the calculated void volume of 
the column, the activity profile confirming that the vast majority of E3 remained in
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Fig. 4.6 Coomassie blue gel profile of tryptic digested OGDC subjected to gel 
filtration
Lanes 1 and 2, undigested OGDC (15pg); lanes 3 and 4, OGDC digested with 
0.01%(w/w) trypsin for 3 min (15pg); lanes 5 and 6, OGDC digested with 
0.02% (w/w) trypsin for 6 min (15pg).
Lane M  - low M r proteins (lOpg)
Mr (x 10-3)
94
67
43
30
Fig. 4.7 Analysis of E3 release from proteolytically degraded OGDC
Bovine heart OGDC was proteolytically degraded with trypsin prior to gel 
filtration treatment. OGDC was diluted in 3mM NAD+/ 2mM MgCl2 /  0.2mM 
TPP/ 50mM potassium phosphate buffer pH 7.6. Digestions with trypsin were 
carried out at the following concentrations: panel A - 0.01%(w/w) trypsin for 3 
min; panel B - 0.01%(w/w) trypsin for 6 min; panel C - 0.02%(w/w) trypsin for 6 
min. A ll digestions were performed at 30°C and stopped by the addition of soya 
bean trypsin inhibitor. In each case the degraded complex was loaded immediately 
onto a Superose 12 gel filtration column (HR 16/50, bed volume 100ml) attached 
to a Pharmacia FPLC system. The column was equilibrated and eluted with 
lOmM NaCl/ 50mM potassium phosphate buffer pH 7.6 at a flow rate of lml/min.
Collected fractions were assayed forE3 activity (o o) as detailed in the
Methods.
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association with the complex at this stage. However, a small amount of E3 activity 
was observed throughout the elution profile. This slow, steady elution of E3 activity 
probably represented E3 which dissociated slowly from the complex during its 
passage through the Superose 12 matrix. It should be stressed that this low 
background level of E3 release from the intact complex was distinct to the elution 
profile obtained for the free E3 pig heart control. E3 (M r 110,000) eluted as a distinct 
peak (Ve 52ml) with between 95-100% of loaded activity being routinely recovered 
from the column. Using this method, the elution profiles obtained with OGDC and the 
free E3 enzyme were sufficiently different to allow for a distinction to be made 
between them. The reproducibility of the gel filtration column was such that the 
elution profiles presented in this chapter, represent an average of 3-4 separate column 
runs in which elution volumes differed by no more than +/- lm l.
4.2.4 EFFECT OF TRYPTIC DIGESTION ON RELEASE OF E3 FROM OGDC
Before commencing these gel filtration studies, it was necessary to optimise 
conditions which would allow for the formation of the E l to E l1 species while leaving 
E2 and E3 virtually intact. Fig. 4.6 shows the results of digesting OGDC under 
several different conditions. At levels of 0.01%(w/w) trypsin (tracks 1 and 2), 
although only a small amount of E l was converted to E l1, the bulk of E l remained 
undegraded within the complex. By increasing the time of incubation with 
0.01%(w/w) trypsin (tracks 3 and 4), a 50:50 E l to El* conversion was possible. 
Approx. 80% conversion of E l to E l1 could be accomplished by treating OGDC with 
0.02%(w/w) trypsin (tracks 5 and 6), but at these concentrations of trypsin some 
minor proteolysis of the E2 enzyme was also observed as deduced by its appearance 
on SDS/polyacrylamide gels. In all of the tryptic digestions shown E3 remained 
intact.
Fig. 4.7 shows the results obtained from the gel filtration of OGDC which had 
been digested with trypsin according to the conditions described above. Digestions
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Fig. 4.8 Effect of protease arg C degradation on the release of E3 from OGDC
Gel filtration was performed using a Superose 12 gel filtration column (HR 
16/50, bed volume 100ml) attached to a Pharmacia FPLC system. Conditions for 
each column run are detailed below.
Panel A - OGDC was incubated with NaCl at a final concentration of 1M for lh 
at 4°C. The gel filtration column was equilibrated and eluted with 1M NaCl/ 
50mM potassium phosphate buffer pH 7.6 at lml/min. The collected fractions 
were assayed for E3 activity.
Panel B - OGDC was digested with protease arg C at a final concentration of 
9%(w/w) for lh at 30°C; aliquots of 3%(w/w) arg C were added at times 0 min, 
20 min, 40 min. Digestion was stopped at 60 min by addition of benzamidine to a 
final concentration of Im M. The degraded complex was loaded immediately onto 
the gel filtration column and eluted with lOmM NaCl/ 50mM potassium phosphate 
buffer pH 7.6 at lml/min. The collected fractions were assayed for E3 activity as 
described in the Methods.
Enzyme activity
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with 0.01%(w/w) trypsin for 3 min and 6 min are shown in panels A and B 
respectively. Both of the elution profiles obtained are characterised by the presence of 
two readily resolvable peaks of E3 activity at elution volumes of 32ml and 52ml. The 
peak eluting at 32ml corresponds to E3 activity which is still associated with the 
complex as was shown previously in Fig. 4.5. In comparison to this, the E3 enzyme 
activity eluting at 52ml represents E3 with an estimated M r 110,000, corresponding to 
E3 which has become dissociated from the core. This E3 release occurs specifically as 
a result of cleavage of the N-terminal region of the E l enzyme. The magnitude of the 
peak of released E3 activity eluting in this region appears to be related to the extent of 
E l degradation such that, the greater the degree of E l proteolysis the larger the peak of 
dissociated E3 activity present at 52ml. When OGDC was incubated with higher 
concentrations of trypsin for longer time intervals such as is shown in panel C of Fig. 
4.7, approx. 80% of E l was converted to E l1 although some proteolysis of E2 had 
also begun to occur. On gel filtration of the digested complex most of the E3 activity 
eluted at 52ml. Although there was no peak of E3 activity at 32ml, a low level of 
activity persisted throughout the column suggesting that E3 may still retain a low 
affinity for the complex.
4.2.5 STABILITY OF El ENZYME INTERACTION WITH THE CORE STRUCTURE
Since it did not prove possible to effect complete conversion of E l to E l1 without 
causing minor proteolysis of E2, it is conceivable that breakdown of the core structure 
may be contributing to release of E3. Digestion of OGDC with protease arg C, which 
in contrast to trypsin extensively degrades E l while leaving both the E2 core structure 
and E3 enzyme intact, was performed and the degraded complex subjected to gel 
filtration. The results of such an experiment are shown in Fig. 4.8. On assaying for 
E3 activity, only one major peak of activity was detected at an elution volume of 52ml 
corresponding to free E3 (Mr 110,000) which had become dissociated from the 
complex. The conclusion that can be drawn from this experiment is that E l is
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Fig. 4.9 Resolution of tryptic digested OGDC by Sephacryl S300 gel filtration.
OGDC diluted in 0.2mM TPP/ 2mM MgCl2 /  3mM NAD+/ 50mM potassium 
phosphate buffer pH 7.6 was digested with 0.01%(w/w) trypsin for 3 min at 
30°C. Digestion was stopped by the addition of soya bean trypsin inhibitor and 
the OGDC loaded immediately onto a Sephacryl S300 gel filtration column (bed 
volume-120ml). Column was equilibrated and eluted with lOmM NaCl/ 50mM 
potassium phosphate buffer pH 7.6 at a flow rate of 25ml/h. The collected
fractions were assayed for OGDC activity (•-----•), E l activity (o o) and E3
activity (A A) .
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involved either, with the direct binding or, in stabilising an interaction between E3 and 
the core structure. In this context, protease arg C has also shown itself to be capable 
of cleaving arg-lys and lys-lys bonds (Bousfield and Ward, 1988; Chartier et a i ,  
1989), in addition to cleaving arg-arg bonds.
Since it has been established that N-terminal cleavage of E l present in OGDC 
results in dissociation of E3 from the core, some consideration should now be given to 
the nature of this association which is proposed to exist between E l and E3. For 
example, on N-terminal cleavage of E l, the El* species may undergo one of several 
fates either remaining associated with the core, being released as a distinct polypeptide 
or, if  E l is bound intimately to E3 in the intact complex, conversion of E l to E l1 may 
result in the release of a distinct El'/E3 subcomplex.
The approach employed to investigate the possible existence of a El'/E3 
subspecies was similar to that described previously, such that OGDC was degraded 
specifically with trypsin to produce the E l1 species and subjected to gel filtration. Both 
E3 and E l enzyme activities were measured in the collected fractions. The Superose 
12 column was not appropriate for use here since it was desirable to be able to detect 
M r differences between polypeptides of similar size i.e. the native E l and E3 enzymes, 
which may be released from the core as a result of tryptic digestion. A Sephacryl 
S300 HR column was used instead, as a set of protein standards showed reasonable 
separation over the M r range of interest (1 x 10 4-1.5 x 10 6). On this column, intact 
OGDC eluted near the void volume which was 54ml; a peak of E l activity eluted at 
54ml with E3 enzymic activity at 53.5ml indicating that both the E l and E3 enzymes 
remained associated with the core complex during elution of the column (not shown). 
In agreement with earlier experiments, a steady low level of E3 release was observed, 
representing dissociation of loosely bound E3 when OGDC was eluted from the 
column. In contrast to E3, no E l release was observed with the control OGDC 
throughout column elution, the only peak of E l activity representing that associated 
with the complex. Fig. 4.9 shows the result of digesting OGDC with 0.01%(w/w) 
trypsin for 3 min and subjecting it gel filtration on a Sephacryl S300 column; intact
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OGDC activity together with the E l and E3 enzymic activities were found to elute at 
54ml, 54ml and 53.5ml, demonstrating that although the OGDC had been tryptic 
digested a considerable amount of both E l and E3 remained associated with the 
complex. In addition to these peaks, two further peaks of enzyme activity were 
present at later elution volumes representing E l and E3 eluting at 70ml and 73ml with 
apparent M r values of approx. 200,000 and 100,000 respectively. Further analysis 
involved the acetone precipitation of protein from those fractions containing peak E l 
and E3 activities and resolving them by SDS/polyacrylamide gel electrophoresis. The 
results obtained did not result in unequivocally proving that E l1 and E3 associated with 
each other after digestion of OGDC with trypsin. From these results it would appear 
that in addition to E3, the E l1 species formed as a result of tryptic digestion, also 
showed a marked tendency to dissociate from the complex. The full significance of 
these results will be discussed later in this chapter.
4.3 D ISC USSIO N
4.3.1 THE ABSENCE OF A CATALYTICALLY ACTIVE LIPOYL DOMAIN AT THE 
N-TERMINUS OF OGDC El
Substrate loading studies involving treatment of OGDC with radiolabelled 
2-oxoglutarate or pyruvate resulted in modification of E2 only. This result is 
explained by the E2 subunits of the 2-oxoacid dehydrogenase complexes containing 
lipoyl prosthetic groups bound to specific lysine residues, which in the presence of 
substrate and absence of Co ASH are reductively acylated by the E l subunits of the 
complex (Perham, 1991). The amino acid sequence surrounding the lysine residue to 
which the lipoyl group is attached has been well characterised and is found to be 
highly conserved (Yeaman, 1989). The lipoylation of the E2 polypeptides of these 
complexes can be inhibited by replacing the highly conserved lysine residue with 
another residue incapable of being lipoylated (Graham et al., 1986). In contrast to the 
labelling observed with the E2 subunits, E l of OGDC was not acylated by either
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pyruvate or 2-oxoglutarate. Lack of incorporation of label into E l might be explained 
by the absence of the region'wherethe highly conserved amino acid sequence 
containing the lipoylated lysine residue is found. Alternatively, the lysine residue may 
have been replaced in the sequence by another residue which is incapable of being 
lipoylated. Analysis of the recently cloned amino acid sequence of OGDC E l from a 
human source reveals the absence of the conserved sequence motif containing the 
lipoylated lysine residue. This confirms the result already deduced from the 
radiolabelling studies that is, that the sequence motif present at the N-terminus of 
OGDC E l which is similar to that found on the E2 acetyltransferases, is not indicative 
of the presence of a complete acetylatable lipoyl domain.
When E l of OGDC was cleaved with trypsin to form the E l1 species, a rapid loss 
of overall complex activity was observed. This was in direct contrast to E l which 
retained almost full enzymic activity. E l degradation seemed to parallel the loss of 
OGDC activity; however, a more careful analysis of this result by densitometric 
scanning of SDS/polyacrylamide gels showed that the earlier stages of E l to E l1 
conversion occurred at a rate faster than the loss of overall complex activity. The areas 
beneath the combined E l and E l1 peaks for each time point remained constant 
throughout the time course, suggesting that the El* species formed was a stable 
intermediate of tryptic degradation. From this result it would appear that the cleaved 
N-terminal region of E l is essential for maintenance of OGDC function. Since 
cleavage of E l is likely to be a random process, initially resulting in the formation of 
E l/E l1 heterodimers which may be able to maintain complex activity, it may be 
necessary to produce El* homodimers before the ability of the individual E l molecules 
to maintain overall complex activity is lost. Thus, in the early stages of tryptic 
digestion, loss of OGDC activity would occur at a slower rate than E l to El* 
conversion consistent with observations in Fig. 4.3.
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4 .3 .2  R O L E  O F  O G D C  E l IN  B IN D IN G  E 3  T O  T H E  C O R E  S T R U C T U R E
Genetic and biochemical studies have shown that protein X  appears to be involved 
in binding and positioning the E3 enzyme with respect to the E2 core in PDC. In 
experiments with S. cerevisiae, the gene encoding protein X  was disrupted and 
although the cells were still viable, PDC isolated from them was found to lack both the 
E3 and protein X  subunits (Lawson et al., 1991). The affinity of E3 for PDC isolated 
from bovine heart was also found to be decreased, when protein X  in the intact 
complex was proteolytically degraded with protease arg C (Neagle and Lindsay,
1991). Both of these results can be explained by the existence of a small domain 
identified on protein X  of PDC which shows distant but significant homology to an E3 
binding domain; in S. cerevisiae, deletion of this putative E3 binding domain on 
protein X  by genetic means resulted in the loss of E3 from the core structure (Lawson 
et a l., 1991). Similarly, protease arg C treatment of protein X  in bovine heart PDC 
resulted in cleavage of a site at, or very close to, the boundary of the putative E3 
binding domain causing the dissociation of E3 from the core complex (Neagle and 
Lindsay, 1991). The possibility that the N-terminal region of E l was involved with 
binding E3 to the core was investigated in view of the sequence similarity between it 
and protein X  from bovine heart PDC.
Evidence presented in this chapter has dealt primarily with effects induced by 
specific degradation of E l of OGDC on the affinity of E3 for the core complex. It was 
shown that when E l was degraded extensively using protease arg C the vast majority 
of E3 was released from the core. This result gave rise to the idea that a particular 
region within E l may have been involved in promoting the binding of E3 to the core 
structure. Specific tryptic degradation of E l to produce E l1, as a result of N-terminal 
cleavage of E l, also had the net effect of causing E3 to show reduced affinity for 
OGDC. It was also observed that as the amount of E l converted to E l1 increased, so 
the extent of E3 release increased until eventually the E2 core itself began to show 
signs of proteolysis. It should be noted that both of these results which showed E3 to
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be released from the core as a consequence of E l degradation, were distinct from the 
small amount of non-specific E3 release which was commonly observed during these 
experiments. This represents E3 which is loosely associated with the core and was 
observed even when intact control OGDC was subjected to gel filtration on either 
Superose or Sephacryl gel matrices. In addition to examining dissociation of E3 from 
the complex, consideration was also given to the fate of E l itself and its possible mode 
of association with the other enzyme subunits after its conversion to E l1. Several 
possibilities were considered regarding the nature of the interaction between E l and the 
other subunits of the complex; for example, the E l1 species may be released on its own 
as a distinct polypeptide species, undergo associations with the E3 enzyme such that a 
stable El*/E3 subspecies is released from the complex, or it may remain associated 
with the core after tryptic degradation.
As shown in Fig. 4.9, E l tryptic degraded OGDC (50% of OGDC activity 
remaining), was subjected to gel filtration on a Sephacryl S300 column during which 
E l and E3 enzyme activities were resolved. The peaks of E l and E3 activity which 
eluted near the void volume, represented enzyme which was still associated with the 
core even after tryptic digestion. In addition, two further peaks of E l and E3 activity 
representing enzyme which had become dissociated from the core were detected at later 
elution volumes. It would appear that on tryptic digestion the E l1 species shows a 
marked tendency to dissociate from the complex, as when untreated OGDC was 
resolved on the same column under identical conditions, E l activity co-eluted with 
overall complex activity at the void volume. If  E l1 and E3 are not released from the 
complex as separate polypeptides following tryptic digestion, it may be postulated that 
they undergo some form of association with each other. The peak of E3 activity 
detected at later elution volumes representing enzyme which has become dissociated 
from the core did not co-elute with El* enzyme activity. This suggests that E l1 and E3 
do not associate specifically with each other. However, the fact that these polypeptide 
species separated from each other during gel filtration does not rule out the possibility 
of an interaction between them as any existing association may be so weak as not to be
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able to withstand passage down the length of the column. If  a direct El*/E3 interaction 
is occurring within OGDC a similar situation may exist to that seen with icosahedral 
forms of PDC; in the complexes isolated from B. stearothermophilus (Packman et al., 
1988) or A. vinelandii (Hanemaaijer et al., 1987), selective cleavage of the E3 binding 
domain results in the simultaneous release of E l and E3 which both bind to the E2 
subunit at or near the same site. This differs from the situation as it exists for OGDC 
and PDC isolated from E. coli where separate regions on E2 have been proposed for 
binding of the E l and E3 subunits (Packman and Perham, 1986).
E3 binding domains are small folded domains of approx. 50 amino acids in 
length, involved with binding E3 to the E2 core, where limited proteolysis conditions 
used to remove this domain from the core also results in the release of E3 (Perham, 
1991). Recent cloning and sequence analysis of rat heart E2 from OGDC has shown 
that the sequence motif for the putative E1/E3 binding site is absent from this subunit 
(Nakano et al., 1991); the isolated cDNA clones showing considerable sequence 
similarity to the E2 subunits of OGDC from E. coli and A. vinelandii except in the 
region of the E1/E3 binding site. This region appeared to have been replaced with an 
unusual sequence motif which has not been detected to date in any of the other 
acyltransferases. I f  the E3 binding domain is not present on the E2 subunit of this 
complex, this raises the question as to the possible location of the E3 binding site in 
this complex. The possible existence and location of a putative E3 binding domain on 
E l of OGDC is considered more fully in the final discussion chapter. Protein X  of 
PDC and E l of OGDC appear to be involved in assisting with binding E3 to the core 
complex, where removal of the putative E3 binding domain from protein X  and the 
N-terminal region of the OGDC E l enzyme, both result in dissociation of E3 from the 
E2 core. If  this is the case, it would appear that in OGDC, a gene shuffling event has 
occurred such that structural elements involved in E3 binding are located on E l of 
OGDC.
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CHAPTER FIVE
FUNCTIONAL PROPERTIES OF THE MODIFIED  
E l ENZYME OF OGDC
5.1 INTRODUCTION
The E l enzyme of bovine heart OGDC is now known not to possess a lipoyl 
domain at its N-terminus. In the absence of an obvious catalytic function for this 
region, much consideration in this thesis has been given to the structural properties of 
E l; for example, it has been proposed that this component performs an integral role in 
assisting with the binding of E3 to the core complex.
The puipose of this chapter was to give closer consideration to any additional 
functions that E l may perform on account of its close interaction with E3. In this 
regard, it has been proposed for PDC that protein X  performs a role in shielding the 
active site of E3 (J. Neagle, unpublished results). In the light of this result, a similar 
role for E l of OGDC was considered. Unfolding studies with the denaturant 
guanidinium hydrochloride (GdnHCl) on the intact E l and tryptic derived E l1 enzymes 
were also performed to assess the importance of the E l N-terminal in maintaining E l 
stability and assembly. Also, since E l is functionally important within the complex 
being responsible for catalysing the rate-limiting reaction of the complex which is Ca2+ 
ion dependent, the effect of E l tryptic degradation with regard to the Ca2+ ion 
sensitivity of the complex was also examined.
5.2 RESULTS
5.2.1 EFFECT OF HIGH IONIC STRENGTH ON OGDC ACTIVITY
When PDC is subjected to conditions of high ionic strength causing release of E l 
and E3 from the core complex, no effect on overall complex activity is observed. This 
suggests that although the affinity of these enzymes for the core complex has been 
lowered, intimate interactions must still be capable of occurring between them so 
allowing the catalytic cycle to continue (Kresze and Steber, 1979). Careful treatment of 
PDC with protease arg C results in selective degradation of the protein X  subunit, a
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Fig. 5.1 Effect of high salt concentrations on overall complex activity of tryptic 
digested OGDC
OGDC was diluted in 0.2mM TPP/2mM MgCl2/3mM NAD+/50mM potassium 
phosphate buffer pH 7.6. Enzyme was digested with 0.01%(w/w) trypsin at 30°C 
for 0 min, 5 min, 10 min and 20 min, at which times aliquots were removed and 
digestion inhibited by the addition of soya bean trypsin inhibitor (xlO). Samples 
(lOOjig) from each time point were then incubated with varying concentrations of 
NaCl at room temperature for 15 min, after which a sample of the enzyme was 
removed and assayed for OGDC enzyme activity as described in the Methods. All 
values shown represent the mean values of triplicate assays. For each time point of 
tryptic degradation, the 100% values were calculated from the residual activity 
remaining after digestion had gone to completion.
Untreated control OGDC (o o), OGDC treated with trypsin for 5 min (a -  -  -A),
10 min ( • ------ •) and 20 min ( A  A) respectively.
oo
CVJ
OID
OO
OCJOo
CDOCDOO
AiiAipV QwAzug %
[N
aC
I] 
(M
)
consequence of which is the reduced affinity of E3 for the core. If  PDC is subjected to 
high ionic strength after protease arg C treatment, a significant decrease in overall 
activity is observed; this can be explained by the affinity of E3 for the core being 
lowered further, such that overall complex activity becomes more susceptible to the 
presence of high concentrations of salt (Neagle and Lindsay, 1991).
In common with PDC, treatment of intact OGDC with high concentrations of salt 
has negligible effects on overall complex activity; the specific degradation of OGDC E l 
component resulting in formation of the E l/E l1 subspecies, which causes E3 to be 
released from the core, was examined to determine if the complex showed an increase 
in its sensitivity to salt as a result of such treatment. Fig. 5.1 shows the results of 
exposing E l trypsin degraded OGDC to conditions of high ionic strength; when intact 
OGDC is treated with increasingly higher salt concentrations, a small decrease in 
overall complex activity from 100% to approx. 80% was observed only at the highest 
salt concentrations. In contrast, OGDC incubated with trypsin causing E l to be 
specifically degraded, resulted in the complex showing an increased sensitivity in 
conditions of high ionic strength; the residual enzyme activity remaining after tryptic 
digestion was 100%, 51%, 24% and 6% for the time points 0 min, 5 min, 10 min and 
20 min respectively. For each time point of tryptic degradation, the 100% value in the 
absence of salt was taken with respect to the residual enzyme activity remaining after 
tryptic digestion had gone to completion; this allowed for comparison of the salt 
sensitivity of the complex which had been degraded to varying extents. Decreases in 
the overall complex activity could not be directly attributed to the degradation of E2 or 
E3 as determined by SDS/polyacrylamide gel electrophoresis (not shown).
5.2.2 EFFECT OF HIGH IONIC STRENGTH ON INHIBITION OF E3 ACTIVITY
In the presence of either pyruvate or NADH, the maleimides represent a class of 
compounds capable of inhibiting the 2-oxoacid dehydrogenase complexes. They do so 
by interacting specifically with free thiol groups present on the E2 dihydrolipoamide
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groups, generated as part of the essential catalytic process of the complex. For
example, treatment of PDC with N-ethyl[2,3-14C]maleimide results in radiolabel being
incorporated into both the E2 and protein X subunits (Hodgson et al., 1986).
Treatment of PDC with protease arg C or high concentrations of salt, promotes 
dissociation of E l and E3 from the core, allowing N-ethyl[2,3-14C]maleimide to 
modify the E3 enzyme of the complex in an NADH dependent manner (J. Neagle, 
unpublished results). It was postulated from such analyses that on dissociation of E3 
from the PDC, the active site redox-active disulphide bridge was unmasked, and in the 
presence of NADH was rendered susceptible to modification by N-ethylmaleimide.
To determine if a similar situation existed for OGDC, the complex was treated in 
conditions known to cause E3 dissociation from the complex, to establish if the active 
site of E3 was capable of being modified in an NADH dependent manner by thiol group 
specific compounds. Since NADH is an end product of the OGDC reaction sequence, 
it is responsible for product inhibition of the complex; it was necessary to establish 
conditions to determine the level of NADH which when added to the complex would 
not affect E3 activity. In early experiments, addition of NADH at concentrations 
between 50pM-0.5mM effected decreases in E3 activity of approx. 50-90% (not 
shown). Removal of NADH by centrifugal gel elution as described by Penefsky 
(1977), resulted in 95% recovery of activity in the elutant. Despite the obvious 
advantages of this method, it proved to be impractical for the purposes of the 
experiment on account of the number of samples which could easily be processed. It 
had been reported in the literature that preparations of NADH invariably seemed to 
contain impurities, some of which inhibited dehydrogenase activity (Fawcett et al., 
1961); it appears that NADH is unstable and forms a large variety of degradation 
products either under acidic conditions or on prolonged exposure to phosphate buffers 
at pH 7.6. The formation of certain enzyme inhibitors have also been reported to form 
in frozen solutions and even damp powder (Margolis et al., 1976). Close inspection of 
NADH used at the start of this study suggested that it had undergone considerable
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Fig. 5.2 Effect of N-ethylmaleimide on E3 enzyme activity in the intact and salt
treated complex
OGDC was diluted in 50mM potassium phosphate buffer, pH 7.6, to a final 
concentration of 1 mg/ml. Complex was then treated as follows: NADH was added to 
samples at final concentration of 0.5mM for 10 min prior to the addition of 
N-ethylmaleimide, which was also present at a final concentration of 0.5mM. In all 
cases, 20mM mercaptoethanol was added 10 mins prior to assaying enzyme activity.
In cases wherert was necessary to incubate OGDC in conditions of high ionic 
strength, the complex was incubated with 0.25M MgCl2  for lh at 4°C and further 
additions made similar to those outlined above. Unless otherwise indicated, values 
shown represent the enzyme activity of the samples after 2h.
Results shown represent the mean value of triplicate assays.
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Fig. 5.3 Effect of p-aminophenyldichloroarsine on E3 enzyme activity in the intact
and salt treated complex
OGDC was diluted in 50mM potassium phosphate buffer, pH 7.6, to a final 
concentration of 1 mg/ml. NADH was added to samples at a final concentration of 
0.5mM for 10 min prior to addition of 0.5mM p-Aminophenyldichloroarsine (termed 
inhibitor in the figureXln cases where it was necessary to subject the complex to high 
ionic strength, OGDC was incubated with 0.25M MgCl2  for lh at 4°C and then 
treated in a similar manner to that described above.
Unless otherwise indicated, values shown represent the enzyme activity of the 
samples after 2h.
Results shown represent the mean value of triplicate assays.
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Fig. 5.4 Effect of glutathione on E3 enzyme activity in the intact and salt treated
complex
OGDC was diluted in 50mM potassium phosphate buffer, pH 7.6, to a final 
concentration of lmg/ml. NADH was added to samples at a final concentration of 
0.5mM for 10 min prior to the addition of 0.5mM glutathione.In cases where it was 
necessary to subject the complex to high ionic stength, OGDC was incubated with 
0.25M MgCl2  for lh at 4°C and then treated in a similar manner to that outlined 
above.
Uless otherwise indicated, values shown represent the enzyme activity of the samples 
after 2h.
Results shown represent the mean value of triplicate assays.

degradation; therefore in subsequent experiments undegraded NADH was prepared just 
prior to use in Tris-HCl, pH 7.2 and was never stored for use in later experiments.
In the studies which follow, OGDC was treated with conditions of high ionic 
strength, known to cause E3 to dissociate from the core, while not affecting overall 
complex activity. Using the appropriate controls, several different thiol group specific 
reagents were incubated with the salt treated complex in conjunction with NADH to 
determine if  E3 activity was affected by such compounds. Fig. 5.2 shows the effect of 
N-ethylmaleimide both on untreated complex and OGDC dissociated with 0.25M 
MgCl2 ; when the intact complex was treated with N-ethylmaleimide only, or NADH in 
the presence of N-ethylmaleimide, there was no appreciable effect on E3 activity even 
after 2h. It would appear that E3 is not susceptible to inactivation by 
N-ethylmaleimide in the native (intact) complex. In contrast, treatment of OGDC with 
high concentrations of salt appeared to cause E3 inhibition by N-ethylmaleimide in a 
time dependent manner. Fig. 5.2 shows that E3 activity, in the dissociated complex, 
was inhibited to 70% of its original activity after lh incubation with N-ethylmaleimide 
in the presence of NADH. Further decreases in E3 activity were observed at later time 
intervals.
p-aminophenyldichloroarsine (H2 NPI1ASCI2 ), is an arsenical compound which 
exhibits a strong affinity for dithiols with a redox-active disulphide pair and has been 
shown to be capable of chemically modifying the E3 enzyme at its active site (Danson 
et a l,  1987). Fig. 5.3 shows the result of treating OGDC with this compound (termed 
inhibitor in the legend). When added to the intact complex in the absence of NADH  
there is no observable effect on E3 activity; however, in contrast to the previous result 
obtained with N-ethylmaleimide, addition of the arsenical compound in conjunction 
with NADH resulted in a significant decrease to approx. 50% of the original activity. 
Treatment of OGDC with high salt concentrations to cause dissociation of the complex 
resulted in further inhibitions of E3 activity to approx. 15% of the original activity after 
2h. The final experiment performed in this section illustrates the effect of glutathione, 
(oxidised and reduced forms), on E3 activity. From Fig. 5.4, it is apparent that within
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Fig. 5.5 Proteolytic degradation of OGDC and the effect of 
N-ethylmaleimide on E3 enzyme activity
OGDC was diluted with 50mM potassium phosphate buffer, pH 7.6, to a final 
concentration of 1 mg/ml. Enzyme was then subjected to proteolytic degradation as 
follows:
Panel A - OGDC was digested with 0.01%(w/w) trypsin for 3 min at 30°C, after 
which soya bean trypsin inhibitor (xlO) was added.
Panel B- OGDC was digested with 9%(w/w) protease arg C for lh at 30°C; 
protease arg C was added in 3%(w/w) aliquots at times 0 min, 20 min and 40 min 
respectively. Digestion was inhibited after lh by the addition of benzamidine to a 
final concentration of ImM.
After digestion, aliquots of enzyme were removed from the initial digest and treated
as follows: NADH added to a final concentration of 0.5mM (A A),
N-ethylmaleimide added to a final concentration of 0.5mM (□----- o), NADH and
N-ethylmaleimide both present at concentrations of 0.5mM (•  •) where NADH
was added 10 min prior to the addition of N-ethylmaleimide. 20mM mercaptoethanol 
was added to all samples 10 min prior to assaying enzyme activity. In addition to the 
above samples, a control sample representing untreated OGDC was assayed
throughout the duration of the experiment (o o). E3 activity was measured as
described in the Methods.
All values shown represent the mean value of triplicate assays.
% 
E3 
ac
ti
vi
ty
| (A)
100
12010080
(B)
-o100
1201008060
Time (min)
the limits of experimental error, glutathione has no significant effect on E3 activity, 
either in the intact or dissociated complex.
It has been shown that treatment of OGDC with conditions of high ionic strength 
has a negligible effect on overall complex activity, demonstrating that under such 
conditions the dissociated subunits of the complex are still able to associate with each 
other. From the experiments performed above, it is apparent that the redox-active 
disulphide group forming the active site of E3 can be inhibited by N-ethylmaleimide in 
an NADH dependent manner, but only when the complex has been salt treated. This 
result implies that when E3 becomes dissociated from the E2 core the active site of E3 
which is normally shielded in the native complex, is unmasked and becomes 
susceptible to inhibition by N-ethylmaleimide.
Further analyses were performed to determine if specific degradation of E l was 
capable of exposing the active site of E3, causing it to become susceptible to inhibition 
by N-ethylmaleimide in an NADH dependent manner, If  E l and E3 associate with each 
other in the native complex as suggested by earlier experiments, degradation of E l, in 
addition to promoting E3 dissociation from the core assembly, may also expose the E3 
active site so allowing it to be modified by thiol group specific reagents. As shown in 
Fig. 5.5, OGDC was treated with either 0.01%(w/w) trypsin or 9%(w/w) protease arg 
C, these levels of protease known to degrade E l specifically; after such treatment, the 
E l degraded complex was incubated with N-ethylmaleimide in the presence of NADH  
and the E3 activity was measured. Panel A shows the results obtained for tryptic 
digestion; initially, after a small decrease in E3 activity within 20 min, the enzyme 
activity remained unchanged for the remainder of the experiment suggesting that 
N-terminal cleavage of E l was not sufficient to unmask the E3 active site. However, in 
the case of protease arg C (panel B), in the presence of both N-ethylmaleimide and 
NADH a decrease in E3 activity was observed throughout the time course of the 
experiment, such that approx. 50% inhibition of E3 activity was achieved within 2h. 
The cause of this steady decrease is unclear as it cannot be attributed to an increase in 
the inhibitory actions of either NADH or N-ethylmaleimide during the course of the
9 0
experiment, as they were seen to have no effect on the E3 activity of the control 
samples. Thus, treatment of OGDC with protease arg C but not trypsin, appears to 
render the E3 enzyme more susceptible to inhibition by N-ethylmaleimide but only in an 
NADH dependent manner. It may be postulated therefore, that E l protects the active 
site redox-active disulphide pair of E3 from the NADH dependent inhibition caused by 
N-ethylmaleimide. However, this experiment does not allow for the exact region of E l 
responsible for such protection of the E3 active site to be directly determined.
5.2.3 EFFECT OF GUANIDINIUM HYDROCHLORIDE TREATMENT ON El ACTIVITY 
OF OGDC
The effect of cleaving OGDC E l specifically with trypsin was investigated with 
respect to the subsequent re-folding of the enzyme after denaturation with GdnHCl. 
This was performed to determine if trypsin cleavage of E l caused significant changes in 
the susceptibility of the denatured enzyme to re-fold and regain its native conformation 
after GdnHCl treatment.
The native conformational states of proteins can usually be reversibly unfolded by the 
addition of denaturants such as GdnHCl to the purified protein in solution. Multi­
domain proteins usually unfold stepwise, with the domains either unfolding 
individually (Privalov, 1982) or with varying degrees of interaction existing between 
them (Brandts et a l ,  1989). Many purified proteins can spontaneously refold in vitro 
after being completely unfolded, so the final three dimensional structure must be 
determined to a large extent by the primary structure. However, not all aspects of the 
primary structure are required for folding as experiments with proteins whose 
N-terminal sequences were altered from linear to circularised orientations, were shown 
to fold at nearly normal rates to the same folded conformation (Goldenberg and 
Creighton, 1983; Luger et al., 1989). From such experiments the conclusion was 
drawn that the termini of neither the original nor the altered primary structures were 
crucial, so folding need not proceed from the N-terminus of the polypeptide chain.
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Fig. 5.6 Effect of guanidinium hydrochloride treatment on the El enzyme activity of
OGDC
Intact OGDC was diluted with 50mM potassium phosphate buffer, pH 7.6, and then 
incubated at 4°C for 15 min with the appropriate concentration of guanidinium 
hydrochloride (GdnHCl). For tryptic degradation, OGDC was incubated with 
0.01%(w/w) trypsin for 5 min after which soya bean trypsin inhibitor (xlO) was 
added.
Panel A- intact and tryptic degraded OGDC were incubated at 4°C for 15 min with 
differing concentrations of GdnHCl. Prior to assay, the enzyme was diluted approx. 
30 fold in assay mix containing the same concentration of GdnHCl as was present in 
the initial incubation mix. After 2 min at 30°C, E l activity was assayed as described 
in the Methods.
Panel B- intact and tryptic degraded OGDC were incubated at 4°C for 15 min with 
varying concentrations of GdnHCl. Prior to assay, the enzyme was diluted approx. 
30 fold in assay mix which contained no additional GdnHCl. After 2 min at 30°C,
E l activity was assayed as described in the Methods.
E l activity measured for the intact complex ( • ------ •), E l activity measured for the
tryptic degraded E l1 complex (A A ).
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When OGDC is incubated with GdnHCl, total complex activity is progressively 
lost on incubation of the complex with increasing concentrations of denaturant (not 
shown); total recovery of complex activity can be achieved by diluting out GdnHCl, 
up to concentrations of approx. 0.2M, above which 100% activity is no longer regained 
and the degree of reactivation observed diminishes rapidly. In experiments where the 
effect of such denaturation on E l activity was measured, E l activity was found to 
recover much more efficiendy than previously observed for OGDC activity (not 
shown). Fig. 5.6 shows the results of using trypsin to degrade specifically E l and the 
effect that this had on the unfolding of this enzyme. Panel A shows the profile obtained 
when loss of E l enzymic activity was plotted against increasing concentrations of 
GdnHCl, panel B depicting the recovery of E l activity as the concentration of 
denaturant was decreased. From panel A it is apparent that both E l and E l1 species are 
equally sensitive to GdnHCl inactivation, a 50% loss of activity for both species 
occurring in the range 0.2-0.25M of denaturant; examining the effect that removal of 
denaturant had on the recovery of enzyme activity revealed that E l1 recovered much 
less efficiendy than E l, where a 50% recovery of activity was achieved at 1.4M and 
1.0M of denaturant for the E l and E l1 species respectively. It would appear therefore, 
that although E l1 is capable of re-folding, its capacity to do so is significantly 
diminished when compared to the activity displayed by the re-folding of native E l.
This suggests that although the cleaved region is not absolutely required for enzyme 
activity, it has a minor effect on the efficiency of the re-folding of E l.
5.2.4 EFFECT OF TRYPTIC DIGESTION ON THE CALCIUM SENSITIVITY OF OGDC
An increase in the concentration of mitochondrial Ca2+ ions in the range 0.1- 
l.OpM, is known to be a common mechanism for enhancing the rate at which 
respiratory fuels are metabolised in mammalian tissues (McCormack and Denton,
1979). This proposal is based on observations that Ca2+ ion concentrations in this 
range greatly alter the activity of the PDC phosphatase in relation to the associated PDC
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Table 5.1 Effect of tryptic digestion on Ca2+ ion sensitivity of OGDC
OGDC was diluted in 50mM potassium phosphate buffer, pH 7.6, and treated with 
0.01%(w/w) trypsin for 10 min. Digestion was terminated by addition of soya bean 
trypsin inhibitor and placing the sample on ice. The Km values shown were 
calculated by measuring the rates of reaction at varying 2-oxoglutarate concentrations 
and conventional Michaelis-Menten reciprocal plot analysis. E l assays were 
performed as described in the Methods except that 50mM MOPS pH 7.0 buffer was 
used instead. Where Ca2+ ions are present in the buffer, 5mM EGTA/5mM CaCl2 
was added; this corresponds to a free Ca2+ ion concentration of approx. 20-33pM.
Km VALUE FOR 2-0X0GLUTARATE (mM)
INTACT E l
TRYPSIN 
DEGRADED El
+ Ca~+ ions - Ca2+ ions
0.16 0.30
0.15 0.32
kinase. The effects of calcium within the cell are important as many regulatory 
hormones and external stimuli acting upon mammalian cells, are capable of increasing 
the cytoplasmic concentration of this ion (Rutter and Denton, 1989). Ca2+ ions are also 
capable of affecting enzyme activity. For example, NADMsocitrate dehydrogenase 
(Denton et a l., 1978) and OGDC, both representing important sites for regulation of the 
citric acid cycle, are known to be stimulated by increases in intracellular Ca2+ ion 
concentration. Experiments performed with purified OGDC demonstrated that the 
activity of isolated E l is sensitive to the Ca2+ ion concentration (Lawlis and Roche, 
1981b). It was postulated that Ca2+ binding sites located on E l cause an increase in 
overall enzyme activity when occupied (Rutter and Denton, 1989). Analyses were 
performed to determine if  the putative Ca2+ ion binding site thought to be present on 
E l, was located within the N-terminal region of E l which is cleaved as a result of 
tryptic degradation. Since the complete amino acid sequence of this enzyme from a 
mammalian source was unknown at the time of these experiments, the exact location of 
the putative Ca2+ ion binding site was a matter for speculation.
In order to control the free concentration of calcium ions used in this experiment, 
free Ca2+ ions in the form of CaCl2 were not added directly to the assay medium; 
instead EGTA buffers were used (Denton et al., 1978; Portzhel et al., 1964). A stock 
solution containing EGTA and CaCl2 , each present at 150mM, was prepared for use in 
regulating the free ion concentration for the experiment. The use of separate stocks of 
EGTA and CaCl2 was avoided since the release of H+ that accompanies the binding of 
the metal ions to EGTA is minimised. Care was taken in the preparation of the 150mM 
EGTA/150mM CaCl2 stock to ensure that they were both present in equimolar 
proportions; this was achieved by monitoring the release of H+ that occurred on 
addition of CaCl2 to EGTA at pH 7.0. Enzyme measurements were performed in the 
presence of 5mM EGTA/5mM CaCl2 , corresponding to a free Ca2+ ion concentration 
of approx. 20-33pM as described by M cCormack and Denton (1979). The results of 
this experiment are shown in Table 5.1; OGDC was treated with a level of trypsin 
sufficient to specifically degrade E l to the E l1 species. The Km values of the intact and
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trypsin-modified enzymes, were calculated by measuring enzyme activity at varying 
concentrations of substrate and plotting the reciprocals of the velocity of the reaction 
against substrate concentration . This was performed both in the presence and absence 
of Ca2+ ions (conc. approx. 30pM). Results obtained show that similar Km values 
(approx. 0.15-0.16mM), were observed for both the intact and tryptic degraded E l 
enzyme in the presence of Ca2+ ions. In the absence of Ca2+ ions, a two-fold increase 
in the Km value (approx. 0.30-0.32mM) was observed; this was true for both the intact 
and E l1 species.
5.3 D ISCUSSIO N
5.3.1 ROLE OF El IN SHIELDING THE E3 ACTIVE SITE REGION
The experiments in this section were performed to examine more closely the nature 
of the association existing between E l and E3 in the complex, in particular the possible 
involvement of E l in the active site protection of E3.
It has been shown that dissociation of the enzyme subunits from each other using 
above physiological concentrations of salt has no effect on overall activity; the complex 
only becoming inhibited if after salt treatment, it is subjected to gel filtration 
chromatography resulting in the physical separation of the subunits from each other. In 
contrast to the effects of salt treatment alone, if OGDC is degraded specifically with 
trypsin, treatment of the degraded complex with increasing salt concentrations results in 
a corresponding decrease in overall activity. This result implies that as E l is cleaved at 
its N-terminus, the subunits are unable to associate with each other such that the 
complex becomes increasingly inhibited in conditions of high ionic strength.
In the salt treated complex it can be shown that E3 activity is unaffected; however, 
it is possible to inhibit E3 activity by the use of certain thiol group specific compounds 
in the presence of NADH. For example, when OGDC dissociated by treatment with
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MgCl2  was incubated with N-ethylmaleimide in the presence of NADH, a decrease in 
E3 activity was observed. Similarly, the arsenical compound
p-aminophenyldichloroarsine was capable of inhibiting E3 activity in the intact complex 
when NADH was present thus, the E3 active site appears to be directly accessible to 
this reagent. The difference between the results obtained with the arsenical compound 
and N-ethylmaleimide, probably reflects differences in the reactivity and accessibility of 
these reagents with the redox-active disulphide pair, present at the E3 active site.
Treatment of OGDC with concentrations of salt capable of causing dissociation of 
the complex resulted in E3 becoming susceptible to inhibition by N-ethylmaleimide, but 
only in an NADH dependent manner. The manner in which the E3 active site in the 
native complex was protected from N-ethylmaleimide inhibition remains unclear. 
Experiments involving the proteolytic degradation of E l with either trypsin or protease 
arg C, were performed to determine if E l was responsible for protecting the E3 active 
site such that it became susceptible to inhibition in the proteolytically degraded 
complex. Tryptic degradation of OGDC resulted in no NADH dependent inhibition of 
E3 activity in the presence of N-ethylmaleimide. As was shown from earlier gel 
filtration experiments, the E l1 species formed as a result of tryptic digestion showed a 
tendency to dissociate from the complex. It is possible that on tryptic digestion, the E l1 
species remains associated with E3 so that its active site remains inaccessible; this 
result would imply that the N-terminal region of E l is involved directly in shielding the 
E3 active site. In contrast, when El was non-specifically degraded using protease arg 
C, a decrease in E3 activity by N-ethylmaleimide in the presence of NADH was 
apparent. This result suggests that E l and E3 do associate with each other in the 
complex such that the active site of E3 is protected by E l, although this function cannot 
be assigned to a particular region on the E l enzyme. It would appear that protease arg 
C treatment of OGDC has a similar effect to that seen when the complex is treated in 
conditions of high ionic strength , where E3 becomes inhibited by the thiol group 
specific compound N-ethylmaleimide in an NADH dependent manner. This result is 
similar to that observed with PDC, the specific degradation of protein X with protease
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arg C rendering the complex susceptible to inhibition by N-ethylmaleimide in the 
presence of NADH. An explanation as to why the E3 active site needs to be protected 
by either E l of OGDC or protein X  of PDC is lacking. It may represent a means of 
shielding the active site from potentially toxic compounds capable of affecting enzyme 
activity, such as free radicals or peroxides within the cell.
5.3.2 ROLE OF THE N-TERMINAL REGION OF El IN Ca2+ SENSITIVITY OF OGDC
The binding of Ca2+ ions to both OGDC and NAD+ -isocitrate dehydrogenase has 
been examined previously in pig heart (Rutter and Denton, 1989). The stoichiometry 
of binding obtained (3.5+/- 0.07mol/mol complex) was less than expected for a site on 
each of the individual molecules of the complex. Since both E l and E3 are 
homodimers, the results obtained were consistent with a single Ca2+ binding site on 
either of these enzymes. As the reaction catalysed by the E l enzyme is the rate-limiting 
step of the overall reaction sequence catalysed by OGDC (Walsh et a l., 1976), this 
enzyme would be the most logical site at which to regulate complex activity.
Supporting this idea, Lawlis and Roche (1981b) found that E l activity, but not E3 
activity, was sensitive to Ca2+ ions in vitro. Ca2+ ions act to stimulate OGDC activity 
by decreasing the Km of the enzyme for 2-oxoglutarate, the substrate for the rate- 
limiting E l enzyme of the complex. From such experiments, the data obtained 
suggested that Ca2+ ions probably bind to the E l subunits. However, the methodology 
used in these experiments did not allow for E l and E2 to be separated. From the 
results presented earlier in Table 5.1, it is apparent that tryptic degradation of the E l 
enzyme to form E l1 has no significant effect on the ability of the enzyme to be 
stimulated by Ca2+ ions; this appears to suggest that the N-terminal region of E l is 
unlikely to be directly involved with the Ca2+ ion dependent regulation of OGDC 
activity. The Km values as calculated from this experiment show only a 2-fold increase 
when measured in the presence and absence of Ca2+ ions. These results differ in some
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respects from those obtained by M cCormack and Denton (1979), who achieved an 
approx. 4-5 fold activation of pig heart OGDC activity in the presence of Ca2+ ions.
The results obtained here may be explained by the failure to include 5mM EGTA in 
those samples where Ca2+ ions should have been absent. Thus endogenous Ca2+ ions 
in the buffers or tightly-associated with the enzyme itself may not have been totally 
removed. More detailed analysis of these preliminary findings is required in particular, 
as regards the inclusion of chelating agents in those samples where Ca2+ ions should be 
rigorously excluded. However, in spite of the obvious limitatons of this experiment, it 
seems likely that the N-terminal region of the E l enzyme is not directly involved with 
the Ca2+-dependent regulation of OGDC activity.
A feature known to be diagnostic of calcium binding sites in proteins is the EF 
hand structure; this region is composed of a linear sequence of between 30-35 amino 
acids, where the N- and C-terminal helical regions flank a 12 residue Ca2+ binding 
loop. By alignment of the primary sequences of the EF sites from several proteins 
stimulated by Ca2+ ions common features were identified, the most conserved being a 
strong p-tum forming region in the Ca2+ ion binding loop (Gariepy and Hodges,
1983). From analysis of the OGDC El sequence from human foetal liver as deduced 
by Koike et al. (1992), no evidence could be found for the existence of such a Ca2+ ion 
binding region on the bovine heart OGDC E l enzyme.
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CHAPTER SIX 
DISCUSSION
6.1 INTRODUCTION
The 2-oxoacid dehydrogenase multienzyme complexes are responsible for 
catalysing the oxidative decarboxylation of a variety of 2-oxoacids in the cell (Perham, 
1991). They perform a central role in metabolism being responsible for catalysing 
several of the key regulatory reactions in carbohydrate and amino acid metabolism.
These large multimeric structures are composed of three distinct subunits termed E l, E2 
and E3, were the E2 subunits bind to each other forming a large core structure around 
which El and E3 bind non-covalently. It has been shown that PDC isolated from 
eukaryotic sources also contains an additional polypeptide, commonly referred to as 
protein X. The exact functioning of this protein within the complex is still a matter of 
some debate, although it is generally believed to be involved in a structural capacity 
assisting with binding E3 to the core. A major problem in proposing such a role for 
protein X  is that OGDC and BCOADC, which both contain the identical E3 gene product 
to that in PDC, do not possess an analogous protein X  subunit. It would appear 
therefore, that protein X  is the product of a specific gene only in PDC.
Direct protein sequencing of the N-terminal region of E l of bovine heart OGDC, 
revealed surprising sequence similarity with the N-terminal region of both the eukaryotic 
E2 acetyltransferases and the protein X  component of PDC. It is postulated that a 
protein X  like sequence which is present as a distinct subunit in PDC, has become 
incorporated onto one of the integral subunits of OGDC as the result of a gene shuffling 
event.
6.1.1 ROLE OF THE N-TERMINAL REGION OF El IN BOVINE HEART OGDC
Lipoyl domains present at the N-terminal region of the E2 acyltransferases and 
protein X  of PDC, can be removed by proteolysis using specific proteases; the cleaved 
lipoyl peptides have an apparent M r 15,000 as determined by their migration in 
SDS/polyacrylamide gels. When the N-terminal amino acid sequence of E l from bovine
98
heart OGDC was obtained by direct protein sequencing it showed sequence similarities, 
also in the N-terminal region, to both the eukaryotic E2 acetyltransferases and protein X.
The amino acid sequence determined for E l of OGDC possessed a slightly modified 
form of the sequence PSLSPTM, which precedes the highly conserved sequence motif 
containing a lipoylatable lysine residue. It was thought originally that the existence of 
such a sequence at the N-terminus of E l might signify the presence of a lipoyl domain; 
this assumption was based not only on the presence of this sequence at the 
N-terminus, but on its ability to be removed by trypsin similar to lipoyl domains, 
although yielding a smaller peptide of M r approx. 8,000. To determine if this subunit 
possessed a catalytically active lipoyl domain at its N-terminus, OGDC was treated with 
radiolabelled pyruvate, a substrate known for its ability to incorporate [14C] acetyl 
groups into the lipoic acid groups of the E2 acetyltransferases and protein X  subunits of 
PDC. Radiolabelling experiments performed with OGDC revealed no incorporation of 
[14C] groups into El; this suggested that the lipoyl-like sequence present on this subunit 
was not catalytically active. Experiments performed with the radiolabelled substrate 2- 
oxoglutarate, yielded similar results with no incorporation of succinyl groups into E l 
observed. These results were later confirmed when the sequence for OGDC E l from 
human foetal liver was published; inspection of this sequence showed the absence of the 
sequence containing the critical lysine residue.
From examination of the effects of proteolytic degradation on complex activity, it 
appeared that the ‘lipoyl-like’ domain present at the N-terminus of OGDC E l was 
essential for the maintenance of overall activity; cleavage of this region resulted in the 
rapid loss of overall enzyme activity, while El activity remained unaffected. Cleavage 
of El by trypsin to form the El* species is probably a random process resulting initially 
in the formation of El/El* heterodimers; observations that E l cleavage proceeds more 
rapidly in the initial stages of digestion indicate that it may be necessary to produce E l1 
homodimers before the ability of the E l subunits to maintain overall activity is lost. It 
would appear, therefore, that the N-terminal region of E l is involved in maintaining 
overall OGDC activity. In view of the sequence similarity between E l of OGDC and
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protein X  of PDC from bovine heart, the results obtained for OGDC are in contrast to 
those for PDC, where protein X  can be cleaved to remove the lipoyl domains only 
without any significant effect on complex activity.
Although protein X  from eukaryotic PDC contains a lipoyl group which is capable 
of being acetylated, its catalytic role within the complex is unclear. When the protein X  
gene from S. cerevisiae was sequenced (Behai et al., 1989), the clone was found to lack 
the highly conserved acetyltransferase active site sequence motif normally present in the 
C-terminal region. They assumed that protein X, in contrast to the E2 
acetyltransferases, was incapable of catalysing the transfer of acetyl groups between 
S-acetyldihydrolipoamide and CoA. Sequencing of a cDNA clone obtained for the 
C-terminal region of protein X  from bovine heart PDC, conflicted with the results 
obtained for S. cerevisiae; the clone isolated from bovine heart was shown to possess a 
variation on the conserved motif, His-Xaa-Xaa-Xaa-Ser-Gly, which is located near the 
C-terminus and is essential for acetyltransferase activity (J. Neagle, unpublished 
results). It would appear that protein X  of bovine heart PDC, may retain the capacity to 
participate in acetyl transfer reactions within the complex. Since the sequence of the 
S. cerevisiae protein X  clone is distinct from that obtained for the partial clone of protein 
X  from bovine heart, itsuggestSthat the clones may differ from each other in their 
C-terminal regions. Collagenase treatment of PDC preferentially removes the lipoyl 
domains from the N-terminus of E2, while leaving those on protein X  intact 
(Rahmatullah et al., 1989). Treatment of bovine heart PDC with collagenase to cause 
total removal of lipoyl domains from the E2 subunits only, resulted in the complex 
retaining approx. 10-20% of its original overall activity. This demonstrates that in 
addition to the lipoyl domains on E2 interacting with E l, those present on protein X  are 
also capable of interacting with E l so allowing overall complex activity to be maintained. 
In mutagenesis experiments performed by Russell and Guest (1990), substitution of the 
acetyltransferase active site histidine residue of E. coli PDC E2, resulted in a total loss of 
enzymic activity; this result was in direct contrast to Niu et al. (1990), who claimed to be 
able to mutate the corresponding acetyltransferase active site histidine for E2 of
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S. cerevisiae without any resultant loss of activity. This result is puzzling since a high 
degree of sequence conservation has been shown to exist between the E2 enzymes.
6.1.2 ROLE OF THE El N-TERMINAL REGION IN BINDING E3 TO THE CORE COMPLEX
Treatment of PDC with protease arg C resulting in removal of the lipoyl domain 
from the N-terminal region of protein X, causes E3 to show a reduced affinity for the E2 
core structure such that it can be preferentially dissociated (Neagle and Lindsay, 1991). 
Protease arg C degradation of PDC resulted in protein X  forming two polypeptides of 
M r 35,000 and 15,000, reduced E3 binding is apparent after release of the lipoyl domain. 
N-terminal amino acid sequence of this M r 35,000 peptide was obtained and compared 
with the sequences corresponding to the linker regions and E3 binding domains of the 
E2 enzymes from the 2-oxoacid dehydrogenase complexes (S. Sanderson and J.
Neagle, unpublished results). By identifying the site at which protease arg C cleaved, it 
was discovered that the protease cleaves within the linker region at, or very close to, the 
boundary of a putative E3 binding domain present on protein X  of bovine heart PDC. 
Thus, cleavage of protein X  with protease arg C and the subsequent release of E3, may 
reflect the instability of the putative E3 binding domain thought to be present on protein 
X; at longer time intervals of incubation the M r 35,000 species can be seen to be 
degraded further producing a polypeptide M r 30,000; cloning studies of S. cerevisiae 
protein X  (Lawson et al., 1991), revealed the presence of a small domain (approx. M r 
5,000) situated between residues 144-180, which showed distant but related homology 
to the E3 binding domain. Thus, production of the lower M r 30,000 species is most 
probably related to cleavage of the putative E3 binding domain region.
When bovine heart OGDC was treated with trypsin, the proteolytically sensitive El 
enzyme was cleaved at the N-terminus as evidenced by protein sequencing. This 
digestion resulted in production of a peptide approx. M r 8,000 to form a lower M r 
species termed El*. During trypsin treatment of OGDC, the lipoyl domains on E2 were 
removed at a slower rate, the E3 enzyme remaining intact. In contrast to trypsin,
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treatment of OGDC with protease arg C caused extensive degradation of the E l enzyme, 
with both the E2 and E3 remaining undegraded. However, in common with tryptic 
degradation, protease arg C treatment of OGDC effected preferential dissociation of E3 
from the core structure; as in the case of trypsin, the newly formed E l1 species exhibited 
a marked tendency to dissociate from the complex. The proteolytic degradation of E l 
and subsequent dissociation of E3 from OGDC would appear to suggest that an 
interaction between these two enzymes exists within the complex.
Sequence motifs for an E3 binding domain have been located on the E2 subunits of 
the 2-oxoacid dehydrogenase complexes; however, when the E2 enzyme of OGDC was 
sequenced from rat heart by Nakano et al. (1991), no sequence which could be identified 
as representing an E3 binding domain was found to be present. It is possible, that the 
novel sequence which was found instead at the expected location of the E3 binding 
domain, was involved with binding E3. Alternatively, a distinct E3 binding domain may 
exist elsewhere in the complex. A possible location for the E3 binding domain if not on 
E2, may be E l as suggested from results presented earlier in this thesis. As stated 
previously, when OGDC was treated with trypsin and then subjected to gel filtration, in 
addition to E3 dissociation, the E l1 species also showed a marked tendency to dissociate 
from the core. The mode of association between E l1 and E3 after tryptic degradation of 
the complex is subject to speculation; for example, E l1 may be released on its own as 
distinct species or, E l1 and E3 may remain in direct association with each other. The 
latter case is unlikely as both E l1 and E3 were found to elute at distinct volumes on the 
gel filtration profile with M r values corresponding to the free enzymes; this indicates that 
they do not associate with each other, although it is possible that any interaction existing 
between them is very weak so as not to be detectable on gel filtration analysis.
102
6.1 Comparison of the OGDC El enzyme isolated from bovine heart and 
human foetal liver
6 1 G S L A A V A H A Q S L V E A Q P N V D K - L V E D H L A V 89
1 t
G P L ----------------------------V E A Q P N V S S L L V E D D L A V
Amino acid sequence of OGDC El from human foetal liver deduced from the 
nucleotide sequence
Amino acid sequence of OGDC El from bovine heart deduced from direct protein 
sequencing. Protein sequence shown is continuous with gaps inserted for the 
purposes of matching.
6 .1 .3  E V ID E N C E  F O R  A  P U T A T IV E  E 3  B IN D IN G  D O M A IN  O N  E l  O F  B O V IN E  H E A R T  O G D C
Prior to starting this project the complete amino acid sequence of El OGDC from a 
mammalian source was unknown. As a result, many of the experiments presented in 
this thesis were performed before publication of the human foetal liver OGDC El 
sequence (Koike etal., 1992). It is known that the specific cleavage of E l from OGDC 
results in dissociation of E3 from the core; this result is similar to that observed in PDC 
on the specific degradation of protein X , which also results in release of E3 from the 
core complex. Protein X  of S. cerevisiae is thought to contain a small domain of 
approx. M r 5,000 which has been implicated in the binding of E3. It has not proved 
possible to identify a similar subunit binding domain on the protein X  subunit of PDC 
from bovine heart, since cloning of a full length copy of the gene has not as yet been 
achieved. However, it is assumed that protein X  from bovine heart contains a putative 
E3 binding domain on the basis of the results of proteolysis experiments; cleavage of 
protein X  in bovine heart PDC using protease arg C resulting in formation of a 
M r 35,000 species as a result of lipoyl domain cleavage. The cleavage site has been 
identified as occurring at, or near, the boundary of a putative E3 binding domain (S. 
Sanderson, unpublished results). In view of the sequence similarity shared by E l of 
OGDC and protein X  of PDC from S. cerevisiae, the existence of a putative E3 binding 
domain on E l of OGDC was considered.
Comparison of the amino acid sequences for E l from bovine heart and human foetal 
liver OGDC, revealed the presence of the sequence motif PFLSGTS at their N-termini. 
Fig. 6.1 shows the result of further matching between the E l1 species from bovine heart 
with the human E l enzyme; the GPL motif present in the bovine sequence can be 
matched with the human El enzyme at the sequence GSL (residues 61-63). Matching 
the sequences at this position presumes that a deletion of approx. 9 amino acid residues 
has occurred in the bovine sequence; alternatively, insertion of additional residues into 
the human E l enzyme may have occurred instead. This sequence alignment shows that 
a degree of similarity exists between the E l enzyme of OGDC isolated from both human
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Sequence alignment between the El^ species of bovine heart OGDC and protein 
X of PDC from S. cerevisiae
(A)
El' OGDC 
Protein X PDC
(B)
El 1 OGDC 
Protein X PDC
The match shown in panel A is a result of visually matching the 
sequences to each other. The match in panel B was obtained using the 
computer programme SWISSPROT.
1 G P L - V E A Q - P N V S S L L V E D D L A  V21
6 4 G S K D V D V G E P I A Y I A D V D D D L A '86
1:G P L V E A Q P N V S S L L V E D D L A V 21
1 4 4 V S L L L A E N N I S K Q K A L K E  I A  P 164
Fig. 6.3 Sequence alignment between human OGDC El and the E3 binding domain as 
determined from human PDC E2
(A)
Human OGDC El 6 1 G S L A A V A H A Q S L V E A Q P N V D K L V E D H L A  V89
H ! i  M i  I III
Human PDC E2 309 P A T P A G P K G R V F V S P    - - L A K K L A  V351
(B)
bovine ogdc ei • i g p l v e a q p n v s s l l v e d d l a v 21
Panel A shows the alignment when human OGDC El sequence was probed with the E3 
binding domain motif from human PDC E2 (residues 309-351).
Panel B depicts the region of E l1 formed as a result of tryptic 
degradation of bovine heart OGDC El. This region was matched earlier 
to residues 61-89 of human OGDC El (see Fig. 6.1).
and bovine sources. The matching of the bovine heart OGDC E l1 sequence to this 
region of the human sequence corresponds closely to the expected site of tryptic cleavage 
in the bovine heart E l enzyme, since a peptide of approx. M r 8,000 is cleaved from the 
N-terminus of E l to form the E l1 species. The validity of the protein sequence obtained 
for the E l1 species is not in doubt as this particular region of the protein was 
independently sequenced several times.
When the N-terminal region of bovine heart OGDC E l was originally sequenced, 
similarity was observed with the N-terminus of protein X  from S. cerevisiae. It was 
postulated that these protein species were performing similar functions in their respective 
complexes by mediating in an interaction between E3 and the core structure. If  this is 
true, it may be assumed that in addition to similarity at the N-terminus, additional 
regions of internal sequence similarity may also exist between the proteins. Following 
this reasoning, the protein X  sequence from S. cerevisiae was matched with the E l1 
amino acid sequence of bovine heart OGDC E l, the results shown in Fig. 6.2. In panel 
A the match was performed visually in contrast to panel B where a best fit was calculated 
using the computer programme SWISSPROT. It is evident that the region to which the 
El* sequence maps is dependent on the method used for matching; when the alignment 
was performed visually, the two sequences mapped to a region between residues 64-86 
of the protein X  sequence, with the computer alignment matching El* with residues 144- 
164 of protein X.
As discussed earlier, proteolytic degradation of bovine heart OGDC E l by trypsin 
results in the dissociation of E3 from the complex, the lower M r El* species formed as a 
result of digestion showing a marked tendency to dissociate from the core. The 
possibility of the existence of an E3 binding domain on E l of OGDC was investigated 
by computer alignment of the human El OGDC sequence with the human E3 binding 
domain present on the E2 enzyme of mammalian PDC (Thekkumkara et a l., 1989). The 
results of such a search are shown in Fig. 6.3. Panel A shows the results of probing the 
entire length of the human E l OGDC sequence with the human E3 binding domain 
(PDC E2 residues 309-351) using the computer programme SWISSPROT. This search
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results in alignment of the human E3 binding domain with residues 61-89 of the human 
OGDC E l sequence. Although gaps have been inserted into the E3 binding domain 
sequence to allow for alignment, out of 963 residues which comprise the entire length of 
the E l enzyme, this particular region was matched with the E3 binding domain. In Fig.
6.3, panel B shows the E l1 sequence of bovine heart which was aligned in an earlier 
search with residues 61-89 of the human E l sequence (see Fig. 6.1). The finding that 
the E l1 sequence of bovine heart OGDC aligns with the region of human El which 
shares homology with the E3 binding domain, implies that a putative E3 binding domain 
is present on the bovine heart OGDC El enzyme. Thus, E l of bovine heart OGDC has 
been shown to possess sequence similarity to protein X; E l differs from protein X  in 
that it appears to contain a residual form of a lipoyl domain at its N-terminus which is 
non-functional. This is closely followed by a region proposed to be involved with E3 
binding, such that cleavage of E l by trypsin results in release of E3 from the core.
When PDC is treated with protease arg C, the protein X  subunit is degraded within 
the complex resulting in removal of the lipoyl domain from the N-terminus in addition to 
which, E3 dissociates from the complex. Fig. 6.4 shows a computer sequence 
alignment performed with the E3 binding domain from human PDC E2, the bovine heart 
OGDC El enzyme and protein X  from S. cerevisiae.; this alignment shows that the 
human E3 binding domain maps to a region within the S. cerevisiae protein X  subunit, 
which in turn maps to the region of the bovine heart OGDC E l enzyme which has 
previously been postulated to contain an E3 binding domain. The existence of an E3 
binding domain within protein X has been proposed previously by Lawson et al.
(1991). Since protein X  aligns to a region within bovine heart OGDC E l which is 
proposed to be involved in E3 binding, and is strong evidence that these two enzyme species 
are involved in promoting similar structural roles within their respective complexes.
Assuming that both protein X  and the N-terminal region of thejEl enzyme of OGDC 
are involved in promoting an interaction of E3 with the complex, it is possible to theorise 
about how they may interact with the core assembly; PDC is thought to contain six 
homodimers of E3 and between 6-12 mols of protein X, although current estimates put this
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value closer to twelve subunits (S. Sanderson, unpublished results). OGDC contains 
six homodimers each of E l and E3. Since both of the interacting species are present 
within the complex in equimolar amounts, the potential exists for a 1:1 stoichiometric 
interaction between them. Whatever type of association that protein X  and the E l 
enzyme exhibit with the E2 core, treating the complexes with strongly dissociating 
conditions (4M urea) has been shown to be necessary to remove them from the core 
complex (Reed and Willms, 1969). In PDC, the E3 enzyme has been shown to exhibit 
an affinity for the E2 core (Gopalakrishnan et al., 1989), meaning that in addition to 
binding the E3 enzyme, protein X  may also be involved in stabilising low affinity 
interactions of E3 with the core although by what mechanism this occurs is unknown.
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6 .2  F U T U R E  W O R K
Future work would involve the isolation of a full length cDNA clone for the bovine 
heart OGDC E l enzyme; this would allow not only for a direct sequence comparison to 
be made with the human E l enzyme, but also to determine conclusively if an E3 binding 
domain motif was present. In addition, it would be desirable to clone and sequence 
OGDC E2 from other mammalian sources to determine if the E3 binding domain was 
present on this enzyme or, if  it had been replaced by the novel sequence as found in rat 
heart OGDC E2. Once the E3 binding domain had been located within the complex, it 
would then be possible to perform studies where this domain could be deleted and the 
effect on complex stability investigated; for example, the mode of association between 
E3 and E l within the complex could be studied in particular, to determine if the truncated 
E l1 species and E3 enzyme associated intimately with each other or were present as 
distinct species on their release from the complex.
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